# num of genes	num of total genes	Log of odds ratio	P-value	Adjusted p-value	GO term ID	GO term name	GO type
2	2	5.31868361267	-	6.26e-04	GO:0098868	bone growth	BP
2	2	5.31868361267	-	6.26e-04	GO:0090218	positive regulation of lipid kinase activity	BP
2	2	5.31868361267	-	6.26e-04	GO:0032615	interleukin-12 production	BP
2	2	5.31868361267	-	6.26e-04	GO:0005986	sucrose biosynthetic process	BP
2	2	5.31868361267	-	6.26e-04	GO:0038188	cholecystokinin signaling pathway	BP
2	2	5.31868361267	-	6.26e-04	GO:0032878	regulation of establishment or maintenance of cell polarity	BP
2	2	5.31868361267	-	6.26e-04	GO:0002752	cell surface pattern recognition receptor signaling pathway	BP
1	1	5.31868361267	-	2.51e-02	GO:2000646	positive regulation of receptor catabolic process	BP
1	1	5.31868361267	-	2.51e-02	GO:0086055	Purkinje myocyte to ventricular cardiac muscle cell communication by electrical coupling	BP
1	1	5.31868361267	-	2.51e-02	GO:0086054	bundle of His cell to Purkinje myocyte communication by electrical coupling	BP
1	1	5.31868361267	-	2.51e-02	GO:0003174	mitral valve development	BP
1	1	5.31868361267	-	2.51e-02	GO:0061582	intestinal epithelial cell migration	BP
1	1	5.31868361267	-	2.51e-02	GO:0098906	regulation of Purkinje myocyte action potential	BP
1	1	5.31868361267	-	2.51e-02	GO:0003284	septum primum development	BP
1	1	5.31868361267	-	2.51e-02	GO:0032361	pyridoxal phosphate catabolic process	BP
1	1	5.31868361267	-	2.51e-02	GO:1904206	positive regulation of skeletal muscle hypertrophy	BP
1	1	5.31868361267	-	2.51e-02	GO:0010021	amylopectin biosynthetic process	BP
1	1	5.31868361267	-	2.51e-02	GO:0032773	positive regulation of monophenol monooxygenase activity	BP
1	1	5.31868361267	-	2.51e-02	GO:0043610	regulation of carbohydrate utilization	BP
1	1	5.31868361267	-	2.51e-02	GO:1904075	positive regulation of trophectodermal cell proliferation	BP
1	1	5.31868361267	-	2.51e-02	GO:1905313	transforming growth factor beta receptor signaling pathway involved in heart development	BP
1	1	5.31868361267	-	2.51e-02	GO:0002840	regulation of T cell mediated immune response to tumor cell	BP
1	1	5.31868361267	-	2.51e-02	GO:0035711	T-helper 1 cell activation	BP
1	1	5.31868361267	-	2.51e-02	GO:2000486	negative regulation of glutamine transport	BP
1	1	5.31868361267	-	2.51e-02	GO:0043371	negative regulation of CD4-positive, alpha-beta T cell differentiation	BP
1	1	5.31868361267	-	2.51e-02	GO:0042774	plasma membrane ATP synthesis coupled electron transport	BP
1	1	5.31868361267	-	2.51e-02	GO:0032072	regulation of restriction endodeoxyribonuclease activity	BP
1	1	5.31868361267	-	2.51e-02	GO:0000097	sulfur amino acid biosynthetic process	BP
1	1	5.31868361267	-	2.51e-02	GO:0033028	myeloid cell apoptotic process	BP
1	1	5.31868361267	-	2.51e-02	GO:0006055	CMP-N-acetylneuraminate biosynthetic process	BP
1	1	5.31868361267	-	2.51e-02	GO:1990774	tumor necrosis factor secretion	BP
1	1	5.31868361267	-	2.51e-02	GO:1901666	positive regulation of NAD+ ADP-ribosyltransferase activity	BP
1	1	5.31868361267	-	2.51e-02	GO:1900133	regulation of renin secretion into blood stream	BP
1	1	5.31868361267	-	2.51e-02	GO:1904651	positive regulation of fat cell apoptotic process	BP
1	1	5.31868361267	-	2.51e-02	GO:0002460	adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains	BP
1	1	5.31868361267	-	2.51e-02	GO:0051796	negative regulation of timing of catagen	BP
1	1	5.31868361267	-	2.51e-02	GO:0060709	glycogen cell differentiation involved in embryonic placenta development	BP
1	1	5.31868361267	-	2.51e-02	GO:0036399	TCR signalosome assembly	BP
1	1	5.31868361267	-	2.51e-02	GO:1905045	negative regulation of Schwann cell proliferation involved in axon regeneration	BP
1	1	5.31868361267	-	2.51e-02	GO:2000655	negative regulation of cellular response to testosterone stimulus	BP
1	1	5.31868361267	-	2.51e-02	GO:0014896	muscle hypertrophy	BP
1	1	5.31868361267	-	2.51e-02	GO:0032667	regulation of interleukin-23 production	BP
1	1	5.31868361267	-	2.51e-02	GO:1990402	embryonic liver development	BP
1	1	5.31868361267	-	2.51e-02	GO:0010533	regulation of activation of Janus kinase activity	BP
1	1	5.31868361267	-	2.51e-02	GO:1903755	positive regulation of SUMO transferase activity	BP
1	1	5.31868361267	-	2.51e-02	GO:1903911	positive regulation of receptor clustering	BP
1	1	5.31868361267	-	2.51e-02	GO:0032814	regulation of natural killer cell activation	BP
1	1	5.31868361267	-	2.51e-02	GO:1990029	vasomotion	BP
1	1	5.31868361267	-	2.51e-02	GO:1904213	negative regulation of iodide transmembrane transport	BP
1	1	5.31868361267	-	2.51e-02	GO:0060283	negative regulation of oocyte development	BP
1	1	5.31868361267	-	2.51e-02	GO:2000753	positive regulation of glucosylceramide catabolic process	BP
1	1	5.31868361267	-	2.51e-02	GO:2000755	positive regulation of sphingomyelin catabolic process	BP
1	1	5.31868361267	-	2.51e-02	GO:0048611	embryonic ectodermal digestive tract development	BP
1	1	5.31868361267	-	2.51e-02	GO:0060587	regulation of lipoprotein lipid oxidation	BP
1	1	5.31868361267	-	2.51e-02	GO:0061185	negative regulation of dermatome development	BP
1	1	5.31868361267	-	2.51e-02	GO:1901389	negative regulation of transforming growth factor beta activation	BP
1	1	5.31868361267	-	2.51e-02	GO:0046318	negative regulation of glucosylceramide biosynthetic process	BP
1	1	5.31868361267	-	2.51e-02	GO:0051838	cytolysis by host of symbiont cells	BP
1	1	5.31868361267	-	2.51e-02	GO:1905208	negative regulation of cardiocyte differentiation	BP
1	1	5.31868361267	-	2.51e-02	GO:0090367	negative regulation of mRNA modification	BP
1	1	5.31868361267	-	2.51e-02	GO:2000351	regulation of endothelial cell apoptotic process	BP
1	1	5.31868361267	-	2.51e-02	GO:0003409	optic cup structural organization	BP
1	1	5.31868361267	-	2.51e-02	GO:1900163	positive regulation of phospholipid scramblase activity	BP
1	1	5.31868361267	-	2.51e-02	GO:0009817	defense response to fungus, incompatible interaction	BP
1	1	5.31868361267	-	2.51e-02	GO:1902910	positive regulation of melanosome transport	BP
1	1	5.31868361267	-	2.51e-02	GO:0060901	regulation of hair cycle by canonical Wnt signaling pathway	BP
1	1	5.31868361267	-	2.51e-02	GO:0006343	establishment of chromatin silencing	BP
1	1	5.31868361267	-	2.51e-02	GO:0035409	histone H3-Y41 phosphorylation	BP
1	1	5.31868361267	-	2.51e-02	GO:0072428	signal transduction involved in intra-S DNA damage checkpoint	BP
1	1	5.31868361267	-	2.51e-02	GO:1903926	cellular response to bisphenol A	BP
1	1	5.31868361267	-	2.51e-02	GO:0098968	neurotransmitter receptor transport postsynaptic membrane to endosome	BP
1	1	5.31868361267	-	2.51e-02	GO:1904197	positive regulation of granulosa cell proliferation	BP
1	1	5.31868361267	-	2.51e-02	GO:1904193	negative regulation of cholangiocyte apoptotic process	BP
1	1	5.31868361267	-	2.51e-02	GO:1904056	positive regulation of cholangiocyte proliferation	BP
1	1	5.31868361267	-	2.51e-02	GO:0051463	negative regulation of cortisol secretion	BP
1	1	5.31868361267	-	2.51e-02	GO:1901563	response to camptothecin	BP
1	1	5.31868361267	-	2.51e-02	GO:1901976	regulation of cell cycle checkpoint	BP
1	1	5.31868361267	-	2.51e-02	GO:0003311	pancreatic D cell differentiation	BP
1	1	5.31868361267	-	2.51e-02	GO:1904635	positive regulation of glomerular visceral epithelial cell apoptotic process	BP
1	1	5.31868361267	-	2.51e-02	GO:2001145	negative regulation of phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity	BP
1	1	5.31868361267	-	2.51e-02	GO:0090104	pancreatic epsilon cell differentiation	BP
1	1	5.31868361267	-	2.51e-02	GO:2000118	regulation of sodium-dependent phosphate transport	BP
1	1	5.31868361267	-	2.51e-02	GO:2000119	negative regulation of sodium-dependent phosphate transport	BP
1	1	5.31868361267	-	2.51e-02	GO:2000808	negative regulation of synaptic vesicle clustering	BP
1	1	5.31868361267	-	2.51e-02	GO:0070512	positive regulation of histone H4-K20 methylation	BP
1	1	5.31868361267	-	2.51e-02	GO:0001971	negative regulation of activation of membrane attack complex	BP
1	1	5.31868361267	-	2.51e-02	GO:0002152	bile acid conjugation	BP
1	1	5.31868361267	-	2.51e-02	GO:1901723	negative regulation of cell proliferation involved in kidney development	BP
1	1	5.31868361267	-	2.51e-02	GO:0086044	atrial cardiac muscle cell to AV node cell communication by electrical coupling	BP
1	1	5.31868361267	-	2.51e-02	GO:0071441	negative regulation of histone H3-K14 acetylation	BP
1	1	5.31868361267	-	2.51e-02	GO:1901863	positive regulation of muscle tissue development	BP
1	1	5.31868361267	-	2.51e-02	GO:0003294	atrial ventricular junction remodeling	BP
1	1	5.31868361267	-	2.51e-02	GO:0071873	response to norepinephrine	BP
1	1	5.31868361267	-	2.51e-02	GO:0071250	cellular response to nitrite	BP
1	1	5.31868361267	-	2.51e-02	GO:0060400	negative regulation of growth hormone receptor signaling pathway	BP
1	1	5.31868361267	-	2.51e-02	GO:0100002	negative regulation of protein kinase activity by protein phosphorylation	BP
1	1	5.31868361267	-	2.51e-02	GO:1903632	positive regulation of aminoacyl-tRNA ligase activity	BP
1	1	5.31868361267	-	2.51e-02	GO:0035491	positive regulation of leukotriene production involved in inflammatory response	BP
1	1	5.31868361267	-	2.51e-02	GO:0051531	NFAT protein import into nucleus	BP
1	1	5.31868361267	-	2.51e-02	GO:0048241	epinephrine transport	BP
1	1	5.31868361267	-	2.51e-02	GO:2000184	positive regulation of progesterone biosynthetic process	BP
1	1	5.31868361267	-	2.51e-02	GO:0060751	branch elongation involved in mammary gland duct branching	BP
1	1	5.31868361267	-	2.51e-02	GO:0032535	regulation of cellular component size	BP
1	1	5.31868361267	-	2.51e-02	GO:0071298	cellular response to L-ascorbic acid	BP
1	1	5.31868361267	-	2.51e-02	GO:1901860	positive regulation of mitochondrial DNA metabolic process	BP
1	1	5.31868361267	-	2.51e-02	GO:1900148	negative regulation of Schwann cell migration	BP
1	1	5.31868361267	-	2.51e-02	GO:0009441	glycolate metabolic process	BP
1	1	5.31868361267	-	2.51e-02	GO:0002270	plasmacytoid dendritic cell activation	BP
2	2	5.31868361267	-	6.26e-04	GO:0004951	cholecystokinin receptor activity	MF
2	2	5.31868361267	-	6.26e-04	GO:0047322	[hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity	MF
2	2	5.31868361267	-	6.26e-04	GO:0042132	fructose 1,6-bisphosphate 1-phosphatase activity	MF
2	2	5.31868361267	-	6.26e-04	GO:0050405	[acetyl-CoA carboxylase] kinase activity	MF
1	1	5.31868361267	-	2.51e-02	GO:0001011	transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting	MF
1	1	5.31868361267	-	2.51e-02	GO:0035033	histone deacetylase regulator activity	MF
1	1	5.31868361267	-	2.51e-02	GO:0004508	steroid 17-alpha-monooxygenase activity	MF
1	1	5.31868361267	-	2.51e-02	GO:0052816	long-chain acyl-CoA hydrolase activity	MF
1	1	5.31868361267	-	2.51e-02	GO:0052817	very long chain acyl-CoA hydrolase activity	MF
1	1	5.31868361267	-	2.51e-02	GO:0002135	CTP binding	MF
1	1	5.31868361267	-	2.51e-02	GO:0001087	transcription factor activity, TFIIB-class binding	MF
1	1	5.31868361267	-	2.51e-02	GO:0004900	erythropoietin receptor activity	MF
1	1	5.31868361267	-	2.51e-02	GO:0001626	nociceptin receptor activity	MF
1	1	5.31868361267	-	2.51e-02	GO:0050462	N-acetylneuraminate synthase activity	MF
1	1	5.31868361267	-	2.51e-02	GO:0047444	N-acylneuraminate-9-phosphate synthase activity	MF
1	1	5.31868361267	-	2.51e-02	GO:0047442	17-alpha-hydroxyprogesterone aldolase activity	MF
1	1	5.31868361267	-	2.51e-02	GO:0061656	SUMO conjugating enzyme activity	MF
1	1	5.31868361267	-	2.51e-02	GO:0086079	gap junction channel activity involved in Purkinje myocyte-ventricular cardiac muscle cell electrical coupling	MF
1	1	5.31868361267	-	2.51e-02	GO:0086078	gap junction channel activity involved in bundle of His cell-Purkinje myocyte electrical coupling	MF
1	1	5.31868361267	-	2.51e-02	GO:0086076	gap junction channel activity involved in atrial cardiac muscle cell-AV node cell electrical coupling	MF
1	1	5.31868361267	-	2.51e-02	GO:0035401	histone kinase activity (H3-Y41 specific)	MF
1	1	5.31868361267	-	2.51e-02	GO:0004728	signal transducer, downstream of receptor, with protein tyrosine phosphatase activity	MF
1	1	5.31868361267	-	2.51e-02	GO:0017172	cysteine dioxygenase activity	MF
1	1	5.31868361267	-	2.51e-02	GO:0005009	insulin-activated receptor activity	MF
1	1	5.31868361267	-	2.51e-02	GO:0061609	fructose-1-phosphate aldolase activity	MF
1	1	5.31868361267	-	2.51e-02	GO:0031687	A2A adenosine receptor binding	MF
1	1	5.31868361267	-	2.51e-02	GO:0016430	tRNA (adenine-N6-)-methyltransferase activity	MF
1	1	5.31868361267	-	2.51e-02	GO:0010858	calcium-dependent protein kinase regulator activity	MF
1	1	5.31868361267	-	2.51e-02	GO:0050379	UDP-glucuronate 5'-epimerase activity	MF
1	1	5.31868361267	-	2.51e-02	GO:0031741	type B gastrin/cholecystokinin receptor binding	MF
1	1	5.31868361267	-	2.51e-02	GO:0015054	gastrin receptor activity	MF
1	1	5.31868361267	-	2.51e-02	GO:0038021	leptin receptor activity	MF
1	1	5.31868361267	-	2.51e-02	GO:0047464	heparosan-N-sulfate-glucuronate 5-epimerase activity	MF
1	1	5.31868361267	-	2.51e-02	GO:0047963	glycine N-choloyltransferase activity	MF
6	7	5.09629119133	-	1.62e-09	GO:0004679	AMP-activated protein kinase activity	MF
4	6	4.73372111195	-	5.58e-06	GO:0033210	leptin-mediated signaling pathway	BP
2	3	4.73372111195	-	6.26e-04	GO:0002803	positive regulation of antibacterial peptide production	BP
2	3	4.73372111195	-	1.85e-03	GO:0070141	response to UV-A	BP
2	3	4.73372111195	-	1.85e-03	GO:2000973	regulation of pro-B cell differentiation	BP
2	3	4.73372111195	-	1.85e-03	GO:0021697	cerebellar cortex formation	BP
4	6	4.73372111195	-	1.90e-06	GO:0046935	1-phosphatidylinositol-3-kinase regulator activity	MF
2	3	4.73372111195	-	1.85e-03	GO:0001156	TFIIIC-class transcription factor binding	MF
2	3	4.73372111195	-	1.85e-03	GO:0055100	adiponectin binding	MF
2	3	4.73372111195	-	1.85e-03	GO:0001030	RNA polymerase III type 1 promoter DNA binding	MF
2	3	4.73372111195	-	1.85e-03	GO:0001031	RNA polymerase III type 2 promoter DNA binding	MF
2	3	4.73372111195	-	1.85e-03	GO:0043398	HLH domain binding	MF
7	11	4.66660691609	-	1.77e-09	GO:0043560	insulin receptor substrate binding	MF
3	5	4.5817180185	-	1.50e-04	GO:0090335	regulation of brown fat cell differentiation	BP
3	5	4.5817180185	-	1.50e-04	GO:0030235	nitric-oxide synthase regulator activity	MF
4	7	4.51132869061	-	5.58e-06	GO:0043551	regulation of phosphatidylinositol 3-kinase activity	BP
2	4	4.31868361267	-	1.85e-03	GO:2000757	negative regulation of peptidyl-lysine acetylation	BP
2	4	4.31868361267	-	1.85e-03	GO:1904058	positive regulation of sensory perception of pain	BP
2	4	4.31868361267	-	3.63e-03	GO:0043201	response to leucine	BP
2	4	4.31868361267	-	3.63e-03	GO:0032079	positive regulation of endodeoxyribonuclease activity	BP
2	4	4.31868361267	-	3.63e-03	GO:0006344	maintenance of chromatin silencing	BP
2	4	4.31868361267	-	3.63e-03	GO:0035404	histone-serine phosphorylation	BP
2	4	4.31868361267	-	3.63e-03	GO:0014878	response to electrical stimulus involved in regulation of muscle adaptation	BP
2	4	4.31868361267	-	3.63e-03	GO:0010748	negative regulation of plasma membrane long-chain fatty acid transport	BP
2	4	4.31868361267	-	3.63e-03	GO:0048679	regulation of axon regeneration	BP
2	4	4.31868361267	-	3.63e-03	GO:0021955	central nervous system neuron axonogenesis	BP
1	2	4.31868361267	-	2.51e-02	GO:0070564	positive regulation of vitamin D receptor signaling pathway	BP
1	2	4.31868361267	-	2.51e-02	GO:0044381	glucose import in response to insulin stimulus	BP
1	2	4.31868361267	-	2.51e-02	GO:0051446	positive regulation of meiotic cell cycle	BP
1	2	4.31868361267	-	2.51e-02	GO:0033594	response to hydroxyisoflavone	BP
1	2	4.31868361267	-	2.51e-02	GO:1901857	positive regulation of cellular respiration	BP
1	2	4.31868361267	-	2.51e-02	GO:0021623	oculomotor nerve formation	BP
1	2	4.31868361267	-	2.51e-02	GO:0003050	regulation of systemic arterial blood pressure by atrial natriuretic peptide	BP
1	2	4.31868361267	-	2.51e-02	GO:0002228	natural killer cell mediated immunity	BP
1	2	4.31868361267	-	2.51e-02	GO:0032528	microvillus organization	BP
1	2	4.31868361267	-	2.51e-02	GO:0002769	natural killer cell inhibitory signaling pathway	BP
1	2	4.31868361267	-	2.51e-02	GO:1904639	cellular response to resveratrol	BP
1	2	4.31868361267	-	2.51e-02	GO:0035358	regulation of peroxisome proliferator activated receptor signaling pathway	BP
1	2	4.31868361267	-	2.51e-02	GO:0002720	positive regulation of cytokine production involved in immune response	BP
1	2	4.31868361267	-	2.51e-02	GO:0034165	positive regulation of toll-like receptor 9 signaling pathway	BP
1	2	4.31868361267	-	2.51e-02	GO:0042595	behavioral response to starvation	BP
1	2	4.31868361267	-	2.51e-02	GO:0090276	regulation of peptide hormone secretion	BP
1	2	4.31868361267	-	2.51e-02	GO:1902613	negative regulation of anti-Mullerian hormone signaling pathway	BP
1	2	4.31868361267	-	2.51e-02	GO:0031658	negative regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle	BP
1	2	4.31868361267	-	2.51e-02	GO:0002879	positive regulation of acute inflammatory response to non-antigenic stimulus	BP
1	2	4.31868361267	-	2.51e-02	GO:0010623	programmed cell death involved in cell development	BP
1	2	4.31868361267	-	4.95e-02	GO:1904956	regulation of midbrain dopaminergic neuron differentiation	BP
1	2	4.31868361267	-	4.95e-02	GO:0017055	negative regulation of RNA polymerase II transcriptional preinitiation complex assembly	BP
1	2	4.31868361267	-	4.95e-02	GO:0001776	leukocyte homeostasis	BP
1	2	4.31868361267	-	4.95e-02	GO:1904527	negative regulation of microtubule binding	BP
1	2	4.31868361267	-	4.95e-02	GO:0086053	AV node cell to bundle of His cell communication by electrical coupling	BP
1	2	4.31868361267	-	4.95e-02	GO:0060341	regulation of cellular localization	BP
1	2	4.31868361267	-	4.95e-02	GO:0098905	regulation of bundle of His cell action potential	BP
1	2	4.31868361267	-	4.95e-02	GO:0046732	active induction of host immune response by virus	BP
1	2	4.31868361267	-	4.95e-02	GO:0071417	cellular response to organonitrogen compound	BP
1	2	4.31868361267	-	4.95e-02	GO:0044818	mitotic G2/M transition checkpoint	BP
1	2	4.31868361267	-	4.95e-02	GO:0043331	response to dsRNA	BP
1	2	4.31868361267	-	4.95e-02	GO:0021681	cerebellar granular layer development	BP
1	2	4.31868361267	-	4.95e-02	GO:0060454	positive regulation of gastric acid secretion	BP
1	2	4.31868361267	-	4.95e-02	GO:0032071	regulation of endodeoxyribonuclease activity	BP
1	2	4.31868361267	-	4.95e-02	GO:0045819	positive regulation of glycogen catabolic process	BP
1	2	4.31868361267	-	4.95e-02	GO:0061035	regulation of cartilage development	BP
1	2	4.31868361267	-	4.95e-02	GO:0009785	blue light signaling pathway	BP
1	2	4.31868361267	-	4.95e-02	GO:0010652	positive regulation of cell communication by chemical coupling	BP
1	2	4.31868361267	-	4.95e-02	GO:0060512	prostate gland morphogenesis	BP
1	2	4.31868361267	-	4.95e-02	GO:0032959	inositol trisphosphate biosynthetic process	BP
1	2	4.31868361267	-	4.95e-02	GO:0023035	CD40 signaling pathway	BP
1	2	4.31868361267	-	4.95e-02	GO:0097107	postsynaptic density assembly	BP
1	2	4.31868361267	-	4.95e-02	GO:0086021	SA node cell to atrial cardiac muscle cell communication by electrical coupling	BP
1	2	4.31868361267	-	4.95e-02	GO:0006116	NADH oxidation	BP
1	2	4.31868361267	-	4.95e-02	GO:0032912	negative regulation of transforming growth factor beta2 production	BP
1	2	4.31868361267	-	4.95e-02	GO:0031393	negative regulation of prostaglandin biosynthetic process	BP
1	2	4.31868361267	-	4.95e-02	GO:0045066	regulatory T cell differentiation	BP
1	2	4.31868361267	-	4.95e-02	GO:0034391	regulation of smooth muscle cell apoptotic process	BP
1	2	4.31868361267	-	4.95e-02	GO:0002327	immature B cell differentiation	BP
1	2	4.31868361267	-	4.95e-02	GO:0032425	positive regulation of mismatch repair	BP
1	2	4.31868361267	-	4.95e-02	GO:1901374	acetate ester transport	BP
1	2	4.31868361267	-	4.95e-02	GO:0030862	positive regulation of polarized epithelial cell differentiation	BP
1	2	4.31868361267	-	4.95e-02	GO:0010934	macrophage cytokine production	BP
1	2	4.31868361267	-	4.95e-02	GO:0048069	eye pigmentation	BP
1	2	4.31868361267	-	4.95e-02	GO:0019087	transformation of host cell by virus	BP
1	2	4.31868361267	-	4.95e-02	GO:0033277	abortive mitotic cell cycle	BP
1	2	4.31868361267	-	4.95e-02	GO:0071624	positive regulation of granulocyte chemotaxis	BP
1	2	4.31868361267	-	4.95e-02	GO:0072604	interleukin-6 secretion	BP
1	2	4.31868361267	-	4.95e-02	GO:0090045	positive regulation of deacetylase activity	BP
1	2	4.31868361267	-	4.95e-02	GO:0019049	evasion or tolerance of host defenses by virus	BP
1	2	4.31868361267	-	4.95e-02	GO:1903033	positive regulation of microtubule plus-end binding	BP
1	2	4.31868361267	-	4.95e-02	GO:0021849	neuroblast division in subventricular zone	BP
1	2	4.31868361267	-	4.95e-02	GO:0032817	regulation of natural killer cell proliferation	BP
1	2	4.31868361267	-	4.95e-02	GO:0002673	regulation of acute inflammatory response	BP
1	2	4.31868361267	-	4.95e-02	GO:1901558	response to metformin	BP
1	2	4.31868361267	-	4.95e-02	GO:0003064	regulation of heart rate by hormone	BP
1	2	4.31868361267	-	4.95e-02	GO:1990264	peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity	BP
1	2	4.31868361267	-	4.95e-02	GO:0060032	notochord regression	BP
1	2	4.31868361267	-	4.95e-02	GO:0010643	cell communication by chemical coupling	BP
1	2	4.31868361267	-	4.95e-02	GO:2000041	negative regulation of planar cell polarity pathway involved in axis elongation	BP
1	2	4.31868361267	-	4.95e-02	GO:0032511	late endosome to vacuole transport via multivesicular body sorting pathway	BP
1	2	4.31868361267	-	4.95e-02	GO:0072738	cellular response to diamide	BP
1	2	4.31868361267	-	4.95e-02	GO:0033032	regulation of myeloid cell apoptotic process	BP
1	2	4.31868361267	-	4.95e-02	GO:0032490	detection of molecule of bacterial origin	BP
1	2	4.31868361267	-	4.95e-02	GO:0060502	epithelial cell proliferation involved in lung morphogenesis	BP
1	2	4.31868361267	-	4.95e-02	GO:0051252	regulation of RNA metabolic process	BP
1	2	4.31868361267	-	4.95e-02	GO:0003404	optic vesicle morphogenesis	BP
1	2	4.31868361267	-	4.95e-02	GO:2000620	positive regulation of histone H4-K16 acetylation	BP
1	2	4.31868361267	-	4.95e-02	GO:0003193	pulmonary valve formation	BP
1	2	4.31868361267	-	4.95e-02	GO:0060125	negative regulation of growth hormone secretion	BP
1	2	4.31868361267	-	4.95e-02	GO:0002316	follicular B cell differentiation	BP
1	2	4.31868361267	-	4.95e-02	GO:0090071	negative regulation of ribosome biogenesis	BP
1	2	4.31868361267	-	4.95e-02	GO:0001300	chronological cell aging	BP
1	2	4.31868361267	-	4.95e-02	GO:2000506	negative regulation of energy homeostasis	BP
1	2	4.31868361267	-	4.95e-02	GO:0061153	trachea gland development	BP
1	2	4.31868361267	-	4.95e-02	GO:0021873	forebrain neuroblast division	BP
1	2	4.31868361267	-	4.95e-02	GO:0061302	smooth muscle cell-matrix adhesion	BP
1	2	4.31868361267	-	4.95e-02	GO:0031959	mineralocorticoid receptor signaling pathway	BP
1	2	4.31868361267	-	4.95e-02	GO:2000098	negative regulation of smooth muscle cell-matrix adhesion	BP
1	2	4.31868361267	-	4.95e-02	GO:2000397	positive regulation of ubiquitin-dependent endocytosis	BP
1	2	4.31868361267	-	4.95e-02	GO:0002643	regulation of tolerance induction	BP
1	2	4.31868361267	-	4.95e-02	GO:1990051	activation of protein kinase C activity	BP
1	2	4.31868361267	-	4.95e-02	GO:1904059	regulation of locomotor rhythm	BP
1	2	4.31868361267	-	4.95e-02	GO:0071900	regulation of protein serine/threonine kinase activity	BP
1	2	4.31868361267	-	4.95e-02	GO:2000194	regulation of female gonad development	BP
1	2	4.31868361267	-	4.95e-02	GO:0051548	negative regulation of keratinocyte migration	BP
1	2	4.31868361267	-	4.95e-02	GO:1902728	positive regulation of growth factor dependent skeletal muscle satellite cell proliferation	BP
1	2	4.31868361267	-	4.95e-02	GO:1902722	positive regulation of prolactin secretion	BP
1	2	4.31868361267	-	4.95e-02	GO:2000426	negative regulation of apoptotic cell clearance	BP
1	2	4.31868361267	-	4.95e-02	GO:0035922	foramen ovale closure	BP
1	2	4.31868361267	-	4.95e-02	GO:0060390	regulation of SMAD protein import into nucleus	BP
1	2	4.31868361267	-	4.95e-02	GO:1902202	regulation of hepatocyte growth factor receptor signaling pathway	BP
1	2	4.31868361267	-	4.95e-02	GO:0000720	pyrimidine dimer repair by nucleotide-excision repair	BP
1	2	4.31868361267	-	4.95e-02	GO:0061647	histone H3-K9 modification	BP
1	2	4.31868361267	-	4.95e-02	GO:1902595	regulation of DNA replication origin binding	BP
1	2	4.31868361267	-	4.95e-02	GO:0042412	taurine biosynthetic process	BP
1	2	4.31868361267	-	4.95e-02	GO:0014736	negative regulation of muscle atrophy	BP
1	2	4.31868361267	-	4.95e-02	GO:0050867	positive regulation of cell activation	BP
1	2	4.31868361267	-	4.95e-02	GO:1990619	histone H3-K9 deacetylation	BP
1	2	4.31868361267	-	4.95e-02	GO:1901255	nucleotide-excision repair involved in interstrand cross-link repair	BP
1	2	4.31868361267	-	4.95e-02	GO:1904021	negative regulation of G-protein coupled receptor internalization	BP
1	2	4.31868361267	-	4.95e-02	GO:0043006	activation of phospholipase A2 activity by calcium-mediated signaling	BP
1	2	4.31868361267	-	4.95e-02	GO:0031204	posttranslational protein targeting to membrane, translocation	BP
1	2	4.31868361267	-	4.95e-02	GO:0006525	arginine metabolic process	BP
1	2	4.31868361267	-	4.95e-02	GO:0031247	actin rod assembly	BP
1	2	4.31868361267	-	4.95e-02	GO:0019516	lactate oxidation	BP
1	2	4.31868361267	-	4.95e-02	GO:1905477	positive regulation of protein localization to membrane	BP
1	2	4.31868361267	-	4.95e-02	GO:2000681	negative regulation of rubidium ion transport	BP
1	2	4.31868361267	-	4.95e-02	GO:0006043	glucosamine catabolic process	BP
1	2	4.31868361267	-	4.95e-02	GO:0009631	cold acclimation	BP
1	2	4.31868361267	-	4.95e-02	GO:0032943	mononuclear cell proliferation	BP
1	2	4.31868361267	-	4.95e-02	GO:0097111	endoplasmic reticulum-Golgi intermediate compartment organization	BP
3	6	4.31868361267	-	2.95e-04	GO:0043559	insulin binding	MF
2	4	4.31868361267	-	1.85e-03	GO:0001032	RNA polymerase III type 3 promoter DNA binding	MF
2	4	4.31868361267	-	3.63e-03	GO:0048408	epidermal growth factor binding	MF
2	4	4.31868361267	-	3.63e-03	GO:0043125	ErbB-3 class receptor binding	MF
1	2	4.31868361267	-	2.51e-02	GO:0017098	sulfonylurea receptor binding	MF
1	2	4.31868361267	-	2.51e-02	GO:0002134	UTP binding	MF
1	2	4.31868361267	-	2.51e-02	GO:0016857	racemase and epimerase activity, acting on carbohydrates and derivatives	MF
1	2	4.31868361267	-	2.51e-02	GO:0004458	D-lactate dehydrogenase (cytochrome) activity	MF
1	2	4.31868361267	-	4.95e-02	GO:0010698	acetyltransferase activator activity	MF
1	2	4.31868361267	-	4.95e-02	GO:0030366	molybdopterin synthase activity	MF
1	2	4.31868361267	-	4.95e-02	GO:0030984	kininogen binding	MF
1	2	4.31868361267	-	4.95e-02	GO:0033883	pyridoxal phosphatase activity	MF
1	2	4.31868361267	-	4.95e-02	GO:0051990	(R)-2-hydroxyglutarate dehydrogenase activity	MF
1	2	4.31868361267	-	4.95e-02	GO:0008781	N-acylneuraminate cytidylyltransferase activity	MF
1	2	4.31868361267	-	4.95e-02	GO:0052815	medium-chain acyl-CoA hydrolase activity	MF
1	2	4.31868361267	-	4.95e-02	GO:0016410	N-acyltransferase activity	MF
1	2	4.31868361267	-	4.95e-02	GO:0086020	gap junction channel activity involved in SA node cell-atrial cardiac muscle cell electrical coupling	MF
1	2	4.31868361267	-	4.95e-02	GO:0051717	inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity	MF
1	2	4.31868361267	-	4.95e-02	GO:0008269	JAK pathway signal transduction adaptor activity	MF
1	2	4.31868361267	-	4.95e-02	GO:0004053	arginase activity	MF
1	2	4.31868361267	-	4.95e-02	GO:0030109	HLA-B specific inhibitory MHC class I receptor activity	MF
1	2	4.31868361267	-	4.95e-02	GO:0086075	gap junction channel activity involved in cardiac conduction electrical coupling	MF
1	2	4.31868361267	-	4.95e-02	GO:0086077	gap junction channel activity involved in AV node cell-bundle of His cell electrical coupling	MF
1	2	4.31868361267	-	4.95e-02	GO:0097003	adipokinetic hormone receptor activity	MF
1	2	4.31868361267	-	4.95e-02	GO:0005006	epidermal growth factor-activated receptor activity	MF
1	2	4.31868361267	-	4.95e-02	GO:0035014	phosphatidylinositol 3-kinase regulator activity	MF
1	2	4.31868361267	-	4.95e-02	GO:0010465	nerve growth factor receptor activity	MF
1	2	4.31868361267	-	4.95e-02	GO:0009882	blue light photoreceptor activity	MF
1	2	4.31868361267	-	4.95e-02	GO:0051800	phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity	MF
1	2	4.31868361267	-	4.95e-02	GO:0046969	NAD-dependent histone deacetylase activity (H3-K9 specific)	MF
1	2	4.31868361267	-	4.95e-02	GO:0038062	protein tyrosine kinase collagen receptor activity	MF
1	2	4.31868361267	-	4.95e-02	GO:0008160	protein tyrosine phosphatase activator activity	MF
1	2	4.31868361267	-	4.95e-02	GO:0004342	glucosamine-6-phosphate deaminase activity	MF
4	9	4.14875861123	-	4.42e-05	GO:0042304	regulation of fatty acid biosynthetic process	BP
3	7	4.09629119133	-	5.06e-04	GO:2000210	positive regulation of anoikis	BP
3	7	4.09629119133	-	5.06e-04	GO:0030388	fructose 1,6-bisphosphate metabolic process	BP
6	15	3.99675551778	-	9.80e-07	GO:0031929	TOR signaling	BP
2	5	3.99675551778	-	3.63e-03	GO:0035630	bone mineralization involved in bone maturation	BP
2	5	3.99675551778	-	5.95e-03	GO:0016202	regulation of striated muscle tissue development	BP
2	5	3.99675551778	-	5.95e-03	GO:0045063	T-helper 1 cell differentiation	BP
2	5	3.99675551778	-	5.95e-03	GO:0060762	regulation of branching involved in mammary gland duct morphogenesis	BP
2	5	3.99675551778	-	5.95e-03	GO:0048639	positive regulation of developmental growth	BP
2	5	3.99675551778	-	5.95e-03	GO:0071681	cellular response to indole-3-methanol	BP
4	10	3.99675551778	-	7.22e-05	GO:0045295	gamma-catenin binding	MF
2	5	3.99675551778	-	5.95e-03	GO:0035174	histone serine kinase activity	MF
2	5	3.99675551778	-	5.95e-03	GO:0005131	growth hormone receptor binding	MF
3	8	3.90364611339	-	7.95e-04	GO:1903800	positive regulation of production of miRNAs involved in gene silencing by miRNA	BP
3	8	3.90364611339	-	7.95e-04	GO:0060396	growth hormone receptor signaling pathway	BP
3	8	3.90364611339	-	7.95e-04	GO:0031995	insulin-like growth factor II binding	MF
4	11	3.85925199403	-	1.11e-04	GO:0006853	carnitine shuttle	BP
5	14	3.8332567855	-	6.57e-06	GO:2001275	positive regulation of glucose import in response to insulin stimulus	BP
5	14	3.8332567855	-	1.05e-05	GO:0001678	cellular glucose homeostasis	BP
5	14	3.8332567855	-	1.59e-05	GO:0048009	insulin-like growth factor receptor signaling pathway	BP
7	20	3.80411043984	-	3.42e-07	GO:0043548	phosphatidylinositol 3-kinase binding	MF
4	12	3.73372111195	-	1.11e-04	GO:0031669	cellular response to nutrient levels	BP
3	9	3.73372111195	-	5.06e-04	GO:0010907	positive regulation of glucose metabolic process	BP
3	9	3.73372111195	-	7.95e-04	GO:0045591	positive regulation of regulatory T cell differentiation	BP
3	9	3.73372111195	-	1.17e-03	GO:0006000	fructose metabolic process	BP
2	6	3.73372111195	-	3.63e-03	GO:0009913	epidermal cell differentiation	BP
2	6	3.73372111195	-	5.95e-03	GO:0090344	negative regulation of cell aging	BP
2	6	3.73372111195	-	5.95e-03	GO:0003179	heart valve morphogenesis	BP
2	6	3.73372111195	-	5.95e-03	GO:0061469	regulation of type B pancreatic cell proliferation	BP
2	6	3.73372111195	-	5.95e-03	GO:0046850	regulation of bone remodeling	BP
2	6	3.73372111195	-	8.78e-03	GO:0043567	regulation of insulin-like growth factor receptor signaling pathway	BP
2	6	3.73372111195	-	8.78e-03	GO:0038202	TORC1 signaling	BP
2	6	3.73372111195	-	8.78e-03	GO:0045639	positive regulation of myeloid cell differentiation	BP
2	6	3.73372111195	-	8.78e-03	GO:0060561	apoptotic process involved in morphogenesis	BP
2	6	3.73372111195	-	8.78e-03	GO:0007435	salivary gland morphogenesis	BP
1	3	3.73372111195	-	2.51e-02	GO:0070172	positive regulation of tooth mineralization	BP
1	3	3.73372111195	-	2.51e-02	GO:0042269	regulation of natural killer cell mediated cytotoxicity	BP
1	3	3.73372111195	-	2.51e-02	GO:1905913	negative regulation of calcium ion export from cell	BP
1	3	3.73372111195	-	2.51e-02	GO:0061044	negative regulation of vascular wound healing	BP
1	3	3.73372111195	-	4.95e-02	GO:1990418	response to insulin-like growth factor stimulus	BP
1	3	3.73372111195	-	4.95e-02	GO:0048732	gland development	BP
1	3	3.73372111195	-	4.95e-02	GO:0061368	behavioral response to formalin induced pain	BP
1	3	3.73372111195	-	4.95e-02	GO:0001828	inner cell mass cellular morphogenesis	BP
1	3	3.73372111195	-	4.95e-02	GO:0032732	positive regulation of interleukin-1 production	BP
1	3	3.73372111195	-	4.95e-02	GO:1904000	positive regulation of eating behavior	BP
1	3	3.73372111195	-	4.95e-02	GO:0051490	negative regulation of filopodium assembly	BP
1	3	3.73372111195	-	4.95e-02	GO:0070634	transepithelial ammonium transport	BP
1	3	3.73372111195	-	4.95e-02	GO:1903691	positive regulation of wound healing, spreading of epidermal cells	BP
1	3	3.73372111195	-	4.95e-02	GO:0007418	ventral midline development	BP
1	3	3.73372111195	-	4.95e-02	GO:0051668	localization within membrane	BP
1	3	3.73372111195	-	4.95e-02	GO:0032696	negative regulation of interleukin-13 production	BP
1	3	3.73372111195	-	4.95e-02	GO:0010866	regulation of triglyceride biosynthetic process	BP
1	3	3.73372111195	-	4.95e-02	GO:0010823	negative regulation of mitochondrion organization	BP
1	3	3.73372111195	-	4.95e-02	GO:0019062	virion attachment to host cell	BP
1	3	3.73372111195	-	4.95e-02	GO:0061762	CAMKK-AMPK signaling cascade	BP
1	3	3.73372111195	-	4.95e-02	GO:1903215	negative regulation of protein targeting to mitochondrion	BP
1	3	3.73372111195	-	4.95e-02	GO:2000479	regulation of cAMP-dependent protein kinase activity	BP
1	3	3.73372111195	-	4.95e-02	GO:0010454	negative regulation of cell fate commitment	BP
1	3	3.73372111195	-	7.33e-02	GO:2000819	regulation of nucleotide-excision repair	BP
1	3	3.73372111195	-	7.33e-02	GO:1903984	positive regulation of TRAIL-activated apoptotic signaling pathway	BP
1	3	3.73372111195	-	7.33e-02	GO:0070562	regulation of vitamin D receptor signaling pathway	BP
1	3	3.73372111195	-	7.33e-02	GO:0001773	myeloid dendritic cell activation	BP
1	3	3.73372111195	-	7.33e-02	GO:0008218	bioluminescence	BP
1	3	3.73372111195	-	7.33e-02	GO:0002513	tolerance induction to self antigen	BP
1	3	3.73372111195	-	7.33e-02	GO:0016052	carbohydrate catabolic process	BP
1	3	3.73372111195	-	7.33e-02	GO:0031937	positive regulation of chromatin silencing	BP
1	3	3.73372111195	-	7.33e-02	GO:1900451	positive regulation of glutamate receptor signaling pathway	BP
1	3	3.73372111195	-	7.33e-02	GO:0098904	regulation of AV node cell action potential	BP
1	3	3.73372111195	-	7.33e-02	GO:0010560	positive regulation of glycoprotein biosynthetic process	BP
1	3	3.73372111195	-	7.33e-02	GO:0015874	norepinephrine transport	BP
1	3	3.73372111195	-	7.33e-02	GO:0001827	inner cell mass cell fate commitment	BP
1	3	3.73372111195	-	7.33e-02	GO:0060024	rhythmic synaptic transmission	BP
1	3	3.73372111195	-	7.33e-02	GO:0033590	response to cobalamin	BP
1	3	3.73372111195	-	7.33e-02	GO:1903660	negative regulation of complement-dependent cytotoxicity	BP
1	3	3.73372111195	-	7.33e-02	GO:0055096	low-density lipoprotein particle mediated signaling	BP
1	3	3.73372111195	-	7.33e-02	GO:0046320	regulation of fatty acid oxidation	BP
1	3	3.73372111195	-	7.33e-02	GO:0060743	epithelial cell maturation involved in prostate gland development	BP
1	3	3.73372111195	-	7.33e-02	GO:2000366	positive regulation of STAT protein import into nucleus	BP
1	3	3.73372111195	-	7.33e-02	GO:0071899	negative regulation of estrogen receptor binding	BP
1	3	3.73372111195	-	7.33e-02	GO:0071895	odontoblast differentiation	BP
1	3	3.73372111195	-	7.33e-02	GO:2000619	negative regulation of histone H4-K16 acetylation	BP
1	3	3.73372111195	-	7.33e-02	GO:0006114	glycerol biosynthetic process	BP
1	3	3.73372111195	-	7.33e-02	GO:0090258	negative regulation of mitochondrial fission	BP
1	3	3.73372111195	-	7.33e-02	GO:0050849	negative regulation of calcium-mediated signaling	BP
1	3	3.73372111195	-	7.33e-02	GO:0038162	erythropoietin-mediated signaling pathway	BP
1	3	3.73372111195	-	7.33e-02	GO:0051280	negative regulation of release of sequestered calcium ion into cytosol	BP
1	3	3.73372111195	-	7.33e-02	GO:1902186	regulation of viral release from host cell	BP
1	3	3.73372111195	-	7.33e-02	GO:1902309	negative regulation of peptidyl-serine dephosphorylation	BP
1	3	3.73372111195	-	7.33e-02	GO:0098910	regulation of atrial cardiac muscle cell action potential	BP
1	3	3.73372111195	-	7.33e-02	GO:0031063	regulation of histone deacetylation	BP
1	3	3.73372111195	-	7.33e-02	GO:0060672	epithelial cell morphogenesis involved in placental branching	BP
1	3	3.73372111195	-	7.33e-02	GO:0070671	response to interleukin-12	BP
1	3	3.73372111195	-	7.33e-02	GO:0000350	generation of catalytic spliceosome for second transesterification step	BP
1	3	3.73372111195	-	7.33e-02	GO:0019724	B cell mediated immunity	BP
1	3	3.73372111195	-	7.33e-02	GO:0002638	negative regulation of immunoglobulin production	BP
1	3	3.73372111195	-	7.33e-02	GO:1990535	neuron projection maintenance	BP
1	3	3.73372111195	-	7.33e-02	GO:0045218	zonula adherens maintenance	BP
1	3	3.73372111195	-	7.33e-02	GO:1900126	negative regulation of hyaluronan biosynthetic process	BP
1	3	3.73372111195	-	7.33e-02	GO:0032613	interleukin-10 production	BP
1	3	3.73372111195	-	7.33e-02	GO:0060242	contact inhibition	BP
1	3	3.73372111195	-	7.33e-02	GO:0023021	termination of signal transduction	BP
1	3	3.73372111195	-	7.33e-02	GO:0021747	cochlear nucleus development	BP
1	3	3.73372111195	-	7.33e-02	GO:1903551	regulation of extracellular exosome assembly	BP
1	3	3.73372111195	-	7.33e-02	GO:2001170	negative regulation of ATP biosynthetic process	BP
1	3	3.73372111195	-	7.33e-02	GO:0048385	regulation of retinoic acid receptor signaling pathway	BP
1	3	3.73372111195	-	7.33e-02	GO:0002902	regulation of B cell apoptotic process	BP
1	3	3.73372111195	-	7.33e-02	GO:0002904	positive regulation of B cell apoptotic process	BP
1	3	3.73372111195	-	7.33e-02	GO:1903721	positive regulation of I-kappaB phosphorylation	BP
1	3	3.73372111195	-	7.33e-02	GO:0060168	positive regulation of adenosine receptor signaling pathway	BP
1	3	3.73372111195	-	7.33e-02	GO:0019448	L-cysteine catabolic process	BP
1	3	3.73372111195	-	7.33e-02	GO:1902174	positive regulation of keratinocyte apoptotic process	BP
1	3	3.73372111195	-	7.33e-02	GO:0000819	sister chromatid segregation	BP
1	3	3.73372111195	-	7.33e-02	GO:0070093	negative regulation of glucagon secretion	BP
1	3	3.73372111195	-	7.33e-02	GO:0061198	fungiform papilla formation	BP
1	3	3.73372111195	-	7.33e-02	GO:0031998	regulation of fatty acid beta-oxidation	BP
1	3	3.73372111195	-	7.33e-02	GO:0003310	pancreatic A cell differentiation	BP
1	3	3.73372111195	-	7.33e-02	GO:0051097	negative regulation of helicase activity	BP
1	3	3.73372111195	-	7.33e-02	GO:2000051	negative regulation of non-canonical Wnt signaling pathway	BP
1	3	3.73372111195	-	7.33e-02	GO:2000058	regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process	BP
1	3	3.73372111195	-	7.33e-02	GO:0021553	olfactory nerve development	BP
1	3	3.73372111195	-	7.33e-02	GO:0060399	positive regulation of growth hormone receptor signaling pathway	BP
1	3	3.73372111195	-	7.33e-02	GO:2000345	regulation of hepatocyte proliferation	BP
1	3	3.73372111195	-	7.33e-02	GO:0001936	regulation of endothelial cell proliferation	BP
1	3	3.73372111195	-	7.33e-02	GO:2000111	positive regulation of macrophage apoptotic process	BP
1	3	3.73372111195	-	7.33e-02	GO:2000630	positive regulation of miRNA metabolic process	BP
1	3	3.73372111195	-	7.33e-02	GO:0097286	iron ion import	BP
1	3	3.73372111195	-	7.33e-02	GO:0060480	lung goblet cell differentiation	BP
1	3	3.73372111195	-	7.33e-02	GO:0032310	prostaglandin secretion	BP
1	3	3.73372111195	-	7.33e-02	GO:1903774	positive regulation of viral budding via host ESCRT complex	BP
1	3	3.73372111195	-	7.33e-02	GO:1903772	regulation of viral budding via host ESCRT complex	BP
1	3	3.73372111195	-	7.33e-02	GO:0071871	response to epinephrine	BP
1	3	3.73372111195	-	7.33e-02	GO:0046890	regulation of lipid biosynthetic process	BP
1	3	3.73372111195	-	7.33e-02	GO:0031281	positive regulation of cyclase activity	BP
1	3	3.73372111195	-	7.33e-02	GO:2000278	regulation of DNA biosynthetic process	BP
1	3	3.73372111195	-	7.33e-02	GO:2000687	negative regulation of rubidium ion transmembrane transporter activity	BP
1	3	3.73372111195	-	7.33e-02	GO:0051572	negative regulation of histone H3-K4 methylation	BP
1	3	3.73372111195	-	7.33e-02	GO:0002232	leukocyte chemotaxis involved in inflammatory response	BP
1	3	3.73372111195	-	7.33e-02	GO:0051389	inactivation of MAPKK activity	BP
1	3	3.73372111195	-	7.33e-02	GO:1904640	response to methionine	BP
1	3	3.73372111195	-	7.33e-02	GO:0048014	Tie signaling pathway	BP
1	3	3.73372111195	-	7.33e-02	GO:0043009	chordate embryonic development	BP
8	24	3.73372111195	-	7.42e-08	GO:0030295	protein kinase activator activity	MF
4	12	3.73372111195	-	1.11e-04	GO:0050321	tau-protein kinase activity	MF
4	12	3.73372111195	-	1.64e-04	GO:0031994	insulin-like growth factor I binding	MF
3	9	3.73372111195	-	1.17e-03	GO:0004716	signal transducer, downstream of receptor, with protein tyrosine kinase activity	MF
2	6	3.73372111195	-	8.78e-03	GO:0005168	neurotrophin TRKA receptor binding	MF
2	6	3.73372111195	-	8.78e-03	GO:0010997	anaphase-promoting complex binding	MF
1	3	3.73372111195	-	4.95e-02	GO:0019958	C-X-C chemokine binding	MF
1	3	3.73372111195	-	4.95e-02	GO:0023024	MHC class I protein complex binding	MF
1	3	3.73372111195	-	4.95e-02	GO:0005277	acetylcholine transmembrane transporter activity	MF
1	3	3.73372111195	-	4.95e-02	GO:0008321	Ral guanyl-nucleotide exchange factor activity	MF
1	3	3.73372111195	-	7.33e-02	GO:0035614	snRNA stem-loop binding	MF
1	3	3.73372111195	-	7.33e-02	GO:0001093	TFIIB-class transcription factor binding	MF
1	3	3.73372111195	-	7.33e-02	GO:0004705	JUN kinase activity	MF
1	3	3.73372111195	-	7.33e-02	GO:0004332	fructose-bisphosphate aldolase activity	MF
1	3	3.73372111195	-	7.33e-02	GO:0005010	insulin-like growth factor-activated receptor activity	MF
1	3	3.73372111195	-	7.33e-02	GO:0005166	neurotrophin p75 receptor binding	MF
1	3	3.73372111195	-	7.33e-02	GO:0034714	type III transforming growth factor beta receptor binding	MF
1	3	3.73372111195	-	7.33e-02	GO:0005333	norepinephrine transmembrane transporter activity	MF
1	3	3.73372111195	-	7.33e-02	GO:0047045	testosterone 17-beta-dehydrogenase (NADP+) activity	MF
1	3	3.73372111195	-	7.33e-02	GO:0004396	hexokinase activity	MF
1	3	3.73372111195	-	7.33e-02	GO:0004060	arylamine N-acetyltransferase activity	MF
1	3	3.73372111195	-	7.33e-02	GO:0016314	phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity	MF
1	3	3.73372111195	-	7.33e-02	GO:0008513	secondary active organic cation transmembrane transporter activity	MF
1	3	3.73372111195	-	7.33e-02	GO:0004924	oncostatin-M receptor activity	MF
1	3	3.73372111195	-	7.33e-02	GO:0004699	calcium-independent protein kinase C activity	MF
1	3	3.73372111195	-	7.33e-02	GO:0004711	ribosomal protein S6 kinase activity	MF
5	16	3.64061170756	-	3.34e-05	GO:0045725	positive regulation of glycogen biosynthetic process	BP
5	16	3.64061170756	-	2.34e-05	GO:0005159	insulin-like growth factor receptor binding	MF
4	13	3.61824389453	-	4.42e-05	GO:0043568	positive regulation of insulin-like growth factor receptor signaling pathway	BP
4	13	3.61824389453	-	1.11e-04	GO:0046628	positive regulation of insulin receptor signaling pathway	BP
4	13	3.61824389453	-	2.32e-04	GO:0060334	regulation of interferon-gamma-mediated signaling pathway	BP
3	10	3.5817180185	-	1.64e-03	GO:0051918	negative regulation of fibrinolysis	BP
3	10	3.5817180185	-	1.17e-03	GO:0051428	peptide hormone receptor binding	MF
4	14	3.51132869061	-	1.11e-04	GO:0022408	negative regulation of cell-cell adhesion	BP
2	7	3.51132869061	-	1.85e-03	GO:2000272	negative regulation of receptor activity	BP
2	7	3.51132869061	-	8.78e-03	GO:1903077	negative regulation of protein localization to plasma membrane	BP
2	7	3.51132869061	-	8.78e-03	GO:0051574	positive regulation of histone H3-K9 methylation	BP
2	7	3.51132869061	-	1.21e-02	GO:0043486	histone exchange	BP
2	7	3.51132869061	-	1.21e-02	GO:2000171	negative regulation of dendrite development	BP
2	7	3.51132869061	-	1.21e-02	GO:0071233	cellular response to leucine	BP
2	7	3.51132869061	-	1.21e-02	GO:0044321	response to leptin	BP
2	7	3.51132869061	-	1.21e-02	GO:0031659	positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle	BP
2	7	3.51132869061	-	8.78e-03	GO:0001848	complement binding	MF
2	7	3.51132869061	-	1.21e-02	GO:0008603	cAMP-dependent protein kinase regulator activity	MF
2	7	3.51132869061	-	1.21e-02	GO:0004691	cAMP-dependent protein kinase activity	MF
3	11	3.44421449475	-	1.64e-03	GO:0032930	positive regulation of superoxide anion generation	BP
3	11	3.44421449475	-	1.64e-03	GO:0045945	positive regulation of transcription from RNA polymerase III promoter	BP
3	11	3.44421449475	-	1.64e-03	GO:0045792	negative regulation of cell size	BP
3	11	3.44421449475	-	2.22e-03	GO:0043276	anoikis	BP
3	11	3.44421449475	-	2.22e-03	GO:0045667	regulation of osteoblast differentiation	BP
3	11	3.44421449475	-	2.22e-03	GO:0016208	AMP binding	MF
8	31	3.36448730228	-	3.88e-07	GO:0005158	insulin receptor binding	MF
3	12	3.31868361267	-	1.64e-03	GO:0007600	sensory perception	BP
3	12	3.31868361267	-	2.22e-03	GO:2000505	regulation of energy homeostasis	BP
3	12	3.31868361267	-	2.90e-03	GO:0033160	positive regulation of protein import into nucleus, translocation	BP
2	8	3.31868361267	-	8.78e-03	GO:0046324	regulation of glucose import	BP
2	8	3.31868361267	-	8.78e-03	GO:2000427	positive regulation of apoptotic cell clearance	BP
2	8	3.31868361267	-	8.78e-03	GO:0051152	positive regulation of smooth muscle cell differentiation	BP
2	8	3.31868361267	-	1.21e-02	GO:0060020	Bergmann glial cell differentiation	BP
2	8	3.31868361267	-	1.21e-02	GO:0033629	negative regulation of cell adhesion mediated by integrin	BP
2	8	3.31868361267	-	1.21e-02	GO:0005979	regulation of glycogen biosynthetic process	BP
2	8	3.31868361267	-	1.21e-02	GO:0007167	enzyme linked receptor protein signaling pathway	BP
2	8	3.31868361267	-	1.21e-02	GO:0001542	ovulation from ovarian follicle	BP
2	8	3.31868361267	-	1.21e-02	GO:1901017	negative regulation of potassium ion transmembrane transporter activity	BP
2	8	3.31868361267	-	1.59e-02	GO:0010544	negative regulation of platelet activation	BP
2	8	3.31868361267	-	1.59e-02	GO:0014732	skeletal muscle atrophy	BP
2	8	3.31868361267	-	1.59e-02	GO:0014909	smooth muscle cell migration	BP
2	8	3.31868361267	-	1.59e-02	GO:0006002	fructose 6-phosphate metabolic process	BP
1	4	3.31868361267	-	4.95e-02	GO:0048609	multicellular organismal reproductive process	BP
1	4	3.31868361267	-	4.95e-02	GO:0021575	hindbrain morphogenesis	BP
1	4	3.31868361267	-	4.95e-02	GO:0010868	negative regulation of triglyceride biosynthetic process	BP
1	4	3.31868361267	-	4.95e-02	GO:0006651	diacylglycerol biosynthetic process	BP
1	4	3.31868361267	-	4.95e-02	GO:0042662	negative regulation of mesodermal cell fate specification	BP
1	4	3.31868361267	-	7.33e-02	GO:0060965	negative regulation of gene silencing by miRNA	BP
1	4	3.31868361267	-	7.33e-02	GO:1904037	positive regulation of epithelial cell apoptotic process	BP
1	4	3.31868361267	-	7.33e-02	GO:1903243	negative regulation of cardiac muscle hypertrophy in response to stress	BP
1	4	3.31868361267	-	7.33e-02	GO:0032286	central nervous system myelin maintenance	BP
1	4	3.31868361267	-	7.33e-02	GO:0006054	N-acetylneuraminate metabolic process	BP
1	4	3.31868361267	-	7.33e-02	GO:0060510	Type II pneumocyte differentiation	BP
1	4	3.31868361267	-	7.33e-02	GO:0050672	negative regulation of lymphocyte proliferation	BP
1	4	3.31868361267	-	7.33e-02	GO:0070857	regulation of bile acid biosynthetic process	BP
1	4	3.31868361267	-	7.33e-02	GO:0072606	interleukin-8 secretion	BP
1	4	3.31868361267	-	7.33e-02	GO:1900738	positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway	BP
1	4	3.31868361267	-	7.33e-02	GO:0021938	smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation	BP
1	4	3.31868361267	-	7.33e-02	GO:0048133	male germ-line stem cell asymmetric division	BP
1	4	3.31868361267	-	7.33e-02	GO:0032348	negative regulation of aldosterone biosynthetic process	BP
1	4	3.31868361267	-	7.33e-02	GO:0033088	negative regulation of immature T cell proliferation in thymus	BP
1	4	3.31868361267	-	7.33e-02	GO:1901097	negative regulation of autophagosome maturation	BP
1	4	3.31868361267	-	7.33e-02	GO:0060571	morphogenesis of an epithelial fold	BP
1	4	3.31868361267	-	7.33e-02	GO:0032392	DNA geometric change	BP
1	4	3.31868361267	-	7.33e-02	GO:0051055	negative regulation of lipid biosynthetic process	BP
1	4	3.31868361267	-	7.33e-02	GO:0046596	regulation of viral entry into host cell	BP
1	4	3.31868361267	-	7.33e-02	GO:2001274	negative regulation of glucose import in response to insulin stimulus	BP
1	4	3.31868361267	-	7.33e-02	GO:2000065	negative regulation of cortisol biosynthetic process	BP
1	4	3.31868361267	-	7.33e-02	GO:0070945	neutrophil mediated killing of gram-negative bacterium	BP
1	4	3.31868361267	-	7.33e-02	GO:0070236	negative regulation of activation-induced cell death of T cells	BP
1	4	3.31868361267	-	9.65e-02	GO:0090400	stress-induced premature senescence	BP
1	4	3.31868361267	-	9.65e-02	GO:0010716	negative regulation of extracellular matrix disassembly	BP
1	4	3.31868361267	-	9.65e-02	GO:0038110	interleukin-2-mediated signaling pathway	BP
1	4	3.31868361267	-	9.65e-02	GO:0035791	platelet-derived growth factor receptor-beta signaling pathway	BP
1	4	3.31868361267	-	9.65e-02	GO:0035655	interleukin-18-mediated signaling pathway	BP
1	4	3.31868361267	-	9.65e-02	GO:0008588	release of cytoplasmic sequestered NF-kappaB	BP
1	4	3.31868361267	-	9.65e-02	GO:0009048	dosage compensation by inactivation of X chromosome	BP
1	4	3.31868361267	-	9.65e-02	GO:1900024	regulation of substrate adhesion-dependent cell spreading	BP
1	4	3.31868361267	-	9.65e-02	GO:0016240	autophagosome membrane docking	BP
1	4	3.31868361267	-	9.65e-02	GO:0051106	positive regulation of DNA ligation	BP
1	4	3.31868361267	-	9.65e-02	GO:1901203	positive regulation of extracellular matrix assembly	BP
1	4	3.31868361267	-	9.65e-02	GO:0030043	actin filament fragmentation	BP
1	4	3.31868361267	-	9.65e-02	GO:0008356	asymmetric cell division	BP
1	4	3.31868361267	-	9.65e-02	GO:0014042	positive regulation of neuron maturation	BP
1	4	3.31868361267	-	9.65e-02	GO:0010883	regulation of lipid storage	BP
1	4	3.31868361267	-	9.65e-02	GO:0002248	connective tissue replacement involved in inflammatory response wound healing	BP
1	4	3.31868361267	-	9.65e-02	GO:0090168	Golgi reassembly	BP
1	4	3.31868361267	-	9.65e-02	GO:0016080	synaptic vesicle targeting	BP
1	4	3.31868361267	-	9.65e-02	GO:0071896	protein localization to adherens junction	BP
1	4	3.31868361267	-	9.65e-02	GO:1903377	negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway	BP
1	4	3.31868361267	-	9.65e-02	GO:0048023	positive regulation of melanin biosynthetic process	BP
1	4	3.31868361267	-	9.65e-02	GO:0002328	pro-B cell differentiation	BP
1	4	3.31868361267	-	9.65e-02	GO:0090244	Wnt signaling pathway involved in somitogenesis	BP
1	4	3.31868361267	-	9.65e-02	GO:0038127	ERBB signaling pathway	BP
1	4	3.31868361267	-	9.65e-02	GO:0007258	JUN phosphorylation	BP
1	4	3.31868361267	-	9.65e-02	GO:0035089	establishment of apical/basal cell polarity	BP
1	4	3.31868361267	-	9.65e-02	GO:0038165	oncostatin-M-mediated signaling pathway	BP
1	4	3.31868361267	-	9.65e-02	GO:1905323	telomerase holoenzyme complex assembly	BP
1	4	3.31868361267	-	9.65e-02	GO:1901020	negative regulation of calcium ion transmembrane transporter activity	BP
1	4	3.31868361267	-	9.65e-02	GO:2000002	negative regulation of DNA damage checkpoint	BP
1	4	3.31868361267	-	9.65e-02	GO:2000491	positive regulation of hepatic stellate cell activation	BP
1	4	3.31868361267	-	9.65e-02	GO:0051450	myoblast proliferation	BP
1	4	3.31868361267	-	9.65e-02	GO:0060033	anatomical structure regression	BP
1	4	3.31868361267	-	9.65e-02	GO:0018394	peptidyl-lysine acetylation	BP
1	4	3.31868361267	-	9.65e-02	GO:1990182	exosomal secretion	BP
1	4	3.31868361267	-	9.65e-02	GO:0042482	positive regulation of odontogenesis	BP
1	4	3.31868361267	-	9.65e-02	GO:1900825	regulation of membrane depolarization during cardiac muscle cell action potential	BP
1	4	3.31868361267	-	9.65e-02	GO:0051599	response to hydrostatic pressure	BP
1	4	3.31868361267	-	9.65e-02	GO:1903690	negative regulation of wound healing, spreading of epidermal cells	BP
1	4	3.31868361267	-	9.65e-02	GO:1904781	positive regulation of protein localization to centrosome	BP
1	4	3.31868361267	-	9.65e-02	GO:0008105	asymmetric protein localization	BP
1	4	3.31868361267	-	9.65e-02	GO:0090170	regulation of Golgi inheritance	BP
1	4	3.31868361267	-	9.65e-02	GO:0072012	glomerulus vasculature development	BP
1	4	3.31868361267	-	9.65e-02	GO:0006642	triglyceride mobilization	BP
1	4	3.31868361267	-	9.65e-02	GO:2001200	positive regulation of dendritic cell differentiation	BP
1	4	3.31868361267	-	9.65e-02	GO:0060364	frontal suture morphogenesis	BP
1	4	3.31868361267	-	9.65e-02	GO:0071677	positive regulation of mononuclear cell migration	BP
1	4	3.31868361267	-	9.65e-02	GO:0006534	cysteine metabolic process	BP
1	4	3.31868361267	-	9.65e-02	GO:0071866	negative regulation of apoptotic process in bone marrow	BP
1	4	3.31868361267	-	9.65e-02	GO:0010822	positive regulation of mitochondrion organization	BP
1	4	3.31868361267	-	9.65e-02	GO:1990834	response to odorant	BP
1	4	3.31868361267	-	9.65e-02	GO:0061056	sclerotome development	BP
1	4	3.31868361267	-	9.65e-02	GO:0031999	negative regulation of fatty acid beta-oxidation	BP
1	4	3.31868361267	-	9.65e-02	GO:0051098	regulation of binding	BP
1	4	3.31868361267	-	9.65e-02	GO:0030223	neutrophil differentiation	BP
1	4	3.31868361267	-	9.65e-02	GO:0034698	response to gonadotropin	BP
1	4	3.31868361267	-	9.65e-02	GO:0042490	mechanoreceptor differentiation	BP
1	4	3.31868361267	-	9.65e-02	GO:0014834	skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration	BP
1	4	3.31868361267	-	9.65e-02	GO:1904637	cellular response to ionomycin	BP
1	4	3.31868361267	-	9.65e-02	GO:0090559	regulation of membrane permeability	BP
1	4	3.31868361267	-	9.65e-02	GO:0021943	formation of radial glial scaffolds	BP
1	4	3.31868361267	-	9.65e-02	GO:0033686	positive regulation of luteinizing hormone secretion	BP
1	4	3.31868361267	-	9.65e-02	GO:0043932	ossification involved in bone remodeling	BP
1	4	3.31868361267	-	9.65e-02	GO:0032095	regulation of response to food	BP
1	4	3.31868361267	-	9.65e-02	GO:0006924	activation-induced cell death of T cells	BP
1	4	3.31868361267	-	9.65e-02	GO:0038108	negative regulation of appetite by leptin-mediated signaling pathway	BP
1	4	3.31868361267	-	9.65e-02	GO:0045906	negative regulation of vasoconstriction	BP
1	4	3.31868361267	-	9.65e-02	GO:0033158	regulation of protein import into nucleus, translocation	BP
1	4	3.31868361267	-	9.65e-02	GO:1903936	cellular response to sodium arsenite	BP
1	4	3.31868361267	-	9.65e-02	GO:1901984	negative regulation of protein acetylation	BP
1	4	3.31868361267	-	9.65e-02	GO:0014904	myotube cell development	BP
1	4	3.31868361267	-	9.65e-02	GO:0048633	positive regulation of skeletal muscle tissue growth	BP
1	4	3.31868361267	-	9.65e-02	GO:0022405	hair cycle process	BP
1	4	3.31868361267	-	9.65e-02	GO:0035021	negative regulation of Rac protein signal transduction	BP
1	4	3.31868361267	-	9.65e-02	GO:0060442	branching involved in prostate gland morphogenesis	BP
1	4	3.31868361267	-	9.65e-02	GO:0097350	neutrophil clearance	BP
1	4	3.31868361267	-	9.65e-02	GO:0046425	regulation of JAK-STAT cascade	BP
1	4	3.31868361267	-	9.65e-02	GO:0051645	Golgi localization	BP
2	8	3.31868361267	-	5.95e-03	GO:0019213	deacetylase activity	MF
1	4	3.31868361267	-	4.95e-02	GO:0031628	opioid receptor binding	MF
1	4	3.31868361267	-	4.95e-02	GO:0005332	gamma-aminobutyric acid:sodium symporter activity	MF
1	4	3.31868361267	-	4.95e-02	GO:0055077	gap junction hemi-channel activity	MF
1	4	3.31868361267	-	7.33e-02	GO:0004647	phosphoserine phosphatase activity	MF
1	4	3.31868361267	-	7.33e-02	GO:0042030	ATPase inhibitor activity	MF
1	4	3.31868361267	-	7.33e-02	GO:0001515	opioid peptide activity	MF
1	4	3.31868361267	-	9.65e-02	GO:0050815	phosphoserine residue binding	MF
1	4	3.31868361267	-	9.65e-02	GO:0005329	dopamine transmembrane transporter activity	MF
1	4	3.31868361267	-	9.65e-02	GO:0003696	satellite DNA binding	MF
1	4	3.31868361267	-	9.65e-02	GO:0019158	mannokinase activity	MF
1	4	3.31868361267	-	9.65e-02	GO:0017136	NAD-dependent histone deacetylase activity	MF
1	4	3.31868361267	-	9.65e-02	GO:0008607	phosphorylase kinase regulator activity	MF
1	4	3.31868361267	-	9.65e-02	GO:0051425	PTB domain binding	MF
1	4	3.31868361267	-	9.65e-02	GO:0008865	fructokinase activity	MF
1	4	3.31868361267	-	9.65e-02	GO:0071535	RING-like zinc finger domain binding	MF
1	4	3.31868361267	-	9.65e-02	GO:0070053	thrombospondin receptor activity	MF
1	4	3.31868361267	-	9.65e-02	GO:0032564	dATP binding	MF
1	4	3.31868361267	-	9.65e-02	GO:0043121	neurotrophin binding	MF
11	47	3.22352637963	-	9.88e-09	GO:0038083	peptidyl-tyrosine autophosphorylation	BP
7	30	3.21914793912	-	5.66e-06	GO:0046627	negative regulation of insulin receptor signaling pathway	BP
3	13	3.20320639525	-	2.22e-03	GO:0010763	positive regulation of fibroblast migration	BP
3	13	3.20320639525	-	2.22e-03	GO:0061029	eyelid development in camera-type eye	BP
3	13	3.20320639525	-	2.22e-03	GO:0048546	digestive tract morphogenesis	BP
3	13	3.20320639525	-	2.22e-03	GO:0055089	fatty acid homeostasis	BP
3	13	3.20320639525	-	2.90e-03	GO:0019395	fatty acid oxidation	BP
3	13	3.20320639525	-	3.70e-03	GO:0070306	lens fiber cell differentiation	BP
3	13	3.20320639525	-	3.70e-03	GO:1904668	positive regulation of ubiquitin protein ligase activity	BP
7	31	3.17184222434	-	3.36e-06	GO:0014065	phosphatidylinositol 3-kinase signaling	BP
4	18	3.14875861123	-	7.12e-04	GO:0046579	positive regulation of Ras protein signal transduction	BP
4	18	3.14875861123	-	8.97e-04	GO:0045821	positive regulation of glycolytic process	BP
2	9	3.14875861123	-	8.78e-03	GO:0032099	negative regulation of appetite	BP
2	9	3.14875861123	-	1.21e-02	GO:0035767	endothelial cell chemotaxis	BP
2	9	3.14875861123	-	1.59e-02	GO:0030836	positive regulation of actin filament depolymerization	BP
2	9	3.14875861123	-	1.59e-02	GO:0019953	sexual reproduction	BP
2	9	3.14875861123	-	1.59e-02	GO:1990314	cellular response to insulin-like growth factor stimulus	BP
2	9	3.14875861123	-	1.59e-02	GO:0006111	regulation of gluconeogenesis	BP
2	9	3.14875861123	-	1.59e-02	GO:0032886	regulation of microtubule-based process	BP
2	9	3.14875861123	-	2.01e-02	GO:0043068	positive regulation of programmed cell death	BP
2	9	3.14875861123	-	2.01e-02	GO:0033762	response to glucagon	BP
2	9	3.14875861123	-	2.01e-02	GO:0046621	negative regulation of organ growth	BP
2	9	3.14875861123	-	2.01e-02	GO:0032000	positive regulation of fatty acid beta-oxidation	BP
2	9	3.14875861123	-	2.01e-02	GO:0019887	protein kinase regulator activity	MF
6	28	3.09629119133	-	3.57e-05	GO:0048008	platelet-derived growth factor receptor signaling pathway	BP
3	14	3.09629119133	-	2.90e-03	GO:0045721	negative regulation of gluconeogenesis	BP
3	14	3.09629119133	-	3.70e-03	GO:0014912	negative regulation of smooth muscle cell migration	BP
3	14	3.09629119133	-	4.62e-03	GO:0008631	intrinsic apoptotic signaling pathway in response to oxidative stress	BP
3	14	3.09629119133	-	4.62e-03	GO:0042993	positive regulation of transcription factor import into nucleus	BP
6	28	3.09629119133	-	5.60e-05	GO:0004714	transmembrane receptor protein tyrosine kinase activity	MF
3	15	2.99675551778	-	2.22e-03	GO:0006112	energy reserve metabolic process	BP
3	15	2.99675551778	-	4.62e-03	GO:2000251	positive regulation of actin cytoskeleton reorganization	BP
3	15	2.99675551778	-	5.67e-03	GO:0051895	negative regulation of focal adhesion assembly	BP
3	15	2.99675551778	-	4.62e-03	GO:0005161	platelet-derived growth factor receptor binding	MF
2	10	2.99675551778	-	8.78e-03	GO:0002021	response to dietary excess	BP
2	10	2.99675551778	-	1.59e-02	GO:0048681	negative regulation of axon regeneration	BP
2	10	2.99675551778	-	1.59e-02	GO:0003300	cardiac muscle hypertrophy	BP
2	10	2.99675551778	-	2.01e-02	GO:0042770	signal transduction in response to DNA damage	BP
2	10	2.99675551778	-	2.01e-02	GO:0010469	regulation of receptor activity	BP
2	10	2.99675551778	-	2.47e-02	GO:0031115	negative regulation of microtubule polymerization	BP
2	10	2.99675551778	-	2.47e-02	GO:0034145	positive regulation of toll-like receptor 4 signaling pathway	BP
2	10	2.99675551778	-	2.47e-02	GO:0044320	cellular response to leptin stimulus	BP
2	10	2.99675551778	-	2.47e-02	GO:0060252	positive regulation of glial cell proliferation	BP
2	10	2.99675551778	-	2.47e-02	GO:0031000	response to caffeine	BP
1	5	2.99675551778	-	4.95e-02	GO:0043270	positive regulation of ion transport	BP
1	5	2.99675551778	-	4.95e-02	GO:0015812	gamma-aminobutyric acid transport	BP
1	5	2.99675551778	-	4.95e-02	GO:0042743	hydrogen peroxide metabolic process	BP
1	5	2.99675551778	-	7.33e-02	GO:0002385	mucosal immune response	BP
1	5	2.99675551778	-	7.33e-02	GO:0038203	TORC2 signaling	BP
1	5	2.99675551778	-	7.33e-02	GO:0003105	negative regulation of glomerular filtration	BP
1	5	2.99675551778	-	7.33e-02	GO:0061370	testosterone biosynthetic process	BP
1	5	2.99675551778	-	7.33e-02	GO:0048513	animal organ development	BP
1	5	2.99675551778	-	7.33e-02	GO:0021879	forebrain neuron differentiation	BP
1	5	2.99675551778	-	7.33e-02	GO:0032714	negative regulation of interleukin-5 production	BP
1	5	2.99675551778	-	7.33e-02	GO:0060312	regulation of blood vessel remodeling	BP
1	5	2.99675551778	-	9.65e-02	GO:0045347	negative regulation of MHC class II biosynthetic process	BP
1	5	2.99675551778	-	9.65e-02	GO:0050851	antigen receptor-mediated signaling pathway	BP
1	5	2.99675551778	-	9.65e-02	GO:1900020	positive regulation of protein kinase C activity	BP
1	5	2.99675551778	-	9.65e-02	GO:0003283	atrial septum development	BP
1	5	2.99675551778	-	9.65e-02	GO:2000035	regulation of stem cell division	BP
1	5	2.99675551778	-	9.65e-02	GO:1904179	positive regulation of adipose tissue development	BP
1	5	2.99675551778	-	9.65e-02	GO:0046600	negative regulation of centriole replication	BP
1	5	2.99675551778	-	9.65e-02	GO:0019217	regulation of fatty acid metabolic process	BP
1	5	2.99675551778	-	9.65e-02	GO:0032237	activation of store-operated calcium channel activity	BP
1	5	2.99675551778	-	9.65e-02	GO:0015696	ammonium transport	BP
1	5	2.99675551778	-	9.65e-02	GO:0002318	myeloid progenitor cell differentiation	BP
1	5	2.99675551778	-	9.65e-02	GO:0001302	replicative cell aging	BP
1	5	2.99675551778	-	9.65e-02	GO:0030300	regulation of intestinal cholesterol absorption	BP
1	5	2.99675551778	-	9.65e-02	GO:0010632	regulation of epithelial cell migration	BP
1	5	2.99675551778	-	9.65e-02	GO:0016101	diterpenoid metabolic process	BP
1	5	2.99675551778	-	9.65e-02	GO:0050716	positive regulation of interleukin-1 secretion	BP
1	5	2.99675551778	-	9.65e-02	GO:0007406	negative regulation of neuroblast proliferation	BP
1	5	2.99675551778	-	9.65e-02	GO:0045542	positive regulation of cholesterol biosynthetic process	BP
1	5	2.99675551778	-	9.65e-02	GO:0021696	cerebellar cortex morphogenesis	BP
1	5	2.99675551778	-	9.65e-02	GO:0010668	ectodermal cell differentiation	BP
1	5	2.99675551778	-	1.19e-01	GO:0072656	maintenance of protein location in mitochondrion	BP
1	5	2.99675551778	-	1.19e-01	GO:0072655	establishment of protein localization to mitochondrion	BP
1	5	2.99675551778	-	1.19e-01	GO:0034134	toll-like receptor 2 signaling pathway	BP
1	5	2.99675551778	-	1.19e-01	GO:0034137	positive regulation of toll-like receptor 2 signaling pathway	BP
1	5	2.99675551778	-	1.19e-01	GO:0007262	STAT protein import into nucleus	BP
1	5	2.99675551778	-	1.19e-01	GO:2000481	positive regulation of cAMP-dependent protein kinase activity	BP
1	5	2.99675551778	-	1.19e-01	GO:0060028	convergent extension involved in axis elongation	BP
1	5	2.99675551778	-	1.19e-01	GO:0065004	protein-DNA complex assembly	BP
1	5	2.99675551778	-	1.19e-01	GO:0042306	regulation of protein import into nucleus	BP
1	5	2.99675551778	-	1.19e-01	GO:0050882	voluntary musculoskeletal movement	BP
1	5	2.99675551778	-	1.19e-01	GO:0060744	mammary gland branching involved in thelarche	BP
1	5	2.99675551778	-	1.19e-01	GO:0061624	fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate	BP
1	5	2.99675551778	-	1.19e-01	GO:0010715	regulation of extracellular matrix disassembly	BP
1	5	2.99675551778	-	1.19e-01	GO:1902262	apoptotic process involved in blood vessel morphogenesis	BP
1	5	2.99675551778	-	1.19e-01	GO:0031536	positive regulation of exit from mitosis	BP
1	5	2.99675551778	-	1.19e-01	GO:0010936	negative regulation of macrophage cytokine production	BP
1	5	2.99675551778	-	1.19e-01	GO:1904714	regulation of chaperone-mediated autophagy	BP
1	5	2.99675551778	-	1.19e-01	GO:0048298	positive regulation of isotype switching to IgA isotypes	BP
1	5	2.99675551778	-	1.19e-01	GO:0060179	male mating behavior	BP
1	5	2.99675551778	-	1.19e-01	GO:0034109	homotypic cell-cell adhesion	BP
1	5	2.99675551778	-	1.19e-01	GO:0010830	regulation of myotube differentiation	BP
1	5	2.99675551778	-	1.19e-01	GO:0008063	Toll signaling pathway	BP
1	5	2.99675551778	-	1.19e-01	GO:0046578	regulation of Ras protein signal transduction	BP
1	5	2.99675551778	-	1.19e-01	GO:0038084	vascular endothelial growth factor signaling pathway	BP
1	5	2.99675551778	-	1.19e-01	GO:0001661	conditioned taste aversion	BP
1	5	2.99675551778	-	1.19e-01	GO:1903898	negative regulation of PERK-mediated unfolded protein response	BP
1	5	2.99675551778	-	1.19e-01	GO:0045843	negative regulation of striated muscle tissue development	BP
1	5	2.99675551778	-	1.19e-01	GO:0040020	regulation of meiotic nuclear division	BP
1	5	2.99675551778	-	1.19e-01	GO:0019530	taurine metabolic process	BP
1	5	2.99675551778	-	1.19e-01	GO:0038007	netrin-activated signaling pathway	BP
1	5	2.99675551778	-	1.19e-01	GO:0055062	phosphate ion homeostasis	BP
1	5	2.99675551778	-	1.19e-01	GO:0015697	quaternary ammonium group transport	BP
1	5	2.99675551778	-	1.19e-01	GO:0030854	positive regulation of granulocyte differentiation	BP
1	5	2.99675551778	-	1.19e-01	GO:0046651	lymphocyte proliferation	BP
1	5	2.99675551778	-	1.19e-01	GO:0071332	cellular response to fructose stimulus	BP
1	5	2.99675551778	-	1.19e-01	GO:0071376	cellular response to corticotropin-releasing hormone stimulus	BP
1	5	2.99675551778	-	1.19e-01	GO:0010543	regulation of platelet activation	BP
1	5	2.99675551778	-	1.19e-01	GO:0071864	positive regulation of cell proliferation in bone marrow	BP
1	5	2.99675551778	-	1.19e-01	GO:0048341	paraxial mesoderm formation	BP
1	5	2.99675551778	-	1.19e-01	GO:1903416	response to glycoside	BP
1	5	2.99675551778	-	1.19e-01	GO:0060603	mammary gland duct morphogenesis	BP
1	5	2.99675551778	-	1.19e-01	GO:0046883	regulation of hormone secretion	BP
1	5	2.99675551778	-	1.19e-01	GO:0002821	positive regulation of adaptive immune response	BP
1	5	2.99675551778	-	1.19e-01	GO:0032713	negative regulation of interleukin-4 production	BP
1	5	2.99675551778	-	1.19e-01	GO:0060761	negative regulation of response to cytokine stimulus	BP
1	5	2.99675551778	-	1.19e-01	GO:1904885	beta-catenin destruction complex assembly	BP
1	5	2.99675551778	-	1.19e-01	GO:0051220	cytoplasmic sequestering of protein	BP
1	5	2.99675551778	-	1.19e-01	GO:0098887	neurotransmitter receptor transport, endosome to postsynaptic membrane	BP
1	5	2.99675551778	-	1.19e-01	GO:0033153	T cell receptor V(D)J recombination	BP
1	5	2.99675551778	-	1.19e-01	GO:0021861	forebrain radial glial cell differentiation	BP
1	5	2.99675551778	-	1.19e-01	GO:0003161	cardiac conduction system development	BP
1	5	2.99675551778	-	1.19e-01	GO:0006896	Golgi to vacuole transport	BP
1	5	2.99675551778	-	1.19e-01	GO:1900015	regulation of cytokine production involved in inflammatory response	BP
1	5	2.99675551778	-	1.19e-01	GO:0042976	activation of Janus kinase activity	BP
1	5	2.99675551778	-	1.19e-01	GO:0051534	negative regulation of NFAT protein import into nucleus	BP
1	5	2.99675551778	-	1.19e-01	GO:0051573	negative regulation of histone H3-K9 methylation	BP
1	5	2.99675551778	-	1.19e-01	GO:1900103	positive regulation of endoplasmic reticulum unfolded protein response	BP
1	5	2.99675551778	-	1.19e-01	GO:0042501	serine phosphorylation of STAT protein	BP
1	5	2.99675551778	-	1.19e-01	GO:0060385	axonogenesis involved in innervation	BP
7	35	2.99675551778	-	2.14e-05	GO:0001784	phosphotyrosine residue binding	MF
4	20	2.99675551778	-	7.12e-04	GO:0005086	ARF guanyl-nucleotide exchange factor activity	MF
2	10	2.99675551778	-	2.47e-02	GO:0033558	protein deacetylase activity	MF
1	5	2.99675551778	-	9.65e-02	GO:0034979	NAD-dependent protein deacetylase activity	MF
1	5	2.99675551778	-	9.65e-02	GO:0071813	lipoprotein particle binding	MF
1	5	2.99675551778	-	9.65e-02	GO:0070290	N-acylphosphatidylethanolamine-specific phospholipase D activity	MF
1	5	2.99675551778	-	9.65e-02	GO:0098519	nucleotide phosphatase activity, acting on free nucleotides	MF
1	5	2.99675551778	-	9.65e-02	GO:1990254	keratin filament binding	MF
1	5	2.99675551778	-	9.65e-02	GO:1990405	protein antigen binding	MF
1	5	2.99675551778	-	9.65e-02	GO:0004556	alpha-amylase activity	MF
1	5	2.99675551778	-	1.19e-01	GO:0051373	FATZ binding	MF
1	5	2.99675551778	-	1.19e-01	GO:0044388	small protein activating enzyme binding	MF
1	5	2.99675551778	-	1.19e-01	GO:0097100	supercoiled DNA binding	MF
1	5	2.99675551778	-	1.19e-01	GO:0031802	type 5 metabotropic glutamate receptor binding	MF
1	5	2.99675551778	-	1.19e-01	GO:0048029	monosaccharide binding	MF
1	5	2.99675551778	-	1.19e-01	GO:0019210	kinase inhibitor activity	MF
1	5	2.99675551778	-	1.19e-01	GO:0015651	quaternary ammonium group transmembrane transporter activity	MF
1	5	2.99675551778	-	1.19e-01	GO:0070061	fructose binding	MF
1	5	2.99675551778	-	1.19e-01	GO:0030284	estrogen receptor activity	MF
1	5	2.99675551778	-	1.19e-01	GO:0004340	glucokinase activity	MF
1	5	2.99675551778	-	1.19e-01	GO:0005143	interleukin-12 receptor binding	MF
6	31	2.949449803	-	5.60e-05	GO:0046326	positive regulation of glucose import	BP
4	21	2.92636618989	-	8.97e-04	GO:0043539	protein serine/threonine kinase activator activity	MF
6	32	2.90364611339	-	4.49e-05	GO:0032007	negative regulation of TOR signaling	BP
3	16	2.90364611339	-	3.70e-03	GO:0032012	regulation of ARF protein signal transduction	BP
2	11	2.85925199403	-	1.21e-02	GO:0006702	androgen biosynthetic process	BP
2	11	2.85925199403	-	1.21e-02	GO:1903672	positive regulation of sprouting angiogenesis	BP
2	11	2.85925199403	-	1.59e-02	GO:0002089	lens morphogenesis in camera-type eye	BP
2	11	2.85925199403	-	1.59e-02	GO:0043586	tongue development	BP
2	11	2.85925199403	-	2.47e-02	GO:0001944	vasculature development	BP
2	11	2.85925199403	-	2.47e-02	GO:0007260	tyrosine phosphorylation of STAT protein	BP
2	11	2.85925199403	-	2.47e-02	GO:0050732	negative regulation of peptidyl-tyrosine phosphorylation	BP
2	11	2.85925199403	-	2.47e-02	GO:0042445	hormone metabolic process	BP
2	11	2.85925199403	-	2.47e-02	GO:0035413	positive regulation of catenin import into nucleus	BP
2	11	2.85925199403	-	2.97e-02	GO:0033628	regulation of cell adhesion mediated by integrin	BP
2	11	2.85925199403	-	2.97e-02	GO:0070914	UV-damage excision repair	BP
2	11	2.85925199403	-	2.97e-02	GO:0032516	positive regulation of phosphoprotein phosphatase activity	BP
2	11	2.85925199403	-	2.97e-02	GO:0016064	immunoglobulin mediated immune response	BP
2	11	2.85925199403	-	2.01e-02	GO:0004629	phospholipase C activity	MF
2	11	2.85925199403	-	2.47e-02	GO:0005068	transmembrane receptor protein tyrosine kinase adaptor activity	MF
14	78	2.84063631587	-	1.96e-09	GO:0008286	insulin receptor signaling pathway	BP
7	39	2.84063631587	-	1.14e-05	GO:0006633	fatty acid biosynthetic process	BP
5	28	2.8332567855	-	3.37e-04	GO:0030010	establishment of cell polarity	BP
3	17	2.81618327214	-	4.62e-03	GO:0010975	regulation of neuron projection development	BP
3	17	2.81618327214	-	5.67e-03	GO:0071380	cellular response to prostaglandin E stimulus	BP
5	29	2.78263071243	-	5.86e-04	GO:0043552	positive regulation of phosphatidylinositol 3-kinase activity	BP
7	41	2.76848653011	-	4.50e-05	GO:0045740	positive regulation of DNA replication	BP
11	66	2.73372111195	-	2.84e-07	GO:0014068	positive regulation of phosphatidylinositol 3-kinase signaling	BP
4	24	2.73372111195	-	2.77e-03	GO:1901216	positive regulation of neuron death	BP
3	18	2.73372111195	-	5.67e-03	GO:0090026	positive regulation of monocyte chemotaxis	BP
3	18	2.73372111195	-	8.17e-03	GO:0035024	negative regulation of Rho protein signal transduction	BP
3	18	2.73372111195	-	8.17e-03	GO:0035066	positive regulation of histone acetylation	BP
3	18	2.73372111195	-	8.17e-03	GO:0035307	positive regulation of protein dephosphorylation	BP
2	12	2.73372111195	-	1.59e-02	GO:0046889	positive regulation of lipid biosynthetic process	BP
2	12	2.73372111195	-	2.47e-02	GO:0030239	myofibril assembly	BP
2	12	2.73372111195	-	2.47e-02	GO:0060391	positive regulation of SMAD protein import into nucleus	BP
2	12	2.73372111195	-	2.47e-02	GO:0008206	bile acid metabolic process	BP
2	12	2.73372111195	-	2.47e-02	GO:0030195	negative regulation of blood coagulation	BP
2	12	2.73372111195	-	2.97e-02	GO:0030833	regulation of actin filament polymerization	BP
2	12	2.73372111195	-	2.97e-02	GO:0030212	hyaluronan metabolic process	BP
2	12	2.73372111195	-	3.50e-02	GO:0035635	entry of bacterium into host cell	BP
2	12	2.73372111195	-	3.50e-02	GO:0045820	negative regulation of glycolytic process	BP
2	12	2.73372111195	-	3.50e-02	GO:0050765	negative regulation of phagocytosis	BP
2	12	2.73372111195	-	3.50e-02	GO:0048012	hepatocyte growth factor receptor signaling pathway	BP
1	6	2.73372111195	-	7.33e-02	GO:0051552	flavone metabolic process	BP
1	6	2.73372111195	-	7.33e-02	GO:0044245	polysaccharide digestion	BP
1	6	2.73372111195	-	7.33e-02	GO:0001696	gastric acid secretion	BP
1	6	2.73372111195	-	7.33e-02	GO:0071286	cellular response to magnesium ion	BP
1	6	2.73372111195	-	9.65e-02	GO:0060267	positive regulation of respiratory burst	BP
1	6	2.73372111195	-	9.65e-02	GO:0086015	SA node cell action potential	BP
1	6	2.73372111195	-	9.65e-02	GO:0060426	lung vasculature development	BP
1	6	2.73372111195	-	9.65e-02	GO:1990845	adaptive thermogenesis	BP
1	6	2.73372111195	-	9.65e-02	GO:2000507	positive regulation of energy homeostasis	BP
1	6	2.73372111195	-	9.65e-02	GO:0055123	digestive system development	BP
1	6	2.73372111195	-	9.65e-02	GO:0007144	female meiosis I	BP
1	6	2.73372111195	-	9.65e-02	GO:0061000	negative regulation of dendritic spine development	BP
1	6	2.73372111195	-	1.19e-01	GO:0061037	negative regulation of cartilage development	BP
1	6	2.73372111195	-	1.19e-01	GO:0033555	multicellular organismal response to stress	BP
1	6	2.73372111195	-	1.19e-01	GO:0042536	negative regulation of tumor necrosis factor biosynthetic process	BP
1	6	2.73372111195	-	1.19e-01	GO:0048524	positive regulation of viral process	BP
1	6	2.73372111195	-	1.19e-01	GO:0060428	lung epithelium development	BP
1	6	2.73372111195	-	1.19e-01	GO:0060074	synapse maturation	BP
1	6	2.73372111195	-	1.19e-01	GO:0061180	mammary gland epithelium development	BP
1	6	2.73372111195	-	1.19e-01	GO:0050707	regulation of cytokine secretion	BP
1	6	2.73372111195	-	1.19e-01	GO:0032792	negative regulation of CREB transcription factor activity	BP
1	6	2.73372111195	-	1.19e-01	GO:0021902	commitment of neuronal cell to specific neuron type in forebrain	BP
1	6	2.73372111195	-	1.19e-01	GO:0033211	adiponectin-activated signaling pathway	BP
1	6	2.73372111195	-	1.19e-01	GO:1904385	cellular response to angiotensin	BP
1	6	2.73372111195	-	1.19e-01	GO:0033157	regulation of intracellular protein transport	BP
1	6	2.73372111195	-	1.19e-01	GO:0010594	regulation of endothelial cell migration	BP
1	6	2.73372111195	-	1.19e-01	GO:0051438	regulation of ubiquitin-protein transferase activity	BP
1	6	2.73372111195	-	1.19e-01	GO:0010960	magnesium ion homeostasis	BP
1	6	2.73372111195	-	1.41e-01	GO:0010757	negative regulation of plasminogen activation	BP
1	6	2.73372111195	-	1.41e-01	GO:0010756	positive regulation of plasminogen activation	BP
1	6	2.73372111195	-	1.41e-01	GO:0046825	regulation of protein export from nucleus	BP
1	6	2.73372111195	-	1.41e-01	GO:0046632	alpha-beta T cell differentiation	BP
1	6	2.73372111195	-	1.41e-01	GO:0051101	regulation of DNA binding	BP
1	6	2.73372111195	-	1.41e-01	GO:0043615	astrocyte cell migration	BP
1	6	2.73372111195	-	1.41e-01	GO:0048642	negative regulation of skeletal muscle tissue development	BP
1	6	2.73372111195	-	1.41e-01	GO:1902533	positive regulation of intracellular signal transduction	BP
1	6	2.73372111195	-	1.41e-01	GO:0046321	positive regulation of fatty acid oxidation	BP
1	6	2.73372111195	-	1.41e-01	GO:0035900	response to isolation stress	BP
1	6	2.73372111195	-	1.41e-01	GO:0055013	cardiac muscle cell development	BP
1	6	2.73372111195	-	1.41e-01	GO:2000323	negative regulation of glucocorticoid receptor signaling pathway	BP
1	6	2.73372111195	-	1.41e-01	GO:0060789	hair follicle placode formation	BP
1	6	2.73372111195	-	1.41e-01	GO:0034620	cellular response to unfolded protein	BP
1	6	2.73372111195	-	1.41e-01	GO:0006777	Mo-molybdopterin cofactor biosynthetic process	BP
1	6	2.73372111195	-	1.41e-01	GO:1903799	negative regulation of production of miRNAs involved in gene silencing by miRNA	BP
1	6	2.73372111195	-	1.41e-01	GO:0031023	microtubule organizing center organization	BP
1	6	2.73372111195	-	1.41e-01	GO:0003309	type B pancreatic cell differentiation	BP
1	6	2.73372111195	-	1.41e-01	GO:0060770	negative regulation of epithelial cell proliferation involved in prostate gland development	BP
1	6	2.73372111195	-	1.41e-01	GO:0032025	response to cobalt ion	BP
1	6	2.73372111195	-	1.41e-01	GO:0003158	endothelium development	BP
1	6	2.73372111195	-	1.41e-01	GO:0007182	common-partner SMAD protein phosphorylation	BP
1	6	2.73372111195	-	1.41e-01	GO:0010042	response to manganese ion	BP
1	6	2.73372111195	-	1.41e-01	GO:0046755	viral budding	BP
1	6	2.73372111195	-	1.41e-01	GO:0071470	cellular response to osmotic stress	BP
1	6	2.73372111195	-	1.41e-01	GO:0071476	cellular hypotonic response	BP
1	6	2.73372111195	-	1.41e-01	GO:1901016	regulation of potassium ion transmembrane transporter activity	BP
1	6	2.73372111195	-	1.41e-01	GO:0046881	positive regulation of follicle-stimulating hormone secretion	BP
1	6	2.73372111195	-	1.41e-01	GO:1900113	negative regulation of histone H3-K9 trimethylation	BP
1	6	2.73372111195	-	1.41e-01	GO:0006616	SRP-dependent cotranslational protein targeting to membrane, translocation	BP
1	6	2.73372111195	-	1.41e-01	GO:0007185	transmembrane receptor protein tyrosine phosphatase signaling pathway	BP
1	6	2.73372111195	-	1.41e-01	GO:0032680	regulation of tumor necrosis factor production	BP
1	6	2.73372111195	-	1.41e-01	GO:0051964	negative regulation of synapse assembly	BP
1	6	2.73372111195	-	1.41e-01	GO:0051346	negative regulation of hydrolase activity	BP
1	6	2.73372111195	-	1.41e-01	GO:0033194	response to hydroperoxide	BP
1	6	2.73372111195	-	1.41e-01	GO:0010035	response to inorganic substance	BP
1	6	2.73372111195	-	1.41e-01	GO:0035020	regulation of Rac protein signal transduction	BP
1	6	2.73372111195	-	1.41e-01	GO:0060440	trachea formation	BP
1	6	2.73372111195	-	1.41e-01	GO:0035897	proteolysis in other organism	BP
1	6	2.73372111195	-	1.41e-01	GO:0006207	'de novo' pyrimidine nucleobase biosynthetic process	BP
3	18	2.73372111195	-	1.64e-03	GO:0005520	insulin-like growth factor binding	MF
2	12	2.73372111195	-	3.50e-02	GO:0051010	microtubule plus-end binding	MF
1	6	2.73372111195	-	7.33e-02	GO:0047035	testosterone dehydrogenase (NAD+) activity	MF
1	6	2.73372111195	-	9.65e-02	GO:0004630	phospholipase D activity	MF
1	6	2.73372111195	-	9.65e-02	GO:0070097	delta-catenin binding	MF
1	6	2.73372111195	-	9.65e-02	GO:0003836	beta-galactoside (CMP) alpha-2,3-sialyltransferase activity	MF
1	6	2.73372111195	-	1.19e-01	GO:0001042	RNA polymerase I core binding	MF
1	6	2.73372111195	-	1.19e-01	GO:1990226	histone methyltransferase binding	MF
1	6	2.73372111195	-	1.41e-01	GO:0061133	endopeptidase activator activity	MF
1	6	2.73372111195	-	1.41e-01	GO:0048406	nerve growth factor binding	MF
1	6	2.73372111195	-	1.41e-01	GO:0030275	LRR domain binding	MF
1	6	2.73372111195	-	1.41e-01	GO:0019870	potassium channel inhibitor activity	MF
1	6	2.73372111195	-	1.41e-01	GO:0030911	TPR domain binding	MF
1	6	2.73372111195	-	1.41e-01	GO:0031730	CCR5 chemokine receptor binding	MF
1	6	2.73372111195	-	1.41e-01	GO:0071253	connexin binding	MF
1	6	2.73372111195	-	1.41e-01	GO:0019237	centromeric DNA binding	MF
7	43	2.69977378003	-	3.77e-05	GO:0016303	1-phosphatidylinositol-3-kinase activity	MF
5	31	2.68641539717	-	6.94e-04	GO:0071276	cellular response to cadmium ion	BP
4	25	2.6748274229	-	2.35e-03	GO:0030511	positive regulation of transforming growth factor beta receptor signaling pathway	BP
4	25	2.6748274229	-	3.23e-03	GO:0071353	cellular response to interleukin-4	BP
4	25	2.6748274229	-	2.77e-03	GO:0071889	14-3-3 protein binding	MF
9	57	2.65571859995	-	5.88e-06	GO:0007173	epidermal growth factor receptor signaling pathway	BP
3	19	2.65571859995	-	9.62e-03	GO:0010906	regulation of glucose metabolic process	BP
3	19	2.65571859995	-	1.12e-02	GO:1900182	positive regulation of protein localization to nucleus	BP
3	19	2.65571859995	-	1.12e-02	GO:0031572	G2 DNA damage checkpoint	BP
5	32	2.64061170756	-	8.16e-04	GO:0001932	regulation of protein phosphorylation	BP
10	64	2.64061170756	-	2.89e-06	GO:0019903	protein phosphatase binding	MF
4	26	2.61824389453	-	2.35e-03	GO:0045840	positive regulation of mitotic nuclear division	BP
4	26	2.61824389453	-	2.77e-03	GO:0010800	positive regulation of peptidyl-threonine phosphorylation	BP
2	13	2.61824389453	-	1.21e-02	GO:0061051	positive regulation of cell growth involved in cardiac muscle cell development	BP
2	13	2.61824389453	-	2.01e-02	GO:0001775	cell activation	BP
2	13	2.61824389453	-	2.01e-02	GO:0072488	ammonium transmembrane transport	BP
2	13	2.61824389453	-	2.97e-02	GO:0008610	lipid biosynthetic process	BP
2	13	2.61824389453	-	3.50e-02	GO:1900181	negative regulation of protein localization to nucleus	BP
2	13	2.61824389453	-	3.50e-02	GO:0090162	establishment of epithelial cell polarity	BP
2	13	2.61824389453	-	3.50e-02	GO:0071361	cellular response to ethanol	BP
2	13	2.61824389453	-	3.50e-02	GO:0030194	positive regulation of blood coagulation	BP
2	13	2.61824389453	-	4.07e-02	GO:0016242	negative regulation of macroautophagy	BP
2	13	2.61824389453	-	4.07e-02	GO:0045197	establishment or maintenance of epithelial cell apical/basal polarity	BP
2	13	2.61824389453	-	4.07e-02	GO:1902176	negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway	BP
2	13	2.61824389453	-	4.07e-02	GO:0006809	nitric oxide biosynthetic process	BP
10	66	2.5962175882	-	3.90e-06	GO:0032147	activation of protein kinase activity	BP
5	33	2.5962175882	-	1.11e-03	GO:0043491	protein kinase B signaling	BP
6	40	2.5817180185	-	2.44e-04	GO:0071902	positive regulation of protein serine/threonine kinase activity	BP
6	40	2.5817180185	-	3.32e-04	GO:0071364	cellular response to epidermal growth factor stimulus	BP
3	20	2.5817180185	-	1.12e-02	GO:0045861	negative regulation of proteolysis	BP
5	34	2.55314886631	-	1.28e-03	GO:0097194	execution phase of apoptosis	BP
14	96	2.54107603401	-	1.92e-08	GO:0042593	glucose homeostasis	BP
6	42	2.51132869061	-	5.08e-04	GO:0045429	positive regulation of nitric oxide biosynthetic process	BP
4	28	2.51132869061	-	1.65e-03	GO:0060338	regulation of type I interferon-mediated signaling pathway	BP
3	21	2.51132869061	-	9.62e-03	GO:0046697	decidualization	BP
3	21	2.51132869061	-	1.12e-02	GO:0042730	fibrinolysis	BP
3	21	2.51132869061	-	1.30e-02	GO:0030879	mammary gland development	BP
2	14	2.51132869061	-	3.50e-02	GO:0050730	regulation of peptidyl-tyrosine phosphorylation	BP
2	14	2.51132869061	-	3.50e-02	GO:1901185	negative regulation of ERBB signaling pathway	BP
2	14	2.51132869061	-	3.50e-02	GO:0031641	regulation of myelination	BP
2	14	2.51132869061	-	4.07e-02	GO:2000060	positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process	BP
2	14	2.51132869061	-	4.67e-02	GO:0031529	ruffle organization	BP
2	14	2.51132869061	-	4.67e-02	GO:0022904	respiratory electron transport chain	BP
2	14	2.51132869061	-	4.67e-02	GO:0060644	mammary gland epithelial cell differentiation	BP
2	14	2.51132869061	-	4.67e-02	GO:0007175	negative regulation of epidermal growth factor-activated receptor activity	BP
1	7	2.51132869061	-	7.33e-02	GO:0019367	fatty acid elongation, saturated fatty acid	BP
1	7	2.51132869061	-	7.33e-02	GO:0034625	fatty acid elongation, monounsaturated fatty acid	BP
1	7	2.51132869061	-	7.33e-02	GO:0034626	fatty acid elongation, polyunsaturated fatty acid	BP
1	7	2.51132869061	-	9.65e-02	GO:0051694	pointed-end actin filament capping	BP
1	7	2.51132869061	-	9.65e-02	GO:0045606	positive regulation of epidermal cell differentiation	BP
1	7	2.51132869061	-	9.65e-02	GO:0035356	cellular triglyceride homeostasis	BP
1	7	2.51132869061	-	9.65e-02	GO:0085029	extracellular matrix assembly	BP
1	7	2.51132869061	-	1.19e-01	GO:0043654	recognition of apoptotic cell	BP
1	7	2.51132869061	-	1.19e-01	GO:0048646	anatomical structure formation involved in morphogenesis	BP
1	7	2.51132869061	-	1.19e-01	GO:0031119	tRNA pseudouridine synthesis	BP
1	7	2.51132869061	-	1.19e-01	GO:0033135	regulation of peptidyl-serine phosphorylation	BP
1	7	2.51132869061	-	1.19e-01	GO:0035878	nail development	BP
1	7	2.51132869061	-	1.19e-01	GO:0021559	trigeminal nerve development	BP
1	7	2.51132869061	-	1.19e-01	GO:0036302	atrioventricular canal development	BP
1	7	2.51132869061	-	1.19e-01	GO:0060710	chorio-allantoic fusion	BP
1	7	2.51132869061	-	1.41e-01	GO:0034138	toll-like receptor 3 signaling pathway	BP
1	7	2.51132869061	-	1.41e-01	GO:0015872	dopamine transport	BP
1	7	2.51132869061	-	1.41e-01	GO:0032287	peripheral nervous system myelin maintenance	BP
1	7	2.51132869061	-	1.41e-01	GO:0045722	positive regulation of gluconeogenesis	BP
1	7	2.51132869061	-	1.41e-01	GO:0060998	regulation of dendritic spine development	BP
1	7	2.51132869061	-	1.41e-01	GO:2000617	positive regulation of histone H3-K9 acetylation	BP
1	7	2.51132869061	-	1.41e-01	GO:0043305	negative regulation of mast cell degranulation	BP
1	7	2.51132869061	-	1.41e-01	GO:0034983	peptidyl-lysine deacetylation	BP
1	7	2.51132869061	-	1.41e-01	GO:0030510	regulation of BMP signaling pathway	BP
1	7	2.51132869061	-	1.41e-01	GO:0060576	intestinal epithelial cell development	BP
1	7	2.51132869061	-	1.41e-01	GO:0071281	cellular response to iron ion	BP
1	7	2.51132869061	-	1.41e-01	GO:0035726	common myeloid progenitor cell proliferation	BP
1	7	2.51132869061	-	1.41e-01	GO:0045822	negative regulation of heart contraction	BP
1	7	2.51132869061	-	1.63e-01	GO:0050810	regulation of steroid biosynthetic process	BP
1	7	2.51132869061	-	1.63e-01	GO:2000641	regulation of early endosome to late endosome transport	BP
1	7	2.51132869061	-	1.63e-01	GO:0032324	molybdopterin cofactor biosynthetic process	BP
1	7	2.51132869061	-	1.63e-01	GO:0036010	protein localization to endosome	BP
1	7	2.51132869061	-	1.63e-01	GO:0099565	chemical synaptic transmission, postsynaptic	BP
1	7	2.51132869061	-	1.63e-01	GO:0030042	actin filament depolymerization	BP
1	7	2.51132869061	-	1.63e-01	GO:0090091	positive regulation of extracellular matrix disassembly	BP
1	7	2.51132869061	-	1.63e-01	GO:0030948	negative regulation of vascular endothelial growth factor receptor signaling pathway	BP
1	7	2.51132869061	-	1.63e-01	GO:0034141	positive regulation of toll-like receptor 3 signaling pathway	BP
1	7	2.51132869061	-	1.63e-01	GO:0043405	regulation of MAP kinase activity	BP
1	7	2.51132869061	-	1.63e-01	GO:0010870	positive regulation of receptor biosynthetic process	BP
1	7	2.51132869061	-	1.63e-01	GO:0048102	autophagic cell death	BP
1	7	2.51132869061	-	1.63e-01	GO:0006544	glycine metabolic process	BP
1	7	2.51132869061	-	1.63e-01	GO:0034351	negative regulation of glial cell apoptotic process	BP
1	7	2.51132869061	-	1.63e-01	GO:1903896	positive regulation of IRE1-mediated unfolded protein response	BP
1	7	2.51132869061	-	1.63e-01	GO:0048261	negative regulation of receptor-mediated endocytosis	BP
1	7	2.51132869061	-	1.63e-01	GO:0051988	regulation of attachment of spindle microtubules to kinetochore	BP
1	7	2.51132869061	-	1.63e-01	GO:0010642	negative regulation of platelet-derived growth factor receptor signaling pathway	BP
1	7	2.51132869061	-	1.63e-01	GO:0035360	positive regulation of peroxisome proliferator activated receptor signaling pathway	BP
1	7	2.51132869061	-	1.63e-01	GO:2001171	positive regulation of ATP biosynthetic process	BP
1	7	2.51132869061	-	1.63e-01	GO:0071474	cellular hyperosmotic response	BP
1	7	2.51132869061	-	1.63e-01	GO:0034616	response to laminar fluid shear stress	BP
1	7	2.51132869061	-	1.63e-01	GO:0031642	negative regulation of myelination	BP
1	7	2.51132869061	-	1.63e-01	GO:0060008	Sertoli cell differentiation	BP
1	7	2.51132869061	-	1.63e-01	GO:0010742	macrophage derived foam cell differentiation	BP
1	7	2.51132869061	-	1.63e-01	GO:0010918	positive regulation of mitochondrial membrane potential	BP
1	7	2.51132869061	-	1.63e-01	GO:0044351	macropinocytosis	BP
1	7	2.51132869061	-	1.63e-01	GO:0071447	cellular response to hydroperoxide	BP
1	7	2.51132869061	-	1.63e-01	GO:0035065	regulation of histone acetylation	BP
1	7	2.51132869061	-	1.63e-01	GO:0014049	positive regulation of glutamate secretion	BP
1	7	2.51132869061	-	1.63e-01	GO:0061002	negative regulation of dendritic spine morphogenesis	BP
1	7	2.51132869061	-	1.63e-01	GO:2000601	positive regulation of Arp2/3 complex-mediated actin nucleation	BP
3	21	2.51132869061	-	1.48e-02	GO:0051019	mitogen-activated protein kinase binding	MF
2	14	2.51132869061	-	2.01e-02	GO:0070403	NAD+ binding	MF
2	14	2.51132869061	-	4.67e-02	GO:0032794	GTPase activating protein binding	MF
1	7	2.51132869061	-	4.95e-02	GO:0050291	sphingosine N-acyltransferase activity	MF
1	7	2.51132869061	-	7.33e-02	GO:0102337	3-oxo-cerotoyl-CoA synthase activity	MF
1	7	2.51132869061	-	7.33e-02	GO:0102336	3-oxo-arachidoyl-CoA synthase activity	MF
1	7	2.51132869061	-	7.33e-02	GO:0102338	3-oxo-lignoceronyl-CoA synthase activity	MF
1	7	2.51132869061	-	7.33e-02	GO:0015101	organic cation transmembrane transporter activity	MF
1	7	2.51132869061	-	7.33e-02	GO:0009922	fatty acid elongase activity	MF
1	7	2.51132869061	-	9.65e-02	GO:0008519	ammonium transmembrane transporter activity	MF
1	7	2.51132869061	-	1.41e-01	GO:0030619	U1 snRNA binding	MF
1	7	2.51132869061	-	1.41e-01	GO:0000405	bubble DNA binding	MF
1	7	2.51132869061	-	1.41e-01	GO:0005004	GPI-linked ephrin receptor activity	MF
1	7	2.51132869061	-	1.63e-01	GO:0005021	vascular endothelial growth factor-activated receptor activity	MF
1	7	2.51132869061	-	1.63e-01	GO:0031433	telethonin binding	MF
1	7	2.51132869061	-	1.63e-01	GO:0005114	type II transforming growth factor beta receptor binding	MF
1	7	2.51132869061	-	1.63e-01	GO:0003720	telomerase activity	MF
1	7	2.51132869061	-	1.63e-01	GO:0009931	calcium-dependent protein serine/threonine kinase activity	MF
1	7	2.51132869061	-	1.63e-01	GO:0008329	signaling pattern recognition receptor activity	MF
7	50	2.48218234495	-	1.01e-04	GO:0036092	phosphatidylinositol-3-phosphate biosynthetic process	BP
15	108	2.47068670612	-	1.98e-08	GO:0048015	phosphatidylinositol-mediated signaling	BP
4	29	2.46070261754	-	4.93e-03	GO:0004712	protein serine/threonine/tyrosine kinase activity	MF
7	51	2.45361319276	-	1.77e-04	GO:0004715	non-membrane spanning protein tyrosine kinase activity	MF
3	22	2.44421449475	-	1.69e-02	GO:0035257	nuclear hormone receptor binding	MF
5	37	2.43115834193	-	1.28e-03	GO:0010507	negative regulation of autophagy	BP
4	30	2.41179301706	-	4.31e-03	GO:0007281	germ cell development	BP
2	15	2.41179301706	-	1.21e-02	GO:0015695	organic cation transport	BP
2	15	2.41179301706	-	4.07e-02	GO:0090303	positive regulation of wound healing	BP
2	15	2.41179301706	-	4.67e-02	GO:0097067	cellular response to thyroid hormone stimulus	BP
2	15	2.41179301706	-	4.67e-02	GO:0060397	JAK-STAT cascade involved in growth hormone signaling pathway	BP
2	15	2.41179301706	-	4.67e-02	GO:0043254	regulation of protein complex assembly	BP
2	15	2.41179301706	-	5.30e-02	GO:2000484	positive regulation of interleukin-8 secretion	BP
2	15	2.41179301706	-	5.30e-02	GO:0043923	positive regulation by host of viral transcription	BP
2	15	2.41179301706	-	5.30e-02	GO:2000679	positive regulation of transcription regulatory region DNA binding	BP
2	15	2.41179301706	-	5.30e-02	GO:0051571	positive regulation of histone H3-K4 methylation	BP
2	15	2.41179301706	-	5.30e-02	GO:0048011	neurotrophin TRK receptor signaling pathway	BP
6	45	2.41179301706	-	5.08e-04	GO:0030971	receptor tyrosine kinase binding	MF
2	15	2.41179301706	-	5.30e-02	GO:0004708	MAP kinase kinase activity	MF
5	38	2.39268419411	-	1.91e-03	GO:0038128	ERBB2 signaling pathway	BP
18	138	2.38008415733	-	1.37e-09	GO:0001934	positive regulation of protein phosphorylation	BP
3	23	2.38008415733	-	1.48e-02	GO:0034394	protein localization to cell surface	BP
3	23	2.38008415733	-	1.69e-02	GO:0090398	cellular senescence	BP
3	23	2.38008415733	-	1.69e-02	GO:0050999	regulation of nitric-oxide synthase activity	BP
4	31	2.36448730228	-	4.93e-03	GO:0034614	cellular response to reactive oxygen species	BP
4	31	2.36448730228	-	7.14e-03	GO:0042059	negative regulation of epidermal growth factor receptor signaling pathway	BP
4	31	2.36448730228	-	6.34e-03	GO:0042169	SH2 domain binding	MF
18	140	2.35932559717	-	2.33e-09	GO:0007050	cell cycle arrest	BP
9	70	2.35932559717	-	5.93e-05	GO:0016241	regulation of macroautophagy	BP
6	48	2.31868361267	-	8.46e-04	GO:0042752	regulation of circadian rhythm	BP
4	32	2.31868361267	-	7.14e-03	GO:0071549	cellular response to dexamethasone stimulus	BP
3	24	2.31868361267	-	1.12e-02	GO:0032967	positive regulation of collagen biosynthetic process	BP
3	24	2.31868361267	-	1.69e-02	GO:0002040	sprouting angiogenesis	BP
1	8	2.31868361267	-	2.51e-02	GO:0010455	positive regulation of cell fate commitment	BP
2	16	2.31868361267	-	4.07e-02	GO:0048714	positive regulation of oligodendrocyte differentiation	BP
2	16	2.31868361267	-	4.07e-02	GO:0035567	non-canonical Wnt signaling pathway	BP
2	16	2.31868361267	-	4.07e-02	GO:0045616	regulation of keratinocyte differentiation	BP
2	16	2.31868361267	-	4.67e-02	GO:0042307	positive regulation of protein import into nucleus	BP
2	16	2.31868361267	-	5.30e-02	GO:0006349	regulation of gene expression by genetic imprinting	BP
2	16	2.31868361267	-	5.30e-02	GO:0010633	negative regulation of epithelial cell migration	BP
2	16	2.31868361267	-	5.96e-02	GO:0036503	ERAD pathway	BP
2	16	2.31868361267	-	5.96e-02	GO:0046328	regulation of JNK cascade	BP
2	16	2.31868361267	-	5.96e-02	GO:0031396	regulation of protein ubiquitination	BP
2	16	2.31868361267	-	5.96e-02	GO:0032270	positive regulation of cellular protein metabolic process	BP
2	16	2.31868361267	-	5.96e-02	GO:0006978	DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator	BP
2	16	2.31868361267	-	5.96e-02	GO:0001935	endothelial cell proliferation	BP
1	8	2.31868361267	-	9.65e-02	GO:0030210	heparin biosynthetic process	BP
1	8	2.31868361267	-	1.19e-01	GO:0031017	exocrine pancreas development	BP
1	8	2.31868361267	-	1.19e-01	GO:0035865	cellular response to potassium ion	BP
1	8	2.31868361267	-	1.19e-01	GO:0034392	negative regulation of smooth muscle cell apoptotic process	BP
1	8	2.31868361267	-	1.19e-01	GO:0097264	self proteolysis	BP
1	8	2.31868361267	-	1.19e-01	GO:0060373	regulation of ventricular cardiac muscle cell membrane depolarization	BP
1	8	2.31868361267	-	1.41e-01	GO:0044342	type B pancreatic cell proliferation	BP
1	8	2.31868361267	-	1.41e-01	GO:0006704	glucocorticoid biosynthetic process	BP
1	8	2.31868361267	-	1.41e-01	GO:0035137	hindlimb morphogenesis	BP
1	8	2.31868361267	-	1.41e-01	GO:0008535	respiratory chain complex IV assembly	BP
1	8	2.31868361267	-	1.41e-01	GO:0060736	prostate gland growth	BP
1	8	2.31868361267	-	1.41e-01	GO:0042698	ovulation cycle	BP
1	8	2.31868361267	-	1.41e-01	GO:0097178	ruffle assembly	BP
1	8	2.31868361267	-	1.41e-01	GO:0007494	midgut development	BP
1	8	2.31868361267	-	1.41e-01	GO:0060259	regulation of feeding behavior	BP
1	8	2.31868361267	-	1.41e-01	GO:0051026	chiasma assembly	BP
1	8	2.31868361267	-	1.41e-01	GO:0071313	cellular response to caffeine	BP
1	8	2.31868361267	-	1.63e-01	GO:0035265	organ growth	BP
1	8	2.31868361267	-	1.63e-01	GO:0000012	single strand break repair	BP
1	8	2.31868361267	-	1.63e-01	GO:0051103	DNA ligation involved in DNA repair	BP
1	8	2.31868361267	-	1.63e-01	GO:0009629	response to gravity	BP
1	8	2.31868361267	-	1.63e-01	GO:0038003	opioid receptor signaling pathway	BP
1	8	2.31868361267	-	1.63e-01	GO:1901380	negative regulation of potassium ion transmembrane transport	BP
1	8	2.31868361267	-	1.63e-01	GO:0045059	positive thymic T cell selection	BP
1	8	2.31868361267	-	1.63e-01	GO:0032691	negative regulation of interleukin-1 beta production	BP
1	8	2.31868361267	-	1.63e-01	GO:0016264	gap junction assembly	BP
1	8	2.31868361267	-	1.63e-01	GO:0051549	positive regulation of keratinocyte migration	BP
1	8	2.31868361267	-	1.63e-01	GO:0007183	SMAD protein complex assembly	BP
1	8	2.31868361267	-	1.63e-01	GO:0050869	negative regulation of B cell activation	BP
1	8	2.31868361267	-	1.63e-01	GO:0009651	response to salt stress	BP
1	8	2.31868361267	-	1.63e-01	GO:0071316	cellular response to nicotine	BP
1	8	2.31868361267	-	1.84e-01	GO:0035148	tube formation	BP
1	8	2.31868361267	-	1.84e-01	GO:0045348	positive regulation of MHC class II biosynthetic process	BP
1	8	2.31868361267	-	1.84e-01	GO:0071493	cellular response to UV-B	BP
1	8	2.31868361267	-	1.84e-01	GO:0070723	response to cholesterol	BP
1	8	2.31868361267	-	1.84e-01	GO:1900029	positive regulation of ruffle assembly	BP
1	8	2.31868361267	-	1.84e-01	GO:0070307	lens fiber cell development	BP
1	8	2.31868361267	-	1.84e-01	GO:0001825	blastocyst formation	BP
1	8	2.31868361267	-	1.84e-01	GO:0006012	galactose metabolic process	BP
1	8	2.31868361267	-	1.84e-01	GO:0010888	negative regulation of lipid storage	BP
1	8	2.31868361267	-	1.84e-01	GO:0035331	negative regulation of hippo signaling	BP
1	8	2.31868361267	-	1.84e-01	GO:0006987	activation of signaling protein activity involved in unfolded protein response	BP
1	8	2.31868361267	-	1.84e-01	GO:0035372	protein localization to microtubule	BP
1	8	2.31868361267	-	1.84e-01	GO:0048143	astrocyte activation	BP
1	8	2.31868361267	-	1.84e-01	GO:0030851	granulocyte differentiation	BP
1	8	2.31868361267	-	1.84e-01	GO:0006975	DNA damage induced protein phosphorylation	BP
1	8	2.31868361267	-	1.84e-01	GO:0002903	negative regulation of B cell apoptotic process	BP
1	8	2.31868361267	-	1.84e-01	GO:0007172	signal complex assembly	BP
1	8	2.31868361267	-	1.84e-01	GO:1990253	cellular response to leucine starvation	BP
1	8	2.31868361267	-	1.84e-01	GO:1900119	positive regulation of execution phase of apoptosis	BP
1	8	2.31868361267	-	1.84e-01	GO:0038180	nerve growth factor signaling pathway	BP
1	8	2.31868361267	-	1.84e-01	GO:0085020	protein K6-linked ubiquitination	BP
1	8	2.31868361267	-	1.84e-01	GO:1901838	positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter	BP
1	8	2.31868361267	-	1.84e-01	GO:0007184	SMAD protein import into nucleus	BP
1	8	2.31868361267	-	1.84e-01	GO:0021795	cerebral cortex cell migration	BP
1	8	2.31868361267	-	1.84e-01	GO:0032872	regulation of stress-activated MAPK cascade	BP
1	8	2.31868361267	-	1.84e-01	GO:0033151	V(D)J recombination	BP
1	8	2.31868361267	-	1.84e-01	GO:0007270	neuron-neuron synaptic transmission	BP
1	8	2.31868361267	-	1.84e-01	GO:2000774	positive regulation of cellular senescence	BP
1	8	2.31868361267	-	1.84e-01	GO:0051683	establishment of Golgi localization	BP
1	8	2.31868361267	-	1.84e-01	GO:0060711	labyrinthine layer development	BP
1	8	2.31868361267	-	1.84e-01	GO:0051646	mitochondrion localization	BP
2	16	2.31868361267	-	5.30e-02	GO:0023026	MHC class II protein complex binding	MF
2	16	2.31868361267	-	5.96e-02	GO:0070182	DNA polymerase binding	MF
2	16	2.31868361267	-	5.96e-02	GO:0005001	transmembrane receptor protein tyrosine phosphatase activity	MF
1	8	2.31868361267	-	1.63e-01	GO:0042379	chemokine receptor binding	MF
1	8	2.31868361267	-	1.63e-01	GO:0015450	P-P-bond-hydrolysis-driven protein transmembrane transporter activity	MF
1	8	2.31868361267	-	1.63e-01	GO:0102991	myristoyl-CoA hydrolase activity	MF
1	8	2.31868361267	-	1.63e-01	GO:0043008	ATP-dependent protein binding	MF
1	8	2.31868361267	-	1.84e-01	GO:0030983	mismatched DNA binding	MF
1	8	2.31868361267	-	1.84e-01	GO:0097027	ubiquitin-protein transferase activator activity	MF
1	8	2.31868361267	-	1.84e-01	GO:0003857	3-hydroxyacyl-CoA dehydrogenase activity	MF
1	8	2.31868361267	-	1.84e-01	GO:0008432	JUN kinase binding	MF
1	8	2.31868361267	-	1.84e-01	GO:0031748	D1 dopamine receptor binding	MF
1	8	2.31868361267	-	1.84e-01	GO:0008140	cAMP response element binding protein binding	MF
1	8	2.31868361267	-	1.84e-01	GO:0001849	complement component C1q binding	MF
1	8	2.31868361267	-	1.84e-01	GO:0004726	non-membrane spanning protein tyrosine phosphatase activity	MF
1	8	2.31868361267	-	1.84e-01	GO:0035591	signaling adaptor activity	MF
7	57	2.29314852056	-	3.75e-04	GO:0048661	positive regulation of smooth muscle cell proliferation	BP
4	33	2.27428949331	-	4.93e-03	GO:0003007	heart morphogenesis	BP
8	66	2.27428949331	-	1.04e-04	GO:0046934	phosphatidylinositol-4,5-bisphosphate 3-kinase activity	MF
3	25	2.25978992362	-	1.12e-02	GO:0060349	bone morphogenesis	BP
3	25	2.25978992362	-	1.90e-02	GO:0043542	endothelial cell migration	BP
3	25	2.25978992362	-	1.90e-02	GO:0006611	protein export from nucleus	BP
3	25	2.25978992362	-	1.30e-02	GO:0019838	growth factor binding	MF
5	42	2.24829428478	-	2.74e-03	GO:0014823	response to activity	BP
12	102	2.23122077142	-	4.27e-06	GO:0038111	interleukin-7-mediated signaling pathway	BP
2	17	2.23122077142	-	3.50e-02	GO:0043537	negative regulation of blood vessel endothelial cell migration	BP
2	17	2.23122077142	-	4.07e-02	GO:0014850	response to muscle activity	BP
2	17	2.23122077142	-	4.07e-02	GO:0001953	negative regulation of cell-matrix adhesion	BP
2	17	2.23122077142	-	4.67e-02	GO:0043651	linoleic acid metabolic process	BP
2	17	2.23122077142	-	5.30e-02	GO:0021542	dentate gyrus development	BP
2	17	2.23122077142	-	5.96e-02	GO:0090201	negative regulation of release of cytochrome c from mitochondria	BP
2	17	2.23122077142	-	6.65e-02	GO:0031668	cellular response to extracellular stimulus	BP
2	17	2.23122077142	-	4.07e-02	GO:0008301	DNA binding, bending	MF
8	69	2.21015915589	-	1.87e-04	GO:0018107	peptidyl-threonine phosphorylation	BP
8	69	2.21015915589	-	2.58e-04	GO:0007265	Ras protein signal transduction	BP
3	26	2.20320639525	-	8.17e-03	GO:0042755	eating behavior	BP
3	26	2.20320639525	-	1.30e-02	GO:0010719	negative regulation of epithelial to mesenchymal transition	BP
3	26	2.20320639525	-	2.65e-02	GO:0016239	positive regulation of macroautophagy	BP
3	26	2.20320639525	-	2.65e-02	GO:0043388	positive regulation of DNA binding	BP
4	35	2.18940059573	-	8.93e-03	GO:1902042	negative regulation of extrinsic apoptotic signaling pathway via death domain receptors	BP
9	79	2.18482786594	-	8.29e-05	GO:0032869	cellular response to insulin stimulus	BP
6	53	2.17572565883	-	1.07e-03	GO:0043406	positive regulation of MAP kinase activity	BP
9	80	2.16668051923	-	1.14e-04	GO:0033138	positive regulation of peptidyl-serine phosphorylation	BP
4	36	2.14875861123	-	4.93e-03	GO:0045859	regulation of protein kinase activity	BP
3	27	2.14875861123	-	1.12e-02	GO:0009755	hormone-mediated signaling pathway	BP
3	27	2.14875861123	-	2.14e-02	GO:0046580	negative regulation of Ras protein signal transduction	BP
3	27	2.14875861123	-	2.14e-02	GO:2000352	negative regulation of endothelial cell apoptotic process	BP
3	27	2.14875861123	-	2.38e-02	GO:0006754	ATP biosynthetic process	BP
3	27	2.14875861123	-	2.65e-02	GO:0043392	negative regulation of DNA binding	BP
2	18	2.14875861123	-	5.30e-02	GO:0046427	positive regulation of JAK-STAT cascade	BP
2	18	2.14875861123	-	5.96e-02	GO:0017015	regulation of transforming growth factor beta receptor signaling pathway	BP
2	18	2.14875861123	-	6.65e-02	GO:0030325	adrenal gland development	BP
2	18	2.14875861123	-	6.65e-02	GO:0048854	brain morphogenesis	BP
2	18	2.14875861123	-	6.65e-02	GO:0030225	macrophage differentiation	BP
2	18	2.14875861123	-	6.65e-02	GO:0009416	response to light stimulus	BP
2	18	2.14875861123	-	6.65e-02	GO:0050860	negative regulation of T cell receptor signaling pathway	BP
1	9	2.14875861123	-	7.33e-02	GO:0016051	carbohydrate biosynthetic process	BP
1	9	2.14875861123	-	9.65e-02	GO:0060371	regulation of atrial cardiac muscle cell membrane depolarization	BP
1	9	2.14875861123	-	1.19e-01	GO:0051205	protein insertion into membrane	BP
1	9	2.14875861123	-	1.19e-01	GO:0043583	ear development	BP
1	9	2.14875861123	-	1.41e-01	GO:0051896	regulation of protein kinase B signaling	BP
1	9	2.14875861123	-	1.41e-01	GO:0042058	regulation of epidermal growth factor receptor signaling pathway	BP
1	9	2.14875861123	-	1.41e-01	GO:0043569	negative regulation of insulin-like growth factor receptor signaling pathway	BP
1	9	2.14875861123	-	1.41e-01	GO:0098773	skin epidermis development	BP
1	9	2.14875861123	-	1.41e-01	GO:0043117	positive regulation of vascular permeability	BP
1	9	2.14875861123	-	1.41e-01	GO:0042448	progesterone metabolic process	BP
1	9	2.14875861123	-	1.41e-01	GO:0046887	positive regulation of hormone secretion	BP
1	9	2.14875861123	-	1.41e-01	GO:2000304	positive regulation of ceramide biosynthetic process	BP
1	9	2.14875861123	-	1.63e-01	GO:0006518	peptide metabolic process	BP
1	9	2.14875861123	-	1.63e-01	GO:0048643	positive regulation of skeletal muscle tissue development	BP
1	9	2.14875861123	-	1.63e-01	GO:0097105	presynaptic membrane assembly	BP
1	9	2.14875861123	-	1.63e-01	GO:0002281	macrophage activation involved in immune response	BP
1	9	2.14875861123	-	1.63e-01	GO:0070072	vacuolar proton-transporting V-type ATPase complex assembly	BP
1	9	2.14875861123	-	1.63e-01	GO:0048806	genitalia development	BP
1	9	2.14875861123	-	1.63e-01	GO:0021702	cerebellar Purkinje cell differentiation	BP
1	9	2.14875861123	-	1.63e-01	GO:0097120	receptor localization to synapse	BP
1	9	2.14875861123	-	1.63e-01	GO:0046620	regulation of organ growth	BP
1	9	2.14875861123	-	1.63e-01	GO:0090277	positive regulation of peptide hormone secretion	BP
1	9	2.14875861123	-	1.63e-01	GO:0097011	cellular response to granulocyte macrophage colony-stimulating factor stimulus	BP
1	9	2.14875861123	-	1.84e-01	GO:0032731	positive regulation of interleukin-1 beta production	BP
1	9	2.14875861123	-	1.84e-01	GO:0016126	sterol biosynthetic process	BP
1	9	2.14875861123	-	1.84e-01	GO:0042119	neutrophil activation	BP
1	9	2.14875861123	-	1.84e-01	GO:0007019	microtubule depolymerization	BP
1	9	2.14875861123	-	1.84e-01	GO:0010762	regulation of fibroblast migration	BP
1	9	2.14875861123	-	1.84e-01	GO:0021675	nerve development	BP
1	9	2.14875861123	-	1.84e-01	GO:1902857	positive regulation of non-motile cilium assembly	BP
1	9	2.14875861123	-	1.84e-01	GO:2000001	regulation of DNA damage checkpoint	BP
1	9	2.14875861123	-	1.84e-01	GO:0070886	positive regulation of calcineurin-NFAT signaling cascade	BP
1	9	2.14875861123	-	1.84e-01	GO:1904153	negative regulation of retrograde protein transport, ER to cytosol	BP
1	9	2.14875861123	-	1.84e-01	GO:0042754	negative regulation of circadian rhythm	BP
1	9	2.14875861123	-	1.84e-01	GO:0010950	positive regulation of endopeptidase activity	BP
1	9	2.14875861123	-	1.84e-01	GO:0042088	T-helper 1 type immune response	BP
1	9	2.14875861123	-	1.84e-01	GO:0046855	inositol phosphate dephosphorylation	BP
1	9	2.14875861123	-	1.84e-01	GO:0032835	glomerulus development	BP
1	9	2.14875861123	-	1.84e-01	GO:0097484	dendrite extension	BP
1	9	2.14875861123	-	2.04e-01	GO:0051146	striated muscle cell differentiation	BP
1	9	2.14875861123	-	2.04e-01	GO:0034405	response to fluid shear stress	BP
1	9	2.14875861123	-	2.04e-01	GO:0008354	germ cell migration	BP
1	9	2.14875861123	-	2.04e-01	GO:0060627	regulation of vesicle-mediated transport	BP
1	9	2.14875861123	-	2.04e-01	GO:0050807	regulation of synapse organization	BP
1	9	2.14875861123	-	2.04e-01	GO:0071340	skeletal muscle acetylcholine-gated channel clustering	BP
1	9	2.14875861123	-	2.04e-01	GO:0008228	opsonization	BP
1	9	2.14875861123	-	2.04e-01	GO:0060670	branching involved in labyrinthine layer morphogenesis	BP
1	9	2.14875861123	-	2.04e-01	GO:0006265	DNA topological change	BP
1	9	2.14875861123	-	2.04e-01	GO:0010944	negative regulation of transcription by competitive promoter binding	BP
1	9	2.14875861123	-	2.04e-01	GO:0043589	skin morphogenesis	BP
1	9	2.14875861123	-	2.04e-01	GO:0070933	histone H4 deacetylation	BP
1	9	2.14875861123	-	2.04e-01	GO:0002262	myeloid cell homeostasis	BP
1	9	2.14875861123	-	2.04e-01	GO:0031497	chromatin assembly	BP
1	9	2.14875861123	-	2.04e-01	GO:0022407	regulation of cell-cell adhesion	BP
1	9	2.14875861123	-	2.04e-01	GO:0038063	collagen-activated tyrosine kinase receptor signaling pathway	BP
3	27	2.14875861123	-	1.48e-02	GO:0004435	phosphatidylinositol phospholipase C activity	MF
3	27	2.14875861123	-	2.92e-02	GO:0051721	protein phosphatase 2A binding	MF
1	9	2.14875861123	-	9.65e-02	GO:0033691	sialic acid binding	MF
1	9	2.14875861123	-	1.19e-01	GO:0055056	D-glucose transmembrane transporter activity	MF
1	9	2.14875861123	-	1.41e-01	GO:0046703	natural killer cell lectin-like receptor binding	MF
1	9	2.14875861123	-	1.63e-01	GO:0031404	chloride ion binding	MF
1	9	2.14875861123	-	1.84e-01	GO:0070679	inositol 1,4,5 trisphosphate binding	MF
1	9	2.14875861123	-	1.84e-01	GO:0000774	adenyl-nucleotide exchange factor activity	MF
1	9	2.14875861123	-	1.84e-01	GO:0046790	virion binding	MF
1	9	2.14875861123	-	1.84e-01	GO:0030291	protein serine/threonine kinase inhibitor activity	MF
1	9	2.14875861123	-	2.04e-01	GO:0004862	cAMP-dependent protein kinase inhibitor activity	MF
1	9	2.14875861123	-	2.04e-01	GO:0003691	double-stranded telomeric DNA binding	MF
1	9	2.14875861123	-	2.04e-01	GO:0032183	SUMO binding	MF
1	9	2.14875861123	-	2.04e-01	GO:0034713	type I transforming growth factor beta receptor binding	MF
9	82	2.13105660949	-	9.24e-05	GO:0014066	regulation of phosphatidylinositol 3-kinase signaling	BP
6	55	2.12228639987	-	1.34e-03	GO:0006950	response to stress	BP
18	166	2.11356918277	-	1.68e-07	GO:0046777	protein autophosphorylation	BP
4	37	2.10923024704	-	8.01e-03	GO:0034332	adherens junction organization	BP
6	56	2.09629119133	-	1.65e-03	GO:0009267	cellular response to starvation	BP
3	28	2.09629119133	-	1.30e-02	GO:0007131	reciprocal meiotic recombination	BP
3	28	2.09629119133	-	2.92e-02	GO:0000060	protein import into nucleus, translocation	BP
3	28	2.09629119133	-	3.22e-02	GO:0045739	positive regulation of DNA repair	BP
5	47	2.08602285588	-	4.67e-03	GO:0032760	positive regulation of tumor necrosis factor production	BP
7	66	2.08164441537	-	5.25e-04	GO:0051291	protein heterooligomerization	BP
9	85	2.07921767798	-	1.40e-04	GO:0019900	kinase binding	MF
2	19	2.07075609923	-	4.07e-02	GO:0033280	response to vitamin D	BP
2	19	2.07075609923	-	5.30e-02	GO:0002028	regulation of sodium ion transport	BP
2	19	2.07075609923	-	6.65e-02	GO:0014911	positive regulation of smooth muscle cell migration	BP
2	19	2.07075609923	-	6.65e-02	GO:0042246	tissue regeneration	BP
2	19	2.07075609923	-	6.65e-02	GO:0051968	positive regulation of synaptic transmission, glutamatergic	BP
2	19	2.07075609923	-	7.36e-02	GO:0046827	positive regulation of protein export from nucleus	BP
2	19	2.07075609923	-	7.36e-02	GO:0043153	entrainment of circadian clock by photoperiod	BP
2	19	2.07075609923	-	7.36e-02	GO:0046597	negative regulation of viral entry into host cell	BP
2	19	2.07075609923	-	8.09e-02	GO:0008637	apoptotic mitochondrial changes	BP
6	57	2.07075609923	-	2.22e-03	GO:0005070	SH3/SH2 adaptor activity	MF
2	19	2.07075609923	-	6.65e-02	GO:0030506	ankyrin binding	MF
3	29	2.04566511826	-	2.38e-02	GO:0007205	protein kinase C-activating G-protein coupled receptor signaling pathway	BP
3	29	2.04566511826	-	2.38e-02	GO:2000379	positive regulation of reactive oxygen species metabolic process	BP
3	29	2.04566511826	-	3.52e-02	GO:1900740	positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway	BP
3	29	2.04566511826	-	3.52e-02	GO:0042771	intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator	BP
5	49	2.02590186344	-	4.67e-03	GO:0071230	cellular response to amino acid stimulus	BP
6	59	2.02100306403	-	1.07e-03	GO:0042277	peptide binding	MF
7	69	2.01751407795	-	8.79e-04	GO:0001938	positive regulation of endothelial cell proliferation	BP
3	30	1.99675551778	-	1.48e-02	GO:0046676	negative regulation of insulin secretion	BP
3	30	1.99675551778	-	1.48e-02	GO:0045930	negative regulation of mitotic cell cycle	BP
3	30	1.99675551778	-	2.38e-02	GO:0060325	face morphogenesis	BP
2	20	1.99675551778	-	6.65e-02	GO:0042267	natural killer cell mediated cytotoxicity	BP
2	20	1.99675551778	-	7.36e-02	GO:0050771	negative regulation of axonogenesis	BP
2	20	1.99675551778	-	8.09e-02	GO:0032465	regulation of cytokinesis	BP
2	20	1.99675551778	-	8.85e-02	GO:1902895	positive regulation of pri-miRNA transcription from RNA polymerase II promoter	BP
2	20	1.99675551778	-	8.85e-02	GO:0016601	Rac protein signal transduction	BP
2	20	1.99675551778	-	8.85e-02	GO:0070932	histone H3 deacetylation	BP
2	20	1.99675551778	-	8.85e-02	GO:0008361	regulation of cell size	BP
1	10	1.99675551778	-	1.19e-01	GO:0006278	RNA-dependent DNA biosynthetic process	BP
1	10	1.99675551778	-	1.41e-01	GO:0008343	adult feeding behavior	BP
1	10	1.99675551778	-	1.63e-01	GO:0060306	regulation of membrane repolarization	BP
1	10	1.99675551778	-	1.63e-01	GO:0001867	complement activation, lectin pathway	BP
1	10	1.99675551778	-	1.63e-01	GO:0048935	peripheral nervous system neuron development	BP
1	10	1.99675551778	-	1.63e-01	GO:0010838	positive regulation of keratinocyte proliferation	BP
1	10	1.99675551778	-	1.84e-01	GO:0031665	negative regulation of lipopolysaccharide-mediated signaling pathway	BP
1	10	1.99675551778	-	1.84e-01	GO:0021680	cerebellar Purkinje cell layer development	BP
1	10	1.99675551778	-	1.84e-01	GO:2000480	negative regulation of cAMP-dependent protein kinase activity	BP
1	10	1.99675551778	-	1.84e-01	GO:0046325	negative regulation of glucose import	BP
1	10	1.99675551778	-	1.84e-01	GO:0050966	detection of mechanical stimulus involved in sensory perception of pain	BP
1	10	1.99675551778	-	1.84e-01	GO:0051256	mitotic spindle midzone assembly	BP
1	10	1.99675551778	-	1.84e-01	GO:0031953	negative regulation of protein autophosphorylation	BP
1	10	1.99675551778	-	1.84e-01	GO:0048853	forebrain morphogenesis	BP
1	10	1.99675551778	-	1.84e-01	GO:0051156	glucose 6-phosphate metabolic process	BP
1	10	1.99675551778	-	2.04e-01	GO:0086013	membrane repolarization during cardiac muscle cell action potential	BP
1	10	1.99675551778	-	2.04e-01	GO:0090394	negative regulation of excitatory postsynaptic potential	BP
1	10	1.99675551778	-	2.04e-01	GO:0042532	negative regulation of tyrosine phosphorylation of STAT protein	BP
1	10	1.99675551778	-	2.04e-01	GO:0051901	positive regulation of mitochondrial depolarization	BP
1	10	1.99675551778	-	2.04e-01	GO:0060674	placenta blood vessel development	BP
1	10	1.99675551778	-	2.04e-01	GO:0033673	negative regulation of kinase activity	BP
1	10	1.99675551778	-	2.04e-01	GO:0002218	activation of innate immune response	BP
1	10	1.99675551778	-	2.04e-01	GO:1902894	negative regulation of pri-miRNA transcription from RNA polymerase II promoter	BP
1	10	1.99675551778	-	2.04e-01	GO:0061564	axon development	BP
1	10	1.99675551778	-	2.04e-01	GO:0045475	locomotor rhythm	BP
1	10	1.99675551778	-	2.04e-01	GO:0003214	cardiac left ventricle morphogenesis	BP
1	10	1.99675551778	-	2.04e-01	GO:2001022	positive regulation of response to DNA damage stimulus	BP
1	10	1.99675551778	-	2.04e-01	GO:0046626	regulation of insulin receptor signaling pathway	BP
1	10	1.99675551778	-	2.04e-01	GO:0045793	positive regulation of cell size	BP
1	10	1.99675551778	-	2.24e-01	GO:0043248	proteasome assembly	BP
1	10	1.99675551778	-	2.24e-01	GO:0051247	positive regulation of protein metabolic process	BP
1	10	1.99675551778	-	2.24e-01	GO:0050678	regulation of epithelial cell proliferation	BP
1	10	1.99675551778	-	2.24e-01	GO:1902188	positive regulation of viral release from host cell	BP
1	10	1.99675551778	-	2.24e-01	GO:0043114	regulation of vascular permeability	BP
1	10	1.99675551778	-	2.24e-01	GO:1902237	positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway	BP
1	10	1.99675551778	-	2.24e-01	GO:0006884	cell volume homeostasis	BP
1	10	1.99675551778	-	2.24e-01	GO:0016572	histone phosphorylation	BP
1	10	1.99675551778	-	2.24e-01	GO:0060009	Sertoli cell development	BP
1	10	1.99675551778	-	2.24e-01	GO:2000637	positive regulation of gene silencing by miRNA	BP
1	10	1.99675551778	-	2.24e-01	GO:2000300	regulation of synaptic vesicle exocytosis	BP
1	10	1.99675551778	-	2.24e-01	GO:0060487	lung epithelial cell differentiation	BP
1	10	1.99675551778	-	2.24e-01	GO:0035067	negative regulation of histone acetylation	BP
2	20	1.99675551778	-	5.96e-02	GO:0042813	Wnt-activated receptor activity	MF
2	20	1.99675551778	-	7.36e-02	GO:0071949	FAD binding	MF
2	20	1.99675551778	-	8.85e-02	GO:0004896	cytokine receptor activity	MF
1	10	1.99675551778	-	1.41e-01	GO:0033130	acetylcholine receptor binding	MF
1	10	1.99675551778	-	2.04e-01	GO:0036312	phosphatidylinositol 3-kinase regulatory subunit binding	MF
1	10	1.99675551778	-	2.04e-01	GO:0030296	protein tyrosine kinase activator activity	MF
1	10	1.99675551778	-	2.24e-01	GO:0031702	type 1 angiotensin receptor binding	MF
1	10	1.99675551778	-	2.24e-01	GO:0045294	alpha-catenin binding	MF
1	10	1.99675551778	-	2.24e-01	GO:1990782	protein tyrosine kinase binding	MF
1	10	1.99675551778	-	2.24e-01	GO:0070016	armadillo repeat domain binding	MF
1	10	1.99675551778	-	2.24e-01	GO:0042975	peroxisome proliferator activated receptor binding	MF
6	61	1.97290877583	-	2.93e-03	GO:0009967	positive regulation of signal transduction	BP
5	51	1.96818636559	-	5.66e-03	GO:0045860	positive regulation of protein kinase activity	BP
8	82	1.96113160805	-	6.13e-04	GO:0030307	positive regulation of cell growth	BP
4	41	1.96113160805	-	1.33e-02	GO:0010718	positive regulation of epithelial to mesenchymal transition	BP
4	41	1.96113160805	-	1.74e-02	GO:0010508	positive regulation of autophagy	BP
6	62	1.949449803	-	2.44e-03	GO:0042531	positive regulation of tyrosine phosphorylation of STAT protein	BP
3	31	1.949449803	-	2.14e-02	GO:0048565	digestive tract development	BP
3	31	1.949449803	-	2.14e-02	GO:0045907	positive regulation of vasoconstriction	BP
3	31	1.949449803	-	4.18e-02	GO:0097421	liver regeneration	BP
9	94	1.93401976244	-	1.14e-04	GO:0051897	positive regulation of protein kinase B signaling	BP
6	63	1.92636618989	-	3.49e-03	GO:0001933	negative regulation of protein phosphorylation	BP
4	42	1.92636618989	-	1.60e-02	GO:0008630	intrinsic apoptotic signaling pathway in response to DNA damage	BP
2	21	1.92636618989	-	7.36e-02	GO:0035902	response to immobilization stress	BP
2	21	1.92636618989	-	7.36e-02	GO:0051493	regulation of cytoskeleton organization	BP
2	21	1.92636618989	-	8.85e-02	GO:0071901	negative regulation of protein serine/threonine kinase activity	BP
7	74	1.9165851691	-	7.96e-04	GO:0007623	circadian rhythm	BP
6	64	1.90364611339	-	2.44e-03	GO:0032868	response to insulin	BP
6	64	1.90364611339	-	3.49e-03	GO:0035690	cellular response to drug	BP
3	32	1.90364611339	-	3.52e-02	GO:0042220	response to cocaine	BP
3	32	1.90364611339	-	3.52e-02	GO:0071479	cellular response to ionizing radiation	BP
3	32	1.90364611339	-	3.84e-02	GO:0032008	positive regulation of TOR signaling	BP
3	32	1.90364611339	-	4.18e-02	GO:0046677	response to antibiotic	BP
3	32	1.90364611339	-	4.53e-02	GO:1990090	cellular response to nerve growth factor stimulus	BP
10	107	1.89914472116	-	6.18e-05	GO:0030336	negative regulation of cell migration	BP
4	43	1.89241885797	-	2.22e-02	GO:0050681	androgen receptor binding	MF
7	76	1.87811102128	-	1.96e-03	GO:0043410	positive regulation of MAPK cascade	BP
17	187	1.85925199403	-	5.93e-07	GO:0030335	positive regulation of cell migration	BP
4	44	1.85925199403	-	2.05e-02	GO:0045785	positive regulation of cell adhesion	BP
2	22	1.85925199403	-	7.36e-02	GO:0097755	positive regulation of blood vessel diameter	BP
2	22	1.85925199403	-	7.36e-02	GO:0045671	negative regulation of osteoclast differentiation	BP
2	22	1.85925199403	-	7.36e-02	GO:0071157	negative regulation of cell cycle arrest	BP
2	22	1.85925199403	-	8.85e-02	GO:0043536	positive regulation of blood vessel endothelial cell migration	BP
2	22	1.85925199403	-	8.85e-02	GO:1901224	positive regulation of NIK/NF-kappaB signaling	BP
2	22	1.85925199403	-	8.85e-02	GO:0035924	cellular response to vascular endothelial growth factor stimulus	BP
2	22	1.85925199403	-	8.85e-02	GO:1904886	beta-catenin destruction complex disassembly	BP
2	22	1.85925199403	-	9.62e-02	GO:0002092	positive regulation of receptor internalization	BP
2	22	1.85925199403	-	9.62e-02	GO:0050769	positive regulation of neurogenesis	BP
2	22	1.85925199403	-	9.62e-02	GO:2000378	negative regulation of reactive oxygen species metabolic process	BP
1	11	1.85925199403	-	1.41e-01	GO:0030166	proteoglycan biosynthetic process	BP
1	11	1.85925199403	-	1.63e-01	GO:0006636	unsaturated fatty acid biosynthetic process	BP
1	11	1.85925199403	-	1.84e-01	GO:0031639	plasminogen activation	BP
1	11	1.85925199403	-	1.84e-01	GO:0006346	methylation-dependent chromatin silencing	BP
1	11	1.85925199403	-	1.84e-01	GO:0060088	auditory receptor cell stereocilium organization	BP
1	11	1.85925199403	-	1.84e-01	GO:0048016	inositol phosphate-mediated signaling	BP
1	11	1.85925199403	-	2.04e-01	GO:0030431	sleep	BP
1	11	1.85925199403	-	2.04e-01	GO:0002675	positive regulation of acute inflammatory response	BP
1	11	1.85925199403	-	2.04e-01	GO:0001893	maternal placenta development	BP
1	11	1.85925199403	-	2.04e-01	GO:0017187	peptidyl-glutamic acid carboxylation	BP
1	11	1.85925199403	-	2.04e-01	GO:0045670	regulation of osteoclast differentiation	BP
1	11	1.85925199403	-	2.04e-01	GO:0045745	positive regulation of G-protein coupled receptor protein signaling pathway	BP
1	11	1.85925199403	-	2.04e-01	GO:0010996	response to auditory stimulus	BP
1	11	1.85925199403	-	2.24e-01	GO:0051489	regulation of filopodium assembly	BP
1	11	1.85925199403	-	2.24e-01	GO:0017156	calcium ion regulated exocytosis	BP
1	11	1.85925199403	-	2.24e-01	GO:0001952	regulation of cell-matrix adhesion	BP
1	11	1.85925199403	-	2.24e-01	GO:2000009	negative regulation of protein localization to cell surface	BP
1	11	1.85925199403	-	2.24e-01	GO:0006476	protein deacetylation	BP
1	11	1.85925199403	-	2.24e-01	GO:0032515	negative regulation of phosphoprotein phosphatase activity	BP
1	11	1.85925199403	-	2.24e-01	GO:0043116	negative regulation of vascular permeability	BP
1	11	1.85925199403	-	2.24e-01	GO:0030850	prostate gland development	BP
1	11	1.85925199403	-	2.44e-01	GO:0043249	erythrocyte maturation	BP
1	11	1.85925199403	-	2.44e-01	GO:0050927	positive regulation of positive chemotaxis	BP
1	11	1.85925199403	-	2.44e-01	GO:0031065	positive regulation of histone deacetylation	BP
1	11	1.85925199403	-	2.44e-01	GO:0032700	negative regulation of interleukin-17 production	BP
1	11	1.85925199403	-	2.44e-01	GO:0030238	male sex determination	BP
1	11	1.85925199403	-	2.44e-01	GO:0048712	negative regulation of astrocyte differentiation	BP
1	11	1.85925199403	-	2.44e-01	GO:0090136	epithelial cell-cell adhesion	BP
1	11	1.85925199403	-	2.44e-01	GO:0071372	cellular response to follicle-stimulating hormone stimulus	BP
1	11	1.85925199403	-	2.44e-01	GO:0033120	positive regulation of RNA splicing	BP
1	11	1.85925199403	-	2.44e-01	GO:0035563	positive regulation of chromatin binding	BP
1	11	1.85925199403	-	2.44e-01	GO:0000302	response to reactive oxygen species	BP
1	11	1.85925199403	-	2.44e-01	GO:0090331	negative regulation of platelet aggregation	BP
1	11	1.85925199403	-	2.44e-01	GO:1902902	negative regulation of autophagosome assembly	BP
1	11	1.85925199403	-	2.44e-01	GO:0071481	cellular response to X-ray	BP
1	11	1.85925199403	-	2.44e-01	GO:0033197	response to vitamin E	BP
1	11	1.85925199403	-	2.44e-01	GO:0032727	positive regulation of interferon-alpha production	BP
1	11	1.85925199403	-	2.44e-01	GO:0060444	branching involved in mammary gland duct morphogenesis	BP
3	33	1.85925199403	-	2.65e-02	GO:0004866	endopeptidase inhibitor activity	MF
2	22	1.85925199403	-	9.62e-02	GO:0004683	calmodulin-dependent protein kinase activity	MF
1	11	1.85925199403	-	1.84e-01	GO:0043394	proteoglycan binding	MF
1	11	1.85925199403	-	2.24e-01	GO:0008349	MAP kinase kinase kinase kinase activity	MF
1	11	1.85925199403	-	2.24e-01	GO:0050786	RAGE receptor binding	MF
1	11	1.85925199403	-	2.24e-01	GO:0016290	palmitoyl-CoA hydrolase activity	MF
1	11	1.85925199403	-	2.24e-01	GO:0005536	glucose binding	MF
1	11	1.85925199403	-	2.44e-01	GO:0008093	cytoskeletal adaptor activity	MF
1	11	1.85925199403	-	2.44e-01	GO:0031996	thioesterase binding	MF
1	11	1.85925199403	-	2.44e-01	GO:0032041	NAD-dependent histone deacetylase activity (H3-K14 specific)	MF
4	45	1.82683051634	-	1.74e-02	GO:0030838	positive regulation of actin filament polymerization	BP
4	45	1.82683051634	-	2.05e-02	GO:0006094	gluconeogenesis	BP
3	34	1.81618327214	-	2.92e-02	GO:0001890	placenta development	BP
3	34	1.81618327214	-	4.18e-02	GO:0031098	stress-activated protein kinase signaling cascade	BP
7	80	1.80411043984	-	2.90e-03	GO:0006928	movement of cell or subcellular component	BP
2	23	1.79512165661	-	8.09e-02	GO:0009954	proximal/distal pattern formation	BP
2	23	1.79512165661	-	8.85e-02	GO:0031018	endocrine pancreas development	BP
2	23	1.79512165661	-	9.62e-02	GO:0048870	cell motility	BP
2	23	1.79512165661	-	9.62e-02	GO:0071345	cellular response to cytokine stimulus	BP
2	23	1.79512165661	-	1.04e-01	GO:0007422	peripheral nervous system development	BP
2	23	1.79512165661	-	1.12e-01	GO:0051894	positive regulation of focal adhesion assembly	BP
2	23	1.79512165661	-	1.12e-01	GO:0090316	positive regulation of intracellular protein transport	BP
2	23	1.79512165661	-	1.12e-01	GO:0045736	negative regulation of cyclin-dependent protein serine/threonine kinase activity	BP
10	115	1.79512165661	-	2.56e-04	GO:0005088	Ras guanyl-nucleotide exchange factor activity	MF
2	23	1.79512165661	-	1.04e-01	GO:0035255	ionotropic glutamate receptor binding	MF
7	81	1.78618853184	-	1.66e-03	GO:0060070	canonical Wnt signaling pathway	BP
5	58	1.78263071243	-	6.79e-03	GO:0050679	positive regulation of epithelial cell proliferation	BP
3	35	1.77436309645	-	4.53e-02	GO:0051219	phosphoprotein binding	MF
3	35	1.77436309645	-	5.27e-02	GO:0005057	signal transducer activity, downstream of receptor	MF
4	47	1.76409476099	-	1.89e-02	GO:0051591	response to cAMP	BP
7	84	1.73372111195	-	4.15e-03	GO:0050731	positive regulation of peptidyl-tyrosine phosphorylation	BP
3	36	1.73372111195	-	5.66e-02	GO:0043407	negative regulation of MAP kinase activity	BP
2	24	1.73372111195	-	8.85e-02	GO:0031334	positive regulation of protein complex assembly	BP
2	24	1.73372111195	-	1.12e-01	GO:0048041	focal adhesion assembly	BP
2	24	1.73372111195	-	1.12e-01	GO:0097352	autophagosome maturation	BP
1	12	1.73372111195	-	1.19e-01	GO:0042446	hormone biosynthetic process	BP
2	24	1.73372111195	-	1.21e-01	GO:0051403	stress-activated MAPK cascade	BP
1	12	1.73372111195	-	1.41e-01	GO:1902475	L-alpha-amino acid transmembrane transport	BP
1	12	1.73372111195	-	1.41e-01	GO:1901652	response to peptide	BP
1	12	1.73372111195	-	1.63e-01	GO:0046323	glucose import	BP
1	12	1.73372111195	-	1.63e-01	GO:0032966	negative regulation of collagen biosynthetic process	BP
1	12	1.73372111195	-	1.84e-01	GO:2000727	positive regulation of cardiac muscle cell differentiation	BP
1	12	1.73372111195	-	2.04e-01	GO:0000050	urea cycle	BP
1	12	1.73372111195	-	2.04e-01	GO:0060416	response to growth hormone	BP
1	12	1.73372111195	-	2.04e-01	GO:0007041	lysosomal transport	BP
1	12	1.73372111195	-	2.04e-01	GO:0009395	phospholipid catabolic process	BP
1	12	1.73372111195	-	2.04e-01	GO:0034122	negative regulation of toll-like receptor signaling pathway	BP
1	12	1.73372111195	-	2.04e-01	GO:1900016	negative regulation of cytokine production involved in inflammatory response	BP
1	12	1.73372111195	-	2.24e-01	GO:0043616	keratinocyte proliferation	BP
1	12	1.73372111195	-	2.24e-01	GO:0097028	dendritic cell differentiation	BP
1	12	1.73372111195	-	2.24e-01	GO:0090399	replicative senescence	BP
1	12	1.73372111195	-	2.24e-01	GO:0019430	removal of superoxide radicals	BP
1	12	1.73372111195	-	2.24e-01	GO:0002009	morphogenesis of an epithelium	BP
1	12	1.73372111195	-	2.24e-01	GO:0002003	angiotensin maturation	BP
1	12	1.73372111195	-	2.24e-01	GO:0002437	inflammatory response to antigenic stimulus	BP
1	12	1.73372111195	-	2.24e-01	GO:0009888	tissue development	BP
1	12	1.73372111195	-	2.24e-01	GO:0046622	positive regulation of organ growth	BP
1	12	1.73372111195	-	2.44e-01	GO:0050921	positive regulation of chemotaxis	BP
1	12	1.73372111195	-	2.44e-01	GO:0008154	actin polymerization or depolymerization	BP
1	12	1.73372111195	-	2.44e-01	GO:0021670	lateral ventricle development	BP
1	12	1.73372111195	-	2.44e-01	GO:0014067	negative regulation of phosphatidylinositol 3-kinase signaling	BP
1	12	1.73372111195	-	2.44e-01	GO:0060766	negative regulation of androgen receptor signaling pathway	BP
1	12	1.73372111195	-	2.44e-01	GO:0034497	protein localization to pre-autophagosomal structure	BP
1	12	1.73372111195	-	2.44e-01	GO:0071257	cellular response to electrical stimulus	BP
1	12	1.73372111195	-	2.63e-01	GO:0010801	negative regulation of peptidyl-threonine phosphorylation	BP
1	12	1.73372111195	-	2.63e-01	GO:0055093	response to hyperoxia	BP
1	12	1.73372111195	-	2.63e-01	GO:0036499	PERK-mediated unfolded protein response	BP
1	12	1.73372111195	-	2.63e-01	GO:0042994	cytoplasmic sequestering of transcription factor	BP
1	12	1.73372111195	-	2.63e-01	GO:0090179	planar cell polarity pathway involved in neural tube closure	BP
1	12	1.73372111195	-	2.63e-01	GO:0035970	peptidyl-threonine dephosphorylation	BP
1	12	1.73372111195	-	2.63e-01	GO:0006301	postreplication repair	BP
1	12	1.73372111195	-	2.63e-01	GO:0032801	receptor catabolic process	BP
1	12	1.73372111195	-	2.63e-01	GO:0046710	GDP metabolic process	BP
1	12	1.73372111195	-	2.63e-01	GO:0061014	positive regulation of mRNA catabolic process	BP
1	12	1.73372111195	-	2.63e-01	GO:0048747	muscle fiber development	BP
1	12	1.73372111195	-	2.63e-01	GO:0097284	hepatocyte apoptotic process	BP
1	12	1.73372111195	-	2.63e-01	GO:0040007	growth	BP
1	12	1.73372111195	-	2.63e-01	GO:0021954	central nervous system neuron development	BP
2	24	1.73372111195	-	1.12e-01	GO:0043325	phosphatidylinositol-3,4-bisphosphate binding	MF
2	24	1.73372111195	-	1.21e-01	GO:0043425	bHLH transcription factor binding	MF
1	12	1.73372111195	-	1.41e-01	GO:0015179	L-amino acid transmembrane transporter activity	MF
1	12	1.73372111195	-	2.04e-01	GO:0016829	lyase activity	MF
1	12	1.73372111195	-	2.24e-01	GO:0005247	voltage-gated chloride channel activity	MF
1	12	1.73372111195	-	2.63e-01	GO:0042974	retinoic acid receptor binding	MF
1	12	1.73372111195	-	2.63e-01	GO:0000989	transcription factor activity, transcription factor binding	MF
11	133	1.72283279581	-	4.53e-04	GO:1901796	regulation of signal transduction by p53 class mediator	BP
9	109	1.72042428934	-	1.11e-03	GO:0000187	activation of MAPK activity	BP
10	122	1.70987437	-	6.21e-04	GO:0004713	protein tyrosine kinase activity	MF
8	98	1.70397376856	-	1.19e-03	GO:0001764	neuron migration	BP
4	49	1.70397376856	-	9.93e-03	GO:0051898	negative regulation of protein kinase B signaling	BP
3	37	1.69419274776	-	4.89e-02	GO:0042149	cellular response to glucose starvation	BP
3	37	1.69419274776	-	4.89e-02	GO:0009790	embryo development	BP
3	37	1.69419274776	-	5.66e-02	GO:0006605	protein targeting	BP
3	37	1.69419274776	-	6.06e-02	GO:2001237	negative regulation of extrinsic apoptotic signaling pathway	BP
3	37	1.69419274776	-	4.89e-02	GO:0005547	phosphatidylinositol-3,4,5-trisphosphate binding	MF
8	99	1.68932699259	-	1.29e-03	GO:0046854	phosphatidylinositol phosphorylation	BP
2	25	1.6748274229	-	1.04e-01	GO:0050772	positive regulation of axonogenesis	BP
2	25	1.6748274229	-	1.04e-01	GO:0021983	pituitary gland development	BP
2	25	1.6748274229	-	1.04e-01	GO:0034612	response to tumor necrosis factor	BP
2	25	1.6748274229	-	1.12e-01	GO:0022604	regulation of cell morphogenesis	BP
2	25	1.6748274229	-	1.12e-01	GO:0007569	cell aging	BP
2	25	1.6748274229	-	1.12e-01	GO:0060612	adipose tissue development	BP
2	25	1.6748274229	-	1.12e-01	GO:0051602	response to electrical stimulus	BP
2	25	1.6748274229	-	1.29e-01	GO:0061621	canonical glycolysis	BP
35	438	1.67317957001	-	1.68e-10	GO:0006468	protein phosphorylation	BP
7	88	1.66660691609	-	4.75e-03	GO:0007169	transmembrane receptor protein tyrosine kinase signaling pathway	BP
12	152	1.65571859995	-	2.54e-04	GO:0018108	peptidyl-tyrosine phosphorylation	BP
6	76	1.65571859995	-	1.12e-02	GO:1900034	regulation of cellular response to heat	BP
3	38	1.65571859995	-	5.66e-02	GO:0004721	phosphoprotein phosphatase activity	MF
4	51	1.6462582707	-	2.58e-02	GO:0048146	positive regulation of fibroblast proliferation	BP
4	51	1.6462582707	-	2.58e-02	GO:0010506	regulation of autophagy	BP
6	77	1.6368595727	-	7.03e-03	GO:0042060	wound healing	BP
2	26	1.61824389453	-	4.67e-02	GO:0006836	neurotransmitter transport	BP
3	39	1.61824389453	-	5.27e-02	GO:0050918	positive chemotaxis	BP
2	26	1.61824389453	-	9.62e-02	GO:0007202	activation of phospholipase C activity	BP
2	26	1.61824389453	-	1.12e-01	GO:0015758	glucose transport	BP
2	26	1.61824389453	-	1.12e-01	GO:0070372	regulation of ERK1 and ERK2 cascade	BP
2	26	1.61824389453	-	1.21e-01	GO:0070371	ERK1 and ERK2 cascade	BP
2	26	1.61824389453	-	1.29e-01	GO:0006096	glycolytic process	BP
2	26	1.61824389453	-	1.29e-01	GO:0071480	cellular response to gamma radiation	BP
2	26	1.61824389453	-	1.37e-01	GO:0007017	microtubule-based process	BP
1	13	1.61824389453	-	1.41e-01	GO:0042761	very long-chain fatty acid biosynthetic process	BP
1	13	1.61824389453	-	1.63e-01	GO:1901386	negative regulation of voltage-gated calcium channel activity	BP
1	13	1.61824389453	-	1.84e-01	GO:0006044	N-acetylglucosamine metabolic process	BP
1	13	1.61824389453	-	2.04e-01	GO:0031643	positive regulation of myelination	BP
1	13	1.61824389453	-	2.04e-01	GO:0071318	cellular response to ATP	BP
1	13	1.61824389453	-	2.24e-01	GO:0097435	supramolecular fiber organization	BP
1	13	1.61824389453	-	2.24e-01	GO:2000773	negative regulation of cellular senescence	BP
1	13	1.61824389453	-	2.24e-01	GO:0060389	pathway-restricted SMAD protein phosphorylation	BP
1	13	1.61824389453	-	2.44e-01	GO:0006359	regulation of transcription from RNA polymerase III promoter	BP
1	13	1.61824389453	-	2.44e-01	GO:0050872	white fat cell differentiation	BP
1	13	1.61824389453	-	2.44e-01	GO:0007171	activation of transmembrane receptor protein tyrosine kinase activity	BP
1	13	1.61824389453	-	2.44e-01	GO:0010248	establishment or maintenance of transmembrane electrochemical gradient	BP
1	13	1.61824389453	-	2.44e-01	GO:0071280	cellular response to copper ion	BP
1	13	1.61824389453	-	2.44e-01	GO:0032228	regulation of synaptic transmission, GABAergic	BP
1	13	1.61824389453	-	2.44e-01	GO:0036109	alpha-linolenic acid metabolic process	BP
1	13	1.61824389453	-	2.44e-01	GO:0044319	wound healing, spreading of cells	BP
1	13	1.61824389453	-	2.44e-01	GO:0045943	positive regulation of transcription from RNA polymerase I promoter	BP
1	13	1.61824389453	-	2.44e-01	GO:0071391	cellular response to estrogen stimulus	BP
1	13	1.61824389453	-	2.44e-01	GO:0045995	regulation of embryonic development	BP
1	13	1.61824389453	-	2.63e-01	GO:0007096	regulation of exit from mitosis	BP
1	13	1.61824389453	-	2.63e-01	GO:0060413	atrial septum morphogenesis	BP
1	13	1.61824389453	-	2.63e-01	GO:0046685	response to arsenic-containing substance	BP
1	13	1.61824389453	-	2.63e-01	GO:0032740	positive regulation of interleukin-17 production	BP
1	13	1.61824389453	-	2.63e-01	GO:0031274	positive regulation of pseudopodium assembly	BP
1	13	1.61824389453	-	2.63e-01	GO:2000010	positive regulation of protein localization to cell surface	BP
1	13	1.61824389453	-	2.63e-01	GO:0045780	positive regulation of bone resorption	BP
1	13	1.61824389453	-	2.63e-01	GO:0071285	cellular response to lithium ion	BP
1	13	1.61824389453	-	2.63e-01	GO:1902166	negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator	BP
1	13	1.61824389453	-	2.63e-01	GO:0035810	positive regulation of urine volume	BP
1	13	1.61824389453	-	2.81e-01	GO:0097296	activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway	BP
1	13	1.61824389453	-	2.81e-01	GO:1900025	negative regulation of substrate adhesion-dependent cell spreading	BP
1	13	1.61824389453	-	2.81e-01	GO:0060134	prepulse inhibition	BP
1	13	1.61824389453	-	2.81e-01	GO:0086064	cell communication by electrical coupling involved in cardiac conduction	BP
1	13	1.61824389453	-	2.81e-01	GO:0033630	positive regulation of cell adhesion mediated by integrin	BP
1	13	1.61824389453	-	2.81e-01	GO:0009650	UV protection	BP
1	13	1.61824389453	-	2.81e-01	GO:0042176	regulation of protein catabolic process	BP
2	26	1.61824389453	-	8.85e-02	GO:0004177	aminopeptidase activity	MF
1	13	1.61824389453	-	2.24e-01	GO:0009982	pseudouridine synthase activity	MF
1	13	1.61824389453	-	2.81e-01	GO:0008143	poly(A) binding	MF
1	13	1.61824389453	-	2.81e-01	GO:1904264	ubiquitin protein ligase activity involved in ERAD pathway	MF
1	13	1.61824389453	-	2.81e-01	GO:0034450	ubiquitin-ubiquitin ligase activity	MF
1	13	1.61824389453	-	2.81e-01	GO:0035259	glucocorticoid receptor binding	MF
1	13	1.61824389453	-	2.81e-01	GO:0004385	guanylate kinase activity	MF
9	119	1.5937908508	-	1.77e-03	GO:0030308	negative regulation of cell growth	BP
4	53	1.59076315811	-	3.18e-02	GO:0048511	rhythmic process	BP
6	80	1.5817180185	-	1.26e-02	GO:0007346	regulation of mitotic cell cycle	BP
3	40	1.5817180185	-	5.66e-02	GO:0009968	negative regulation of signal transduction	BP
6	80	1.5817180185	-	1.05e-02	GO:0008013	beta-catenin binding	MF
14	188	1.57144968305	-	1.58e-04	GO:0004672	protein kinase activity	MF
2	27	1.56379611051	-	1.04e-01	GO:0010575	positive regulation of vascular endothelial growth factor production	BP
2	27	1.56379611051	-	1.29e-01	GO:0040014	regulation of multicellular organism growth	BP
2	27	1.56379611051	-	1.37e-01	GO:0007093	mitotic cell cycle checkpoint	BP
2	27	1.56379611051	-	1.37e-01	GO:0035329	hippo signaling	BP
2	27	1.56379611051	-	1.46e-01	GO:0045931	positive regulation of mitotic cell cycle	BP
4	54	1.56379611051	-	3.39e-02	GO:0031072	heat shock protein binding	MF
2	27	1.56379611051	-	8.09e-02	GO:0001530	lipopolysaccharide binding	MF
2	27	1.56379611051	-	1.29e-01	GO:0001968	fibronectin binding	MF
7	95	1.5561829264	-	8.77e-03	GO:0016236	macroautophagy	BP
5	68	1.55314886631	-	1.70e-02	GO:0009749	response to glucose	BP
12	164	1.54609410877	-	3.08e-04	GO:0090090	negative regulation of canonical Wnt signaling pathway	BP
3	41	1.54609410877	-	7.35e-02	GO:0030331	estrogen receptor binding	MF
4	55	1.53732389915	-	4.60e-02	GO:0032922	circadian regulation of gene expression	BP
7	98	1.51132869061	-	6.53e-03	GO:0035335	peptidyl-tyrosine dephosphorylation	BP
5	70	1.51132869061	-	1.29e-02	GO:0001558	regulation of cell growth	BP
5	70	1.51132869061	-	2.47e-02	GO:0007584	response to nutrient	BP
4	56	1.51132869061	-	3.85e-02	GO:0006006	glucose metabolic process	BP
2	28	1.51132869061	-	1.21e-01	GO:0045595	regulation of cell differentiation	BP
2	28	1.51132869061	-	1.21e-01	GO:0032148	activation of protein kinase B activity	BP
2	28	1.51132869061	-	1.21e-01	GO:0016358	dendrite development	BP
2	28	1.51132869061	-	1.21e-01	GO:0071158	positive regulation of cell cycle arrest	BP
2	28	1.51132869061	-	1.37e-01	GO:0001662	behavioral fear response	BP
2	28	1.51132869061	-	1.37e-01	GO:0051090	regulation of sequence-specific DNA binding transcription factor activity	BP
2	28	1.51132869061	-	1.46e-01	GO:0051603	proteolysis involved in cellular protein catabolic process	BP
1	14	1.51132869061	-	1.63e-01	GO:0048149	behavioral response to ethanol	BP
1	14	1.51132869061	-	2.04e-01	GO:0021854	hypothalamus development	BP
1	14	1.51132869061	-	2.04e-01	GO:1904262	negative regulation of TORC1 signaling	BP
1	14	1.51132869061	-	2.04e-01	GO:1901223	negative regulation of NIK/NF-kappaB signaling	BP
1	14	1.51132869061	-	2.24e-01	GO:0031103	axon regeneration	BP
1	14	1.51132869061	-	2.24e-01	GO:0021591	ventricular system development	BP
1	14	1.51132869061	-	2.24e-01	GO:0002063	chondrocyte development	BP
1	14	1.51132869061	-	2.24e-01	GO:0010666	positive regulation of cardiac muscle cell apoptotic process	BP
1	14	1.51132869061	-	2.44e-01	GO:0010875	positive regulation of cholesterol efflux	BP
1	14	1.51132869061	-	2.44e-01	GO:0045717	negative regulation of fatty acid biosynthetic process	BP
1	14	1.51132869061	-	2.44e-01	GO:0061045	negative regulation of wound healing	BP
1	14	1.51132869061	-	2.44e-01	GO:0022011	myelination in peripheral nervous system	BP
1	14	1.51132869061	-	2.63e-01	GO:1903078	positive regulation of protein localization to plasma membrane	BP
1	14	1.51132869061	-	2.63e-01	GO:0071425	hematopoietic stem cell proliferation	BP
1	14	1.51132869061	-	2.63e-01	GO:0042711	maternal behavior	BP
1	14	1.51132869061	-	2.81e-01	GO:0030837	negative regulation of actin filament polymerization	BP
1	14	1.51132869061	-	2.81e-01	GO:0033147	negative regulation of intracellular estrogen receptor signaling pathway	BP
1	14	1.51132869061	-	2.81e-01	GO:0001921	positive regulation of receptor recycling	BP
1	14	1.51132869061	-	2.81e-01	GO:0030818	negative regulation of cAMP biosynthetic process	BP
1	14	1.51132869061	-	2.81e-01	GO:1903351	cellular response to dopamine	BP
1	14	1.51132869061	-	2.81e-01	GO:0050892	intestinal absorption	BP
1	14	1.51132869061	-	2.99e-01	GO:1902187	negative regulation of viral release from host cell	BP
1	14	1.51132869061	-	2.99e-01	GO:0043069	negative regulation of programmed cell death	BP
1	14	1.51132869061	-	2.99e-01	GO:0051492	regulation of stress fiber assembly	BP
1	14	1.51132869061	-	2.99e-01	GO:0010243	response to organonitrogen compound	BP
1	14	1.51132869061	-	2.99e-01	GO:0043518	negative regulation of DNA damage response, signal transduction by p53 class mediator	BP
1	14	1.51132869061	-	2.99e-01	GO:0030970	retrograde protein transport, ER to cytosol	BP
1	14	1.51132869061	-	2.99e-01	GO:0032006	regulation of TOR signaling	BP
4	56	1.51132869061	-	3.62e-02	GO:0004722	protein serine/threonine phosphatase activity	MF
2	28	1.51132869061	-	1.55e-01	GO:0046875	ephrin receptor binding	MF
2	28	1.51132869061	-	1.55e-01	GO:0097718	disordered domain specific binding	MF
1	14	1.51132869061	-	1.63e-01	GO:0005355	glucose transmembrane transporter activity	MF
1	14	1.51132869061	-	1.84e-01	GO:0030280	structural constituent of epidermis	MF
1	14	1.51132869061	-	2.04e-01	GO:0005149	interleukin-1 receptor binding	MF
1	14	1.51132869061	-	2.44e-01	GO:0005523	tropomyosin binding	MF
1	14	1.51132869061	-	2.63e-01	GO:0043274	phospholipase binding	MF
1	14	1.51132869061	-	2.63e-01	GO:0005344	oxygen transporter activity	MF
1	14	1.51132869061	-	2.63e-01	GO:0000982	transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding	MF
1	14	1.51132869061	-	2.81e-01	GO:0030169	low-density lipoprotein particle binding	MF
1	14	1.51132869061	-	2.99e-01	GO:1990381	ubiquitin-specific protease binding	MF
1	14	1.51132869061	-	2.99e-01	GO:0070063	RNA polymerase binding	MF
5	71	1.49086458805	-	3.09e-02	GO:0048010	vascular endothelial growth factor receptor signaling pathway	BP
4	57	1.48579359851	-	4.60e-02	GO:0003684	damaged DNA binding	MF
3	43	1.47738135869	-	6.06e-02	GO:0030178	negative regulation of Wnt signaling pathway	BP
3	43	1.47738135869	-	8.28e-02	GO:1901215	negative regulation of neuron death	BP
3	43	1.47738135869	-	8.75e-02	GO:0051496	positive regulation of stress fiber assembly	BP
4	58	1.46070261754	-	3.18e-02	GO:0050680	negative regulation of epithelial cell proliferation	BP
2	29	1.46070261754	-	9.62e-02	GO:0030163	protein catabolic process	BP
2	29	1.46070261754	-	1.12e-01	GO:0045776	negative regulation of blood pressure	BP
2	29	1.46070261754	-	1.21e-01	GO:0050873	brown fat cell differentiation	BP
2	29	1.46070261754	-	1.21e-01	GO:0001569	branching involved in blood vessel morphogenesis	BP
2	29	1.46070261754	-	1.29e-01	GO:2000145	regulation of cell motility	BP
2	29	1.46070261754	-	1.46e-01	GO:0045765	regulation of angiogenesis	BP
2	29	1.46070261754	-	1.55e-01	GO:0030032	lamellipodium assembly	BP
2	29	1.46070261754	-	1.64e-01	GO:0000077	DNA damage checkpoint	BP
2	29	1.46070261754	-	5.96e-02	GO:0005184	neuropeptide hormone activity	MF
2	29	1.46070261754	-	1.37e-01	GO:0008234	cysteine-type peptidase activity	MF
5	73	1.45078714868	-	5.15e-03	GO:0030216	keratinocyte differentiation	BP
6	88	1.44421449475	-	9.24e-03	GO:0007565	female pregnancy	BP
3	44	1.44421449475	-	3.52e-02	GO:0046426	negative regulation of JAK-STAT cascade	BP
3	44	1.44421449475	-	5.66e-02	GO:0032870	cellular response to hormone stimulus	BP
3	44	1.44421449475	-	7.35e-02	GO:0071363	cellular response to growth factor stimulus	BP
3	44	1.44421449475	-	8.75e-02	GO:0002224	toll-like receptor signaling pathway	BP
27	398	1.43694649429	-	7.49e-07	GO:0019901	protein kinase binding	MF
4	59	1.43604056331	-	1.33e-02	GO:0016266	O-glycan processing	BP
18	266	1.43332617861	-	6.68e-05	GO:0000165	MAPK cascade	BP
5	74	1.43115834193	-	3.25e-02	GO:0043154	negative regulation of cysteine-type endopeptidase activity involved in apoptotic process	BP
6	89	1.42791268243	-	1.51e-02	GO:0004725	protein tyrosine phosphatase activity	MF
7	104	1.42559881659	-	9.28e-03	GO:0071456	cellular response to hypoxia	BP
8	120	1.41179301706	-	1.29e-03	GO:0010951	negative regulation of endopeptidase activity	BP
4	60	1.41179301706	-	5.43e-02	GO:0070301	cellular response to hydrogen peroxide	BP
3	45	1.41179301706	-	5.66e-02	GO:0048839	inner ear development	BP
3	45	1.41179301706	-	7.35e-02	GO:0030900	forebrain development	BP
3	45	1.41179301706	-	7.35e-02	GO:0034605	cellular response to heat	BP
3	45	1.41179301706	-	7.81e-02	GO:0032956	regulation of actin cytoskeleton organization	BP
2	30	1.41179301706	-	1.04e-01	GO:0042104	positive regulation of activated T cell proliferation	BP
1	15	1.41179301706	-	1.41e-01	GO:0018298	protein-chromophore linkage	BP
2	30	1.41179301706	-	1.46e-01	GO:0007259	JAK-STAT cascade	BP
2	30	1.41179301706	-	1.46e-01	GO:0007616	long-term memory	BP
1	15	1.41179301706	-	2.04e-01	GO:0010831	positive regulation of myotube differentiation	BP
1	15	1.41179301706	-	2.24e-01	GO:0008209	androgen metabolic process	BP
1	15	1.41179301706	-	2.44e-01	GO:0050901	leukocyte tethering or rolling	BP
1	15	1.41179301706	-	2.63e-01	GO:0048485	sympathetic nervous system development	BP
1	15	1.41179301706	-	2.63e-01	GO:0010765	positive regulation of sodium ion transport	BP
1	15	1.41179301706	-	2.63e-01	GO:0006940	regulation of smooth muscle contraction	BP
1	15	1.41179301706	-	2.63e-01	GO:0032461	positive regulation of protein oligomerization	BP
1	15	1.41179301706	-	2.63e-01	GO:0035050	embryonic heart tube development	BP
1	15	1.41179301706	-	2.63e-01	GO:0086005	ventricular cardiac muscle cell action potential	BP
1	15	1.41179301706	-	2.81e-01	GO:0048738	cardiac muscle tissue development	BP
1	15	1.41179301706	-	2.81e-01	GO:0060347	heart trabecula formation	BP
1	15	1.41179301706	-	2.81e-01	GO:0007548	sex differentiation	BP
1	15	1.41179301706	-	2.81e-01	GO:0050965	detection of temperature stimulus involved in sensory perception of pain	BP
1	15	1.41179301706	-	2.81e-01	GO:0002042	cell migration involved in sprouting angiogenesis	BP
1	15	1.41179301706	-	2.81e-01	GO:2000310	regulation of NMDA receptor activity	BP
1	15	1.41179301706	-	2.81e-01	GO:0006309	apoptotic DNA fragmentation	BP
1	15	1.41179301706	-	2.81e-01	GO:0044849	estrous cycle	BP
1	15	1.41179301706	-	2.81e-01	GO:0050995	negative regulation of lipid catabolic process	BP
1	15	1.41179301706	-	2.81e-01	GO:0015671	oxygen transport	BP
1	15	1.41179301706	-	2.99e-01	GO:0033146	regulation of intracellular estrogen receptor signaling pathway	BP
1	15	1.41179301706	-	2.99e-01	GO:0071850	mitotic cell cycle arrest	BP
1	15	1.41179301706	-	2.99e-01	GO:0043277	apoptotic cell clearance	BP
1	15	1.41179301706	-	2.99e-01	GO:0030330	DNA damage response, signal transduction by p53 class mediator	BP
1	15	1.41179301706	-	2.99e-01	GO:0051412	response to corticosterone	BP
1	15	1.41179301706	-	2.99e-01	GO:0007076	mitotic chromosome condensation	BP
1	15	1.41179301706	-	2.99e-01	GO:0000729	DNA double-strand break processing	BP
1	15	1.41179301706	-	2.99e-01	GO:0034162	toll-like receptor 9 signaling pathway	BP
1	15	1.41179301706	-	2.99e-01	GO:0043162	ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway	BP
1	15	1.41179301706	-	2.99e-01	GO:0006414	translational elongation	BP
1	15	1.41179301706	-	3.17e-01	GO:0060997	dendritic spine morphogenesis	BP
1	15	1.41179301706	-	3.17e-01	GO:1903543	positive regulation of exosomal secretion	BP
1	15	1.41179301706	-	3.17e-01	GO:1902230	negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage	BP
1	15	1.41179301706	-	3.17e-01	GO:0044257	cellular protein catabolic process	BP
1	15	1.41179301706	-	3.17e-01	GO:0051770	positive regulation of nitric-oxide synthase biosynthetic process	BP
1	15	1.41179301706	-	2.04e-01	GO:0030247	polysaccharide binding	MF
1	15	1.41179301706	-	2.81e-01	GO:0017016	Ras GTPase binding	MF
1	15	1.41179301706	-	2.99e-01	GO:0004438	phosphatidylinositol-3-phosphatase activity	MF
1	15	1.41179301706	-	2.99e-01	GO:0035326	enhancer binding	MF
1	15	1.41179301706	-	3.17e-01	GO:0042809	vitamin D receptor binding	MF
1	15	1.41179301706	-	3.17e-01	GO:0005123	death receptor binding	MF
1	15	1.41179301706	-	3.17e-01	GO:0070742	C2H2 zinc finger domain binding	MF
1	15	1.41179301706	-	3.17e-01	GO:0004697	protein kinase C activity	MF
5	76	1.39268419411	-	2.47e-02	GO:0006661	phosphatidylinositol biosynthetic process	BP
4	61	1.38794627511	-	6.02e-02	GO:0031398	positive regulation of protein ubiquitination	BP
3	46	1.38008415733	-	6.91e-02	GO:0043647	inositol phosphate metabolic process	BP
3	46	1.38008415733	-	8.28e-02	GO:0007611	learning or memory	BP
3	46	1.38008415733	-	8.28e-02	GO:0009408	response to heat	BP
3	46	1.38008415733	-	9.75e-02	GO:0031100	animal organ regeneration	BP
3	46	1.38008415733	-	9.75e-02	GO:0030521	androgen receptor signaling pathway	BP
5	77	1.37382516686	-	3.79e-02	GO:0071260	cellular response to mechanical stimulus	BP
2	31	1.36448730228	-	5.30e-02	GO:0010667	negative regulation of cardiac muscle cell apoptotic process	BP
2	31	1.36448730228	-	1.21e-01	GO:0035115	embryonic forelimb morphogenesis	BP
2	31	1.36448730228	-	1.55e-01	GO:0048662	negative regulation of smooth muscle cell proliferation	BP
2	31	1.36448730228	-	1.55e-01	GO:0061098	positive regulation of protein tyrosine kinase activity	BP
2	31	1.36448730228	-	1.55e-01	GO:0021510	spinal cord development	BP
2	31	1.36448730228	-	1.55e-01	GO:0030217	T cell differentiation	BP
2	31	1.36448730228	-	1.64e-01	GO:0006284	base-excision repair	BP
2	31	1.36448730228	-	1.82e-01	GO:0031663	lipopolysaccharide-mediated signaling pathway	BP
2	31	1.36448730228	-	1.21e-01	GO:0017147	Wnt-protein binding	MF
5	78	1.3552094887	-	1.59e-02	GO:0008544	epidermis development	BP
3	47	1.34905726171	-	1.13e-01	GO:0000186	activation of MAPKK activity	BP
10	157	1.34599095867	-	2.62e-03	GO:0007010	cytoskeleton organization	BP
7	110	1.3446788212	-	1.15e-02	GO:0030168	platelet activation	BP
4	63	1.34140368917	-	4.87e-02	GO:0009611	response to wounding	BP
4	63	1.34140368917	-	5.72e-02	GO:0051384	response to glucocorticoid	BP
5	79	1.33683095938	-	2.33e-02	GO:0031295	T cell costimulation	BP
6	96	1.31868361267	-	3.35e-02	GO:0097711	ciliary basal body-plasma membrane docking	BP
4	64	1.31868361267	-	4.87e-02	GO:0070373	negative regulation of ERK1 and ERK2 cascade	BP
2	32	1.31868361267	-	1.64e-01	GO:0043200	response to amino acid	BP
2	32	1.31868361267	-	1.82e-01	GO:0006513	protein monoubiquitination	BP
2	32	1.31868361267	-	1.82e-01	GO:0042594	response to starvation	BP
1	16	1.31868361267	-	1.84e-01	GO:0050909	sensory perception of taste	BP
2	32	1.31868361267	-	1.91e-01	GO:0000281	mitotic cytokinesis	BP
2	32	1.31868361267	-	1.91e-01	GO:0070911	global genome nucleotide-excision repair	BP
2	32	1.31868361267	-	1.91e-01	GO:0008625	extrinsic apoptotic signaling pathway via death domain receptors	BP
1	16	1.31868361267	-	2.04e-01	GO:0015012	heparan sulfate proteoglycan biosynthetic process	BP
1	16	1.31868361267	-	2.24e-01	GO:0030322	stabilization of membrane potential	BP
1	16	1.31868361267	-	2.81e-01	GO:0050708	regulation of protein secretion	BP
1	16	1.31868361267	-	2.99e-01	GO:0043032	positive regulation of macrophage activation	BP
1	16	1.31868361267	-	2.99e-01	GO:0055117	regulation of cardiac muscle contraction	BP
1	16	1.31868361267	-	2.99e-01	GO:0031293	membrane protein intracellular domain proteolysis	BP
1	16	1.31868361267	-	2.99e-01	GO:0048593	camera-type eye morphogenesis	BP
1	16	1.31868361267	-	2.99e-01	GO:0048384	retinoic acid receptor signaling pathway	BP
1	16	1.31868361267	-	2.99e-01	GO:0060292	long term synaptic depression	BP
1	16	1.31868361267	-	2.99e-01	GO:0043508	negative regulation of JUN kinase activity	BP
1	16	1.31868361267	-	2.99e-01	GO:0060216	definitive hemopoiesis	BP
1	16	1.31868361267	-	2.99e-01	GO:0035855	megakaryocyte development	BP
1	16	1.31868361267	-	2.99e-01	GO:0070498	interleukin-1-mediated signaling pathway	BP
1	16	1.31868361267	-	3.17e-01	GO:2000811	negative regulation of anoikis	BP
1	16	1.31868361267	-	3.17e-01	GO:0051893	regulation of focal adhesion assembly	BP
1	16	1.31868361267	-	3.17e-01	GO:0046037	GMP metabolic process	BP
1	16	1.31868361267	-	3.17e-01	GO:0060749	mammary gland alveolus development	BP
1	16	1.31868361267	-	3.17e-01	GO:0051131	chaperone-mediated protein complex assembly	BP
1	16	1.31868361267	-	3.17e-01	GO:0010608	posttranscriptional regulation of gene expression	BP
1	16	1.31868361267	-	3.17e-01	GO:0010259	multicellular organism aging	BP
1	16	1.31868361267	-	3.17e-01	GO:0006261	DNA-dependent DNA replication	BP
1	16	1.31868361267	-	3.17e-01	GO:0007026	negative regulation of microtubule depolymerization	BP
1	16	1.31868361267	-	3.34e-01	GO:0034142	toll-like receptor 4 signaling pathway	BP
1	16	1.31868361267	-	3.34e-01	GO:0030214	hyaluronan catabolic process	BP
5	80	1.31868361267	-	3.25e-02	GO:0016301	kinase activity	MF
3	48	1.31868361267	-	9.24e-02	GO:0000976	transcription regulatory region sequence-specific DNA binding	MF
1	16	1.31868361267	-	1.84e-01	GO:0005328	neurotransmitter:sodium symporter activity	MF
1	16	1.31868361267	-	2.04e-01	GO:0022841	potassium ion leak channel activity	MF
1	16	1.31868361267	-	2.99e-01	GO:0019789	SUMO transferase activity	MF
1	16	1.31868361267	-	3.34e-01	GO:0000400	four-way junction DNA binding	MF
9	146	1.29878405523	-	9.10e-03	GO:0018105	peptidyl-serine phosphorylation	BP
4	65	1.29631579964	-	4.34e-02	GO:0030183	B cell differentiation	BP
4	65	1.29631579964	-	7.30e-02	GO:0000226	microtubule cytoskeleton organization	BP
4	65	1.29631579964	-	2.05e-02	GO:0008236	serine-type peptidase activity	MF
11	179	1.29429945404	-	4.84e-03	GO:0008022	protein C-terminus binding	MF
3	49	1.28893626928	-	1.19e-01	GO:0042542	response to hydrogen peroxide	BP
3	49	1.28893626928	-	1.08e-01	GO:0030374	ligand-dependent nuclear receptor transcription coactivator activity	MF
11	180	1.28626213498	-	2.22e-03	GO:0016477	cell migration	BP
5	82	1.28305970294	-	2.06e-02	GO:0007409	axonogenesis	BP
9	148	1.27915524848	-	7.25e-03	GO:0050852	T cell receptor signaling pathway	BP
2	33	1.27428949331	-	1.12e-01	GO:0042100	B cell proliferation	BP
2	33	1.27428949331	-	1.64e-01	GO:0070830	bicellular tight junction assembly	BP
2	33	1.27428949331	-	1.91e-01	GO:0030100	regulation of endocytosis	BP
15	248	1.27137789789	-	5.31e-07	GO:0004252	serine-type endopeptidase activity	MF
3	50	1.25978992362	-	1.03e-01	GO:0034097	response to cytokine	BP
3	50	1.25978992362	-	1.08e-01	GO:0071407	cellular response to organic cyclic compound	BP
21	355	1.23932582106	-	1.02e-04	GO:0004674	protein serine/threonine kinase activity	MF
2	34	1.23122077142	-	1.55e-01	GO:0030501	positive regulation of bone mineralization	BP
2	34	1.23122077142	-	1.64e-01	GO:0042130	negative regulation of T cell proliferation	BP
2	34	1.23122077142	-	1.73e-01	GO:0002931	response to ischemia	BP
2	34	1.23122077142	-	1.91e-01	GO:2001240	negative regulation of extrinsic apoptotic signaling pathway in absence of ligand	BP
2	34	1.23122077142	-	2.00e-01	GO:0051973	positive regulation of telomerase activity	BP
2	34	1.23122077142	-	2.09e-01	GO:0000731	DNA synthesis involved in DNA repair	BP
1	17	1.23122077142	-	2.63e-01	GO:0044030	regulation of DNA methylation	BP
1	17	1.23122077142	-	2.63e-01	GO:0097009	energy homeostasis	BP
1	17	1.23122077142	-	2.63e-01	GO:0006796	phosphate-containing compound metabolic process	BP
1	17	1.23122077142	-	2.81e-01	GO:0043171	peptide catabolic process	BP
1	17	1.23122077142	-	2.81e-01	GO:0048514	blood vessel morphogenesis	BP
1	17	1.23122077142	-	2.99e-01	GO:1903506	regulation of nucleic acid-templated transcription	BP
1	17	1.23122077142	-	2.99e-01	GO:0007043	cell-cell junction assembly	BP
1	17	1.23122077142	-	2.99e-01	GO:0006970	response to osmotic stress	BP
1	17	1.23122077142	-	2.99e-01	GO:0030193	regulation of blood coagulation	BP
1	17	1.23122077142	-	3.17e-01	GO:0071354	cellular response to interleukin-6	BP
1	17	1.23122077142	-	3.17e-01	GO:0006103	2-oxoglutarate metabolic process	BP
1	17	1.23122077142	-	3.17e-01	GO:0048255	mRNA stabilization	BP
1	17	1.23122077142	-	3.17e-01	GO:0002407	dendritic cell chemotaxis	BP
1	17	1.23122077142	-	3.17e-01	GO:0032722	positive regulation of chemokine production	BP
1	17	1.23122077142	-	3.34e-01	GO:0048535	lymph node development	BP
1	17	1.23122077142	-	3.34e-01	GO:2000249	regulation of actin cytoskeleton reorganization	BP
1	17	1.23122077142	-	3.34e-01	GO:1990138	neuron projection extension	BP
1	17	1.23122077142	-	3.34e-01	GO:1902041	regulation of extrinsic apoptotic signaling pathway via death domain receptors	BP
1	17	1.23122077142	-	3.34e-01	GO:0048814	regulation of dendrite morphogenesis	BP
1	17	1.23122077142	-	3.34e-01	GO:0008045	motor neuron axon guidance	BP
1	17	1.23122077142	-	3.51e-01	GO:0035994	response to muscle stretch	BP
1	17	1.23122077142	-	3.51e-01	GO:0007094	mitotic spindle assembly checkpoint	BP
1	17	1.23122077142	-	2.04e-01	GO:0015297	antiporter activity	MF
1	17	1.23122077142	-	2.44e-01	GO:0005537	mannose binding	MF
1	17	1.23122077142	-	2.99e-01	GO:0046933	proton-transporting ATP synthase activity, rotational mechanism	MF
1	17	1.23122077142	-	3.17e-01	GO:0000987	core promoter proximal region sequence-specific DNA binding	MF
1	17	1.23122077142	-	3.34e-01	GO:0070300	phosphatidic acid binding	MF
1	17	1.23122077142	-	3.34e-01	GO:0003746	translation elongation factor activity	MF
7	120	1.21914793912	-	2.16e-02	GO:0071222	cellular response to lipopolysaccharide	BP
5	86	1.21434695286	-	5.72e-02	GO:0048013	ephrin receptor signaling pathway	BP
11	190	1.20825962298	-	1.82e-03	GO:0070374	positive regulation of ERK1 and ERK2 cascade	BP
6	104	1.20320639525	-	4.48e-02	GO:0047485	protein N-terminus binding	MF
10	175	1.18940059573	-	3.74e-03	GO:0016055	Wnt signaling pathway	BP
2	35	1.18940059573	-	1.37e-01	GO:0051480	regulation of cytosolic calcium ion concentration	BP
2	35	1.18940059573	-	1.64e-01	GO:0010043	response to zinc ion	BP
2	35	1.18940059573	-	2.00e-01	GO:0045786	negative regulation of cell cycle	BP
2	35	1.18940059573	-	2.09e-01	GO:0019985	translesion synthesis	BP
4	70	1.18940059573	-	8.71e-02	GO:0002039	p53 binding	MF
7	123	1.18352402939	-	1.97e-02	GO:0002223	stimulatory C-type lectin receptor signaling pathway	BP
10	176	1.18118008892	-	1.05e-03	GO:0038095	Fc-epsilon receptor signaling pathway	BP
6	106	1.17572565883	-	3.20e-02	GO:0051091	positive regulation of sequence-specific DNA binding transcription factor activity	BP
4	71	1.16893649317	-	7.64e-02	GO:0060333	interferon-gamma-mediated signaling pathway	BP
9	160	1.16668051923	-	8.32e-03	GO:0032496	response to lipopolysaccharide	BP
7	125	1.16025425007	-	2.35e-02	GO:0006470	protein dephosphorylation	BP
3	54	1.14875861123	-	1.35e-01	GO:0071560	cellular response to transforming growth factor beta stimulus	BP
3	54	1.14875861123	-	1.41e-01	GO:0016049	cell growth	BP
2	36	1.14875861123	-	1.46e-01	GO:0086091	regulation of heart rate by cardiac conduction	BP
2	36	1.14875861123	-	1.91e-01	GO:0000079	regulation of cyclin-dependent protein serine/threonine kinase activity	BP
2	36	1.14875861123	-	2.00e-01	GO:0071392	cellular response to estradiol stimulus	BP
2	36	1.14875861123	-	2.09e-01	GO:0001837	epithelial to mesenchymal transition	BP
1	18	1.14875861123	-	2.24e-01	GO:2000117	negative regulation of cysteine-type endopeptidase activity	BP
2	36	1.14875861123	-	2.28e-01	GO:0007257	activation of JUN kinase activity	BP
1	18	1.14875861123	-	2.44e-01	GO:0030539	male genitalia development	BP
1	18	1.14875861123	-	2.44e-01	GO:0060044	negative regulation of cardiac muscle cell proliferation	BP
1	18	1.14875861123	-	2.63e-01	GO:0060307	regulation of ventricular cardiac muscle cell membrane repolarization	BP
1	18	1.14875861123	-	2.63e-01	GO:0046907	intracellular transport	BP
1	18	1.14875861123	-	2.63e-01	GO:0036342	post-anal tail morphogenesis	BP
1	18	1.14875861123	-	2.81e-01	GO:0035338	long-chain fatty-acyl-CoA biosynthetic process	BP
1	18	1.14875861123	-	2.99e-01	GO:0030279	negative regulation of ossification	BP
1	18	1.14875861123	-	3.17e-01	GO:0002076	osteoblast development	BP
1	18	1.14875861123	-	3.17e-01	GO:1903959	regulation of anion transmembrane transport	BP
1	18	1.14875861123	-	3.17e-01	GO:0007597	blood coagulation, intrinsic pathway	BP
1	18	1.14875861123	-	3.17e-01	GO:0060324	face development	BP
1	18	1.14875861123	-	3.51e-01	GO:0048260	positive regulation of receptor-mediated endocytosis	BP
1	18	1.14875861123	-	3.51e-01	GO:0001894	tissue homeostasis	BP
1	18	1.14875861123	-	3.51e-01	GO:0001892	embryonic placenta development	BP
1	18	1.14875861123	-	3.51e-01	GO:1902236	negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway	BP
1	18	1.14875861123	-	3.51e-01	GO:0051000	positive regulation of nitric-oxide synthase activity	BP
1	18	1.14875861123	-	3.51e-01	GO:0045445	myoblast differentiation	BP
1	18	1.14875861123	-	3.51e-01	GO:0000185	activation of MAPKKK activity	BP
1	18	1.14875861123	-	3.51e-01	GO:0030490	maturation of SSU-rRNA	BP
1	18	1.14875861123	-	3.51e-01	GO:2000114	regulation of establishment of cell polarity	BP
1	18	1.14875861123	-	3.51e-01	GO:0045664	regulation of neuron differentiation	BP
1	18	1.14875861123	-	3.51e-01	GO:0045948	positive regulation of translational initiation	BP
1	18	1.14875861123	-	3.67e-01	GO:0030705	cytoskeleton-dependent intracellular transport	BP
1	18	1.14875861123	-	3.67e-01	GO:0043523	regulation of neuron apoptotic process	BP
1	18	1.14875861123	-	3.67e-01	GO:1901741	positive regulation of myoblast fusion	BP
1	18	1.14875861123	-	3.67e-01	GO:0007004	telomere maintenance via telomerase	BP
2	36	1.14875861123	-	1.37e-01	GO:0008138	protein tyrosine/serine/threonine phosphatase activity	MF
1	18	1.14875861123	-	1.84e-01	GO:0008569	ATP-dependent microtubule motor activity, minus-end-directed	MF
2	36	1.14875861123	-	2.09e-01	GO:0043531	ADP binding	MF
1	18	1.14875861123	-	2.63e-01	GO:0016746	transferase activity, transferring acyl groups	MF
1	18	1.14875861123	-	3.34e-01	GO:0001190	transcriptional activator activity, RNA polymerase II transcription factor binding	MF
1	18	1.14875861123	-	3.51e-01	GO:0051371	muscle alpha-actinin binding	MF
1	18	1.14875861123	-	3.51e-01	GO:0070577	lysine-acetylated histone binding	MF
5	91	1.13281706736	-	4.59e-02	GO:0006464	cellular protein modification process	BP
9	164	1.13105660949	-	1.33e-02	GO:0007568	aging	BP
10	183	1.12491186927	-	7.70e-03	GO:0007596	blood coagulation	BP
3	55	1.12228639987	-	1.03e-01	GO:0000902	cell morphogenesis	BP
3	55	1.12228639987	-	1.13e-01	GO:0001570	vasculogenesis	BP
4	74	1.10923024704	-	1.21e-02	GO:0006501	C-terminal protein lipidation	BP
4	74	1.10923024704	-	9.84e-02	GO:0001843	neural tube closure	BP
2	37	1.10923024704	-	2.37e-01	GO:0006110	regulation of glycolytic process	BP
6	111	1.10923024704	-	3.20e-02	GO:0044325	ion channel binding	MF
13	241	1.10623399458	-	2.59e-03	GO:0042981	regulation of apoptotic process	BP
7	130	1.1036707217	-	2.49e-03	GO:0038096	Fc-gamma receptor signaling pathway involved in phagocytosis	BP
7	130	1.1036707217	-	3.92e-02	GO:0042393	histone binding	MF
3	56	1.09629119133	-	1.47e-01	GO:0004197	cysteine-type endopeptidase activity	MF
25	467	1.09526106274	-	3.94e-05	GO:0043066	negative regulation of apoptotic process	BP
8	150	1.08986492217	-	2.47e-02	GO:0050821	protein stabilization	BP
7	132	1.08164441537	-	3.13e-02	GO:0043524	negative regulation of neuron apoptotic process	BP
6	114	1.07075609923	-	3.97e-02	GO:0071356	cellular response to tumor necrosis factor	BP
2	38	1.07075609923	-	1.21e-01	GO:0009409	response to cold	BP
2	38	1.07075609923	-	1.82e-01	GO:0001657	ureteric bud development	BP
2	38	1.07075609923	-	1.91e-01	GO:0045597	positive regulation of cell differentiation	BP
1	19	1.07075609923	-	2.99e-01	GO:0033198	response to ATP	BP
1	19	1.07075609923	-	3.17e-01	GO:0050850	positive regulation of calcium-mediated signaling	BP
1	19	1.07075609923	-	3.17e-01	GO:0045216	cell-cell junction organization	BP
1	19	1.07075609923	-	3.34e-01	GO:0008156	negative regulation of DNA replication	BP
1	19	1.07075609923	-	3.34e-01	GO:0048026	positive regulation of mRNA splicing, via spliceosome	BP
1	19	1.07075609923	-	3.34e-01	GO:0030220	platelet formation	BP
1	19	1.07075609923	-	3.34e-01	GO:0010592	positive regulation of lamellipodium assembly	BP
1	19	1.07075609923	-	3.51e-01	GO:0008589	regulation of smoothened signaling pathway	BP
1	19	1.07075609923	-	3.51e-01	GO:0071385	cellular response to glucocorticoid stimulus	BP
1	19	1.07075609923	-	3.51e-01	GO:0050770	regulation of axonogenesis	BP
1	19	1.07075609923	-	3.51e-01	GO:0036120	cellular response to platelet-derived growth factor stimulus	BP
1	19	1.07075609923	-	3.51e-01	GO:0010613	positive regulation of cardiac muscle hypertrophy	BP
1	19	1.07075609923	-	3.67e-01	GO:0090190	positive regulation of branching involved in ureteric bud morphogenesis	BP
1	19	1.07075609923	-	3.67e-01	GO:0042776	mitochondrial ATP synthesis coupled proton transport	BP
1	19	1.07075609923	-	3.67e-01	GO:0031954	positive regulation of protein autophosphorylation	BP
1	19	1.07075609923	-	3.67e-01	GO:0046716	muscle cell cellular homeostasis	BP
1	19	1.07075609923	-	3.67e-01	GO:0048169	regulation of long-term neuronal synaptic plasticity	BP
1	19	1.07075609923	-	3.67e-01	GO:0030099	myeloid cell differentiation	BP
1	19	1.07075609923	-	3.83e-01	GO:0043011	myeloid dendritic cell differentiation	BP
5	95	1.07075609923	-	1.82e-02	GO:0004867	serine-type endopeptidase inhibitor activity	MF
2	38	1.07075609923	-	1.82e-01	GO:0001786	phosphatidylserine binding	MF
1	19	1.07075609923	-	2.44e-01	GO:0004653	polypeptide N-acetylgalactosaminyltransferase activity	MF
1	19	1.07075609923	-	2.63e-01	GO:0046914	transition metal ion binding	MF
1	19	1.07075609923	-	3.67e-01	GO:0008157	protein phosphatase 1 binding	MF
1	19	1.07075609923	-	3.83e-01	GO:0070064	proline-rich region binding	MF
9	172	1.06234385941	-	1.23e-02	GO:0042127	regulation of cell proliferation	BP
25	480	1.05564920684	-	2.03e-05	GO:0008284	positive regulation of cell proliferation	BP
30	579	1.04815467029	-	1.11e-05	GO:0043547	positive regulation of GTPase activity	BP
3	58	1.04566511826	-	1.47e-01	GO:0050729	positive regulation of inflammatory response	BP
21	407	1.04211605118	-	1.68e-04	GO:0008285	negative regulation of cell proliferation	BP
2	39	1.03328139381	-	1.12e-01	GO:0007631	feeding behavior	BP
4	78	1.03328139381	-	1.15e-01	GO:0006919	activation of cysteine-type endopeptidase activity involved in apoptotic process	BP
2	39	1.03328139381	-	1.82e-01	GO:0030326	embryonic limb morphogenesis	BP
2	39	1.03328139381	-	1.91e-01	GO:0048704	embryonic skeletal system morphogenesis	BP
2	39	1.03328139381	-	2.09e-01	GO:0000422	autophagy of mitochondrion	BP
2	39	1.03328139381	-	2.28e-01	GO:0050714	positive regulation of protein secretion	BP
2	39	1.03328139381	-	2.46e-01	GO:0030890	positive regulation of B cell proliferation	BP
2	39	1.03328139381	-	2.46e-01	GO:0030155	regulation of cell adhesion	BP
2	39	1.03328139381	-	2.56e-01	GO:0030522	intracellular receptor signaling pathway	BP
2	39	1.03328139381	-	2.37e-01	GO:0001102	RNA polymerase II activating transcription factor binding	MF
3	59	1.02100306403	-	1.19e-01	GO:0006968	cellular defense response	BP
10	197	1.0185598881	-	1.19e-02	GO:0000287	magnesium ion binding	MF
7	138	1.01751407795	-	4.21e-02	GO:0008360	regulation of cell shape	BP
8	159	1.00580065739	-	1.59e-02	GO:0010629	negative regulation of gene expression	BP
10	199	1.00398708701	-	2.84e-02	GO:0003714	transcription corepressor activity	MF
3	60	0.996755517783	-	1.08e-01	GO:0003777	microtubule motor activity	MF
5	100	0.996755517783	-	6.73e-02	GO:0006979	response to oxidative stress	BP
2	40	0.996755517783	-	2.00e-01	GO:0032570	response to progesterone	BP
2	40	0.996755517783	-	2.18e-01	GO:0007162	negative regulation of cell adhesion	BP
2	40	0.996755517783	-	2.18e-01	GO:0006695	cholesterol biosynthetic process	BP
1	20	0.996755517783	-	2.24e-01	GO:0007130	synaptonemal complex assembly	BP
2	40	0.996755517783	-	2.28e-01	GO:0043434	response to peptide hormone	BP
2	40	0.996755517783	-	2.37e-01	GO:0032024	positive regulation of insulin secretion	BP
2	40	0.996755517783	-	2.37e-01	GO:0021549	cerebellum development	BP
2	40	0.996755517783	-	2.37e-01	GO:0009411	response to UV	BP
1	20	0.996755517783	-	2.44e-01	GO:0097503	sialylation	BP
1	20	0.996755517783	-	2.63e-01	GO:0015711	organic anion transport	BP
1	20	0.996755517783	-	2.63e-01	GO:0055074	calcium ion homeostasis	BP
1	20	0.996755517783	-	2.99e-01	GO:0001659	temperature homeostasis	BP
1	20	0.996755517783	-	3.17e-01	GO:0006465	signal peptide processing	BP
1	20	0.996755517783	-	3.34e-01	GO:0060716	labyrinthine layer blood vessel development	BP
1	20	0.996755517783	-	3.51e-01	GO:0061436	establishment of skin barrier	BP
1	20	0.996755517783	-	3.67e-01	GO:0045862	positive regulation of proteolysis	BP
1	20	0.996755517783	-	3.67e-01	GO:0071310	cellular response to organic substance	BP
1	20	0.996755517783	-	3.98e-01	GO:0039702	viral budding via host ESCRT complex	BP
1	20	0.996755517783	-	3.98e-01	GO:0042326	negative regulation of phosphorylation	BP
1	20	0.996755517783	-	3.98e-01	GO:0045663	positive regulation of myoblast differentiation	BP
2	40	0.996755517783	-	2.65e-01	GO:0004407	histone deacetylase activity	MF
1	20	0.996755517783	-	2.99e-01	GO:0070006	metalloaminopeptidase activity	MF
1	20	0.996755517783	-	3.17e-01	GO:0042923	neuropeptide binding	MF
1	20	0.996755517783	-	3.17e-01	GO:0031267	small GTPase binding	MF
1	20	0.996755517783	-	3.34e-01	GO:0004601	peroxidase activity	MF
1	20	0.996755517783	-	3.67e-01	GO:0004602	glutathione peroxidase activity	MF
19	383	0.985410544189	-	9.02e-04	GO:0035556	intracellular signal transduction	BP
4	81	0.978833609786	-	5.14e-02	GO:0008233	peptidase activity	MF
10	203	0.975275790373	-	1.60e-03	GO:0050900	leukocyte migration	BP
3	61	0.972908775829	-	1.84e-01	GO:0007249	I-kappaB kinase/NF-kappaB signaling	BP
3	61	0.972908775829	-	1.30e-01	GO:0005518	collagen binding	MF
5	102	0.968186365586	-	7.54e-02	GO:0001649	osteoblast differentiation	BP
14	286	0.96616719795	-	1.79e-02	GO:0045296	cadherin binding	MF
8	164	0.961131608053	-	2.76e-02	GO:0007507	heart development	BP
4	82	0.961131608053	-	9.46e-02	GO:0060021	palate development	BP
2	41	0.961131608053	-	2.46e-01	GO:0007595	lactation	BP
2	41	0.961131608053	-	2.46e-01	GO:0097191	extrinsic apoptotic signaling pathway	BP
2	41	0.961131608053	-	2.56e-01	GO:0043124	negative regulation of I-kappaB kinase/NF-kappaB signaling	BP
5	103	0.954111180375	-	9.02e-02	GO:0045471	response to ethanol	BP
3	62	0.949449803005	-	1.59e-01	GO:0045727	positive regulation of translation	BP
3	62	0.949449803005	-	1.84e-01	GO:0043433	negative regulation of sequence-specific DNA binding transcription factor activity	BP
3	62	0.949449803005	-	1.41e-01	GO:0050839	cell adhesion molecule binding	MF
4	83	0.943644181324	-	1.15e-01	GO:0046718	viral entry into host cell	BP
4	83	0.943644181324	-	1.45e-01	GO:0010389	regulation of G2/M transition of mitotic cell cycle	BP
6	126	0.926366189892	-	6.24e-02	GO:0007264	small GTPase mediated signal transduction	BP
3	63	0.926366189892	-	8.28e-02	GO:0007200	phospholipase C-activating G-protein coupled receptor signaling pathway	BP
3	63	0.926366189892	-	1.77e-01	GO:0032091	negative regulation of protein binding	BP
1	21	0.926366189892	-	2.04e-01	GO:1904659	glucose transmembrane transport	BP
2	42	0.926366189892	-	2.46e-01	GO:0006635	fatty acid beta-oxidation	BP
2	42	0.926366189892	-	2.46e-01	GO:0034198	cellular response to amino acid starvation	BP
1	21	0.926366189892	-	2.81e-01	GO:0032094	response to food	BP
1	21	0.926366189892	-	3.67e-01	GO:0051497	negative regulation of stress fiber assembly	BP
1	21	0.926366189892	-	3.67e-01	GO:0048844	artery morphogenesis	BP
1	21	0.926366189892	-	3.67e-01	GO:0045672	positive regulation of osteoclast differentiation	BP
1	21	0.926366189892	-	3.67e-01	GO:0007492	endoderm development	BP
1	21	0.926366189892	-	3.83e-01	GO:0097150	neuronal stem cell population maintenance	BP
1	21	0.926366189892	-	3.83e-01	GO:0043113	receptor clustering	BP
1	21	0.926366189892	-	4.13e-01	GO:0006295	nucleotide-excision repair, DNA incision, 3'-to lesion	BP
1	21	0.926366189892	-	4.13e-01	GO:0006293	nucleotide-excision repair, preincision complex stabilization	BP
1	21	0.926366189892	-	4.13e-01	GO:0001836	release of cytochrome c from mitochondria	BP
1	21	0.926366189892	-	2.81e-01	GO:0008514	organic anion transmembrane transporter activity	MF
1	21	0.926366189892	-	3.34e-01	GO:0005112	Notch binding	MF
1	21	0.926366189892	-	3.51e-01	GO:0048018	receptor agonist activity	MF
1	21	0.926366189892	-	3.98e-01	GO:0004298	threonine-type endopeptidase activity	MF
1	21	0.926366189892	-	4.13e-01	GO:0016922	ligand-dependent nuclear receptor binding	MF
5	106	0.912691252995	-	1.17e-01	GO:0042826	histone deacetylase binding	MF
4	85	0.909292676533	-	1.45e-01	GO:0030165	PDZ domain binding	MF
3	64	0.903646113392	-	7.81e-02	GO:0007586	digestion	BP
3	64	0.903646113392	-	1.53e-01	GO:0006310	DNA recombination	BP
3	64	0.903646113392	-	1.53e-01	GO:0043627	response to estrogen	BP
2	43	0.892418857969	-	2.09e-01	GO:0045599	negative regulation of fat cell differentiation	BP
2	43	0.892418857969	-	2.65e-01	GO:0043280	positive regulation of cysteine-type endopeptidase activity involved in apoptotic process	BP
6	130	0.881278300363	-	1.43e-01	GO:0000086	G2/M transition of mitotic cell cycle	BP
3	65	0.881278300363	-	2.03e-01	GO:0030433	ubiquitin-dependent ERAD pathway	BP
4	88	0.859251994033	-	1.36e-01	GO:0016192	vesicle-mediated transport	BP
3	66	0.859251994033	-	1.77e-01	GO:0030855	epithelial cell differentiation	BP
2	44	0.859251994033	-	2.74e-01	GO:0034260	negative regulation of GTPase activity	BP
1	22	0.859251994033	-	2.81e-01	GO:0016125	sterol metabolic process	BP
1	22	0.859251994033	-	3.17e-01	GO:0045333	cellular respiration	BP
1	22	0.859251994033	-	3.34e-01	GO:0019915	lipid storage	BP
1	22	0.859251994033	-	3.34e-01	GO:0006855	drug transmembrane transport	BP
1	22	0.859251994033	-	3.67e-01	GO:0010842	retina layer formation	BP
1	22	0.859251994033	-	3.67e-01	GO:0048488	synaptic vesicle endocytosis	BP
1	22	0.859251994033	-	3.67e-01	GO:0030101	natural killer cell activation	BP
1	22	0.859251994033	-	3.83e-01	GO:0042832	defense response to protozoan	BP
1	22	0.859251994033	-	3.83e-01	GO:0030111	regulation of Wnt signaling pathway	BP
1	22	0.859251994033	-	3.98e-01	GO:0060999	positive regulation of dendritic spine development	BP
1	22	0.859251994033	-	4.13e-01	GO:0010165	response to X-ray	BP
1	22	0.859251994033	-	4.13e-01	GO:0048278	vesicle docking	BP
1	22	0.859251994033	-	4.13e-01	GO:1901687	glutathione derivative biosynthetic process	BP
1	22	0.859251994033	-	4.13e-01	GO:0045662	negative regulation of myoblast differentiation	BP
1	22	0.859251994033	-	4.28e-01	GO:0006306	DNA methylation	BP
1	22	0.859251994033	-	4.28e-01	GO:0000717	nucleotide-excision repair, DNA duplex unwinding	BP
1	22	0.859251994033	-	3.67e-01	GO:0008198	ferrous iron binding	MF
1	22	0.859251994033	-	4.28e-01	GO:0004709	MAP kinase kinase kinase activity	MF
15	330	0.859251994033	-	1.65e-02	GO:0019899	enzyme binding	MF
6	133	0.848363677891	-	3.97e-02	GO:0007204	positive regulation of cytosolic calcium ion concentration	BP
4	89	0.842950181704	-	1.60e-01	GO:0034599	cellular response to oxidative stress	BP
4	90	0.826830516341	-	1.36e-01	GO:0010976	positive regulation of neuron projection development	BP
2	45	0.826830516341	-	2.28e-01	GO:0042552	myelination	BP
2	45	0.826830516341	-	2.46e-01	GO:1903507	negative regulation of nucleic acid-templated transcription	BP
5	113	0.820432745143	-	3.79e-02	GO:0070268	cornification	BP
13	294	0.819450985975	-	1.34e-02	GO:0010628	positive regulation of gene expression	BP
3	68	0.816183272141	-	1.90e-01	GO:0045444	fat cell differentiation	BP
3	68	0.816183272141	-	2.03e-01	GO:0034976	response to endoplasmic reticulum stress	BP
13	295	0.814552186562	-	3.51e-02	GO:0031625	ubiquitin protein ligase binding	MF
4	91	0.810888972472	-	1.60e-01	GO:0007179	transforming growth factor beta receptor signaling pathway	BP
4	92	0.795121656614	-	1.15e-01	GO:0009636	response to toxic substance	BP
4	92	0.795121656614	-	1.50e-01	GO:0032355	response to estradiol	BP
1	23	0.795121656614	-	2.24e-01	GO:0003333	amino acid transmembrane transport	BP
2	46	0.795121656614	-	2.46e-01	GO:0003151	outflow tract morphogenesis	BP
2	46	0.795121656614	-	2.84e-01	GO:0007519	skeletal muscle tissue development	BP
1	23	0.795121656614	-	2.99e-01	GO:0007140	male meiotic nuclear division	BP
1	23	0.795121656614	-	3.17e-01	GO:0006694	steroid biosynthetic process	BP
1	23	0.795121656614	-	3.34e-01	GO:1904707	positive regulation of vascular smooth muscle cell proliferation	BP
1	23	0.795121656614	-	3.34e-01	GO:0046856	phosphatidylinositol dephosphorylation	BP
1	23	0.795121656614	-	3.51e-01	GO:0002376	immune system process	BP
1	23	0.795121656614	-	3.67e-01	GO:0001819	positive regulation of cytokine production	BP
1	23	0.795121656614	-	3.83e-01	GO:0030488	tRNA methylation	BP
1	23	0.795121656614	-	3.98e-01	GO:0006941	striated muscle contraction	BP
1	23	0.795121656614	-	3.98e-01	GO:0071398	cellular response to fatty acid	BP
1	23	0.795121656614	-	4.13e-01	GO:0046835	carbohydrate phosphorylation	BP
1	23	0.795121656614	-	4.13e-01	GO:0032456	endocytic recycling	BP
1	23	0.795121656614	-	4.13e-01	GO:2000463	positive regulation of excitatory postsynaptic potential	BP
1	23	0.795121656614	-	4.28e-01	GO:0005978	glycogen biosynthetic process	BP
1	23	0.795121656614	-	4.28e-01	GO:0007088	regulation of mitotic nuclear division	BP
1	23	0.795121656614	-	4.28e-01	GO:0003009	skeletal muscle contraction	BP
1	23	0.795121656614	-	4.42e-01	GO:0030866	cortical actin cytoskeleton organization	BP
1	23	0.795121656614	-	4.42e-01	GO:0001954	positive regulation of cell-matrix adhesion	BP
1	23	0.795121656614	-	4.42e-01	GO:2001235	positive regulation of apoptotic signaling pathway	BP
1	23	0.795121656614	-	4.42e-01	GO:0043044	ATP-dependent chromatin remodeling	BP
1	23	0.795121656614	-	4.42e-01	GO:0051439	regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle	BP
1	23	0.795121656614	-	4.42e-01	GO:0000715	nucleotide-excision repair, DNA damage recognition	BP
5	115	0.795121656614	-	1.13e-01	GO:0005085	guanyl-nucleotide exchange factor activity	MF
1	23	0.795121656614	-	3.98e-01	GO:0070840	dynein complex binding	MF
1	23	0.795121656614	-	4.28e-01	GO:0070412	R-SMAD binding	MF
1	23	0.795121656614	-	4.28e-01	GO:0042162	telomeric DNA binding	MF
14	322	0.795121656614	-	1.81e-02	GO:0043065	positive regulation of apoptotic process	BP
3	70	0.774363096447	-	2.16e-01	GO:0032088	negative regulation of NF-kappaB transcription factor activity	BP
2	47	0.764094760993	-	1.04e-01	GO:0045596	negative regulation of cell differentiation	BP
2	47	0.764094760993	-	2.18e-01	GO:0019722	calcium-mediated signaling	BP
2	47	0.764094760993	-	2.74e-01	GO:0023014	signal transduction by protein phosphorylation	BP
2	47	0.764094760993	-	2.84e-01	GO:0051781	positive regulation of cell division	BP
2	47	0.764094760993	-	2.93e-01	GO:0006909	phagocytosis	BP
2	47	0.764094760993	-	3.02e-01	GO:0010595	positive regulation of endothelial cell migration	BP
2	47	0.764094760993	-	3.12e-01	GO:0016575	histone deacetylation	BP
2	47	0.764094760993	-	3.30e-01	GO:0070936	protein K48-linked ubiquitination	BP
2	47	0.764094760993	-	2.93e-01	GO:0005080	protein kinase C binding	MF
5	118	0.757968658196	-	9.33e-02	GO:0045766	positive regulation of angiogenesis	BP
3	71	0.753898993887	-	1.65e-01	GO:0071300	cellular response to retinoic acid	BP
20	479	0.736729861822	-	6.94e-03	GO:0045892	negative regulation of transcription, DNA-templated	BP
3	72	0.733721111949	-	1.96e-01	GO:0007018	microtubule-based movement	BP
2	48	0.733721111949	-	2.18e-01	GO:0010862	positive regulation of pathway-restricted SMAD protein phosphorylation	BP
1	24	0.733721111949	-	3.67e-01	GO:0030878	thyroid gland development	BP
1	24	0.733721111949	-	3.98e-01	GO:0014003	oligodendrocyte development	BP
1	24	0.733721111949	-	3.98e-01	GO:0032733	positive regulation of interleukin-10 production	BP
1	24	0.733721111949	-	3.98e-01	GO:0060135	maternal process involved in female pregnancy	BP
1	24	0.733721111949	-	3.98e-01	GO:0055088	lipid homeostasis	BP
1	24	0.733721111949	-	4.13e-01	GO:0032435	negative regulation of proteasomal ubiquitin-dependent protein catabolic process	BP
1	24	0.733721111949	-	4.28e-01	GO:0055007	cardiac muscle cell differentiation	BP
1	24	0.733721111949	-	4.28e-01	GO:0042327	positive regulation of phosphorylation	BP
1	24	0.733721111949	-	4.42e-01	GO:2000778	positive regulation of interleukin-6 secretion	BP
1	24	0.733721111949	-	3.98e-01	GO:0043236	laminin binding	MF
1	24	0.733721111949	-	4.56e-01	GO:0031593	polyubiquitin modification-dependent protein binding	MF
9	216	0.733721111949	-	5.56e-02	GO:0001525	angiogenesis	BP
46	1114	0.720712051388	-	1.28e-06	GO:0007165	signal transduction	BP
2	49	0.703973768555	-	2.56e-01	GO:0035176	social behavior	BP
2	49	0.703973768555	-	3.30e-01	GO:0010212	response to ionizing radiation	BP
5	124	0.686415397171	-	2.24e-01	GO:0006461	protein complex assembly	BP
2	50	0.674827422896	-	2.28e-01	GO:0045600	positive regulation of fat cell differentiation	BP
1	25	0.674827422896	-	3.67e-01	GO:1900745	positive regulation of p38MAPK cascade	BP
1	25	0.674827422896	-	3.83e-01	GO:0045880	positive regulation of smoothened signaling pathway	BP
1	25	0.674827422896	-	3.83e-01	GO:0032689	negative regulation of interferon-gamma production	BP
1	25	0.674827422896	-	4.13e-01	GO:0046329	negative regulation of JNK cascade	BP
1	25	0.674827422896	-	4.28e-01	GO:0048709	oligodendrocyte differentiation	BP
1	25	0.674827422896	-	4.42e-01	GO:0030041	actin filament polymerization	BP
1	25	0.674827422896	-	4.42e-01	GO:0001578	microtubule bundle formation	BP
1	25	0.674827422896	-	4.42e-01	GO:0002053	positive regulation of mesenchymal cell proliferation	BP
1	25	0.674827422896	-	4.42e-01	GO:0001975	response to amphetamine	BP
1	25	0.674827422896	-	4.56e-01	GO:0055010	ventricular cardiac muscle tissue morphogenesis	BP
1	25	0.674827422896	-	4.56e-01	GO:0032757	positive regulation of interleukin-8 production	BP
1	25	0.674827422896	-	4.56e-01	GO:0048678	response to axon injury	BP
1	25	0.674827422896	-	4.70e-01	GO:0032735	positive regulation of interleukin-12 production	BP
1	25	0.674827422896	-	4.70e-01	GO:0045742	positive regulation of epidermal growth factor receptor signaling pathway	BP
8	200	0.674827422896	-	1.39e-03	GO:0004888	transmembrane signaling receptor activity	MF
1	25	0.674827422896	-	4.28e-01	GO:0005246	calcium channel regulator activity	MF
1	25	0.674827422896	-	4.70e-01	GO:0043027	cysteine-type endopeptidase inhibitor activity involved in apoptotic process	MF
12	302	0.665241374067	-	4.77e-02	GO:0042493	response to drug	BP
3	76	0.655718599948	-	1.96e-01	GO:0022617	extracellular matrix disassembly	BP
8	203	0.653347695485	-	1.48e-01	GO:0006281	DNA repair	BP
2	51	0.646258270699	-	2.65e-01	GO:0048666	neuron development	BP
2	51	0.646258270699	-	2.84e-01	GO:0008344	adult locomotory behavior	BP
2	51	0.646258270699	-	3.58e-01	GO:0051865	protein autoubiquitination	BP
8	205	0.639203513165	-	1.44e-01	GO:0004871	signal transducer activity	MF
3	77	0.636859572697	-	1.65e-01	GO:0045666	positive regulation of neuron differentiation	BP
3	77	0.636859572697	-	2.36e-01	GO:0009952	anterior/posterior pattern specification	BP
4	103	0.632183085487	-	1.64e-01	GO:0006469	negative regulation of protein kinase activity	BP
20	516	0.629384452135	-	2.47e-02	GO:0045893	positive regulation of transcription, DNA-templated	BP
5	129	0.629384452135	-	1.06e-01	GO:0008289	lipid binding	MF
2	52	0.61824389453	-	2.00e-01	GO:0030148	sphingolipid biosynthetic process	BP
3	78	0.61824389453	-	2.03e-01	GO:0030324	lung development	BP
1	26	0.61824389453	-	2.99e-01	GO:0016339	calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules	BP
1	26	0.61824389453	-	3.17e-01	GO:0009311	oligosaccharide metabolic process	BP
2	52	0.61824389453	-	3.21e-01	GO:0060326	cell chemotaxis	BP
1	26	0.61824389453	-	3.34e-01	GO:0009880	embryonic pattern specification	BP
1	26	0.61824389453	-	3.51e-01	GO:0046513	ceramide biosynthetic process	BP
1	26	0.61824389453	-	3.67e-01	GO:0007274	neuromuscular synaptic transmission	BP
1	26	0.61824389453	-	3.98e-01	GO:0030534	adult behavior	BP
1	26	0.61824389453	-	3.98e-01	GO:0009966	regulation of signal transduction	BP
1	26	0.61824389453	-	4.28e-01	GO:0017157	regulation of exocytosis	BP
1	26	0.61824389453	-	4.28e-01	GO:0051930	regulation of sensory perception of pain	BP
1	26	0.61824389453	-	4.70e-01	GO:0000732	strand displacement	BP
1	26	0.61824389453	-	4.56e-01	GO:0043014	alpha-tubulin binding	MF
1	26	0.61824389453	-	4.70e-01	GO:0043015	gamma-tubulin binding	MF
1	26	0.61824389453	-	4.83e-01	GO:0035035	histone acetyltransferase binding	MF
11	286	0.61824389453	-	1.15e-01	GO:0008134	transcription factor binding	MF
4	105	0.604438095004	-	2.05e-02	GO:0030449	regulation of complement activation	BP
4	105	0.604438095004	-	3.31e-01	GO:0043488	regulation of mRNA stability	BP
3	79	0.599865365215	-	4.35e-01	GO:0007030	Golgi organization	BP
7	185	0.594657074212	-	1.18e-01	GO:0007411	axon guidance	BP
2	53	0.590763158107	-	3.49e-01	GO:0043401	steroid hormone mediated signaling pathway	BP
4	106	0.590763158107	-	3.20e-01	GO:0005200	structural constituent of cytoskeleton	MF
6	160	0.581718018504	-	2.83e-01	GO:0001666	response to hypoxia	BP
4	108	0.563796110507	-	3.01e-01	GO:0006914	autophagy	BP
2	54	0.563796110507	-	3.49e-01	GO:0008104	protein localization	BP
2	54	0.563796110507	-	3.49e-01	GO:0030097	hemopoiesis	BP
1	27	0.563796110507	-	3.83e-01	GO:0006699	bile acid biosynthetic process	BP
1	27	0.563796110507	-	3.98e-01	GO:0048791	calcium ion-regulated exocytosis of neurotransmitter	BP
1	27	0.563796110507	-	4.28e-01	GO:0030030	cell projection organization	BP
1	27	0.563796110507	-	4.28e-01	GO:0035774	positive regulation of insulin secretion involved in cellular response to glucose stimulus	BP
1	27	0.563796110507	-	4.28e-01	GO:0006612	protein targeting to membrane	BP
1	27	0.563796110507	-	4.42e-01	GO:0001958	endochondral ossification	BP
1	27	0.563796110507	-	4.70e-01	GO:0051281	positive regulation of release of sequestered calcium ion into cytosol	BP
1	27	0.563796110507	-	4.83e-01	GO:0090314	positive regulation of protein targeting to membrane	BP
1	27	0.563796110507	-	4.96e-01	GO:0043278	response to morphine	BP
1	27	0.563796110507	-	4.96e-01	GO:0050718	positive regulation of interleukin-1 beta secretion	BP
1	27	0.563796110507	-	4.96e-01	GO:0050690	regulation of defense response to virus by virus	BP
1	27	0.563796110507	-	4.96e-01	GO:0032728	positive regulation of interferon-beta production	BP
1	27	0.563796110507	-	4.13e-01	GO:0005244	voltage-gated ion channel activity	MF
1	27	0.563796110507	-	4.56e-01	GO:0004364	glutathione transferase activity	MF
1	27	0.563796110507	-	4.56e-01	GO:0008135	translation factor activity, RNA binding	MF
1	27	0.563796110507	-	4.83e-01	GO:0061631	ubiquitin conjugating enzyme activity	MF
8	217	0.557132380226	-	1.49e-01	GO:0044267	cellular protein metabolic process	BP
3	82	0.546094108774	-	2.63e-01	GO:0035264	multicellular organism growth	BP
3	82	0.546094108774	-	4.30e-01	GO:0007229	integrin-mediated signaling pathway	BP
3	82	0.546094108774	-	4.45e-01	GO:0008543	fibroblast growth factor receptor signaling pathway	BP
3	82	0.546094108774	-	4.52e-01	GO:0006338	chromatin remodeling	BP
2	55	0.537323899146	-	3.30e-01	GO:0042733	embryonic digit morphogenesis	BP
4	110	0.537323899146	-	3.35e-01	GO:0016569	covalent chromatin modification	BP
2	55	0.537323899146	-	3.39e-01	GO:0048812	neuron projection morphogenesis	BP
8	220	0.537323899146	-	2.56e-01	GO:0032403	protein complex binding	MF
3	83	0.528606682045	-	2.43e-01	GO:0009887	animal organ morphogenesis	BP
4	112	0.511328690613	-	1.74e-01	GO:0007417	central nervous system development	BP
2	56	0.511328690613	-	3.21e-01	GO:0009612	response to mechanical stimulus	BP
2	56	0.511328690613	-	3.30e-01	GO:0042475	odontogenesis of dentin-containing tooth	BP
1	28	0.511328690613	-	4.13e-01	GO:0043029	T cell homeostasis	BP
1	28	0.511328690613	-	4.13e-01	GO:0001755	neural crest cell migration	BP
1	28	0.511328690613	-	4.13e-01	GO:0045746	negative regulation of Notch signaling pathway	BP
1	28	0.511328690613	-	4.13e-01	GO:0048706	embryonic skeletal system development	BP
1	28	0.511328690613	-	4.42e-01	GO:0003281	ventricular septum development	BP
1	28	0.511328690613	-	4.42e-01	GO:0048873	homeostasis of number of cells within a tissue	BP
1	28	0.511328690613	-	4.42e-01	GO:0097193	intrinsic apoptotic signaling pathway	BP
1	28	0.511328690613	-	4.56e-01	GO:0042407	cristae formation	BP
1	28	0.511328690613	-	4.56e-01	GO:0048863	stem cell differentiation	BP
1	28	0.511328690613	-	4.70e-01	GO:0005977	glycogen metabolic process	BP
1	28	0.511328690613	-	4.83e-01	GO:0007528	neuromuscular junction development	BP
1	28	0.511328690613	-	5.09e-01	GO:0070979	protein K11-linked ubiquitination	BP
1	28	0.511328690613	-	5.09e-01	GO:0010332	response to gamma radiation	BP
1	28	0.511328690613	-	5.09e-01	GO:0046966	thyroid hormone receptor binding	MF
1	28	0.511328690613	-	5.09e-01	GO:0051059	NF-kappaB binding	MF
9	252	0.511328690613	-	2.19e-01	GO:0019904	protein domain specific binding	MF
10	282	0.501060355159	-	1.45e-01	GO:0003924	GTPase activity	MF
7	198	0.496681914649	-	1.07e-01	GO:0004872	receptor activity	MF
13	368	0.495561374755	-	1.12e-01	GO:0003682	chromatin binding	MF
2	57	0.485793598506	-	2.84e-01	GO:0060395	SMAD protein signal transduction	BP
2	57	0.485793598506	-	3.39e-01	GO:0045669	positive regulation of osteoblast differentiation	BP
2	57	0.485793598506	-	3.39e-01	GO:0043087	regulation of GTPase activity	BP
2	57	0.485793598506	-	3.67e-01	GO:0071333	cellular response to glucose stimulus	BP
2	57	0.485793598506	-	3.94e-01	GO:0035722	interleukin-12-mediated signaling pathway	BP
1	29	0.460702617543	-	3.17e-01	GO:0018146	keratan sulfate biosynthetic process	BP
2	58	0.460702617543	-	3.94e-01	GO:0036498	IRE1-mediated unfolded protein response	BP
1	29	0.460702617543	-	3.98e-01	GO:0055072	iron ion homeostasis	BP
1	29	0.460702617543	-	4.42e-01	GO:0044344	cellular response to fibroblast growth factor stimulus	BP
3	87	0.460702617543	-	4.52e-01	GO:0019216	regulation of lipid metabolic process	BP
1	29	0.460702617543	-	4.96e-01	GO:0051491	positive regulation of filopodium assembly	BP
1	29	0.460702617543	-	5.21e-01	GO:0006294	nucleotide-excision repair, preincision complex assembly	BP
1	29	0.460702617543	-	5.21e-01	GO:0035666	TRIF-dependent toll-like receptor signaling pathway	BP
2	58	0.460702617543	-	6.55e-01	GO:0045732	positive regulation of protein catabolic process	BP
3	87	0.460702617543	-	4.30e-01	GO:0001227	transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding	MF
1	29	0.460702617543	-	4.83e-01	GO:0042056	chemoattractant activity	MF
1	29	0.460702617543	-	4.83e-01	GO:0001103	RNA polymerase II repressing transcription factor binding	MF
1	29	0.460702617543	-	4.96e-01	GO:0004003	ATP-dependent DNA helicase activity	MF
3	88	0.444214494754	-	3.22e-02	GO:0006956	complement activation	BP
12	354	0.436040563309	-	2.04e-01	GO:0008283	cell proliferation	BP
2	59	0.436040563309	-	2.74e-01	GO:0007338	single fertilization	BP
2	59	0.436040563309	-	3.67e-01	GO:0042102	positive regulation of T cell proliferation	BP
6	177	0.436040563309	-	6.46e-02	GO:0030246	carbohydrate binding	MF
2	59	0.436040563309	-	3.49e-01	GO:0005546	phosphatidylinositol-4,5-bisphosphate binding	MF
2	59	0.436040563309	-	3.58e-01	GO:0004175	endopeptidase activity	MF
2	59	0.436040563309	-	3.94e-01	GO:0000979	RNA polymerase II core promoter sequence-specific DNA binding	MF
12	356	0.427912682425	-	1.30e-01	GO:0005102	receptor binding	MF
17	505	0.426006876282	-	1.47e-02	GO:0030154	cell differentiation	BP
7	208	0.425598816587	-	3.43e-01	GO:0006974	cellular response to DNA damage stimulus	BP
8	238	0.423865849363	-	8.66e-02	GO:0007166	cell surface receptor signaling pathway	BP
4	119	0.423865849363	-	3.10e-01	GO:0006935	chemotaxis	BP
2	60	0.411793017062	-	3.76e-01	GO:0050727	regulation of inflammatory response	BP
1	30	0.411793017062	-	4.28e-01	GO:0006637	acyl-CoA metabolic process	BP
1	30	0.411793017062	-	4.56e-01	GO:0099132	ATP hydrolysis coupled cation transmembrane transport	BP
1	30	0.411793017062	-	4.70e-01	GO:0031667	response to nutrient levels	BP
1	30	0.411793017062	-	4.70e-01	GO:0007163	establishment or maintenance of cell polarity	BP
1	30	0.411793017062	-	4.70e-01	GO:0009953	dorsal/ventral pattern formation	BP
1	30	0.411793017062	-	4.96e-01	GO:0021915	neural tube development	BP
1	30	0.411793017062	-	5.09e-01	GO:0042177	negative regulation of protein catabolic process	BP
1	30	0.411793017062	-	5.33e-01	GO:0006352	DNA-templated transcription, initiation	BP
1	30	0.411793017062	-	5.33e-01	GO:0036258	multivesicular body assembly	BP
1	30	0.411793017062	-	5.33e-01	GO:0009314	response to radiation	BP
1	30	0.411793017062	-	5.33e-01	GO:0090307	mitotic spindle assembly	BP
2	60	0.411793017062	-	6.52e-01	GO:0030334	regulation of cell migration	BP
7	210	0.411793017062	-	3.54e-01	GO:0044212	transcription regulatory region DNA binding	MF
1	30	0.411793017062	-	4.56e-01	GO:0016874	ligase activity	MF
2	60	0.411793017062	-	6.55e-01	GO:0003725	double-stranded RNA binding	MF
2	61	0.387946275108	-	2.65e-01	GO:0007416	synapse assembly	BP
2	61	0.387946275108	-	4.02e-01	GO:0006302	double-strand break repair	BP
34	1041	0.382392100622	-	2.18e-02	GO:0045944	positive regulation of transcription from RNA polymerase II promoter	BP
4	123	0.376169107331	-	1.55e-01	GO:0019221	cytokine-mediated signaling pathway	BP
26	801	0.373464898403	-	9.14e-02	GO:0042802	identical protein binding	MF
11	339	0.372973768172	-	2.75e-01	GO:0051301	cell division	BP
6	186	0.364487302284	-	3.50e-02	GO:0050776	regulation of immune response	BP
4	124	0.364487302284	-	3.35e-01	GO:0030036	actin cytoskeleton organization	BP
1	31	0.364487302284	-	3.83e-01	GO:0006821	chloride transport	BP
1	31	0.364487302284	-	4.56e-01	GO:0030073	insulin secretion	BP
1	31	0.364487302284	-	4.83e-01	GO:0048286	lung alveolus development	BP
1	31	0.364487302284	-	4.96e-01	GO:0060412	ventricular septum morphogenesis	BP
1	31	0.364487302284	-	4.96e-01	GO:0072332	intrinsic apoptotic signaling pathway by p53 class mediator	BP
1	31	0.364487302284	-	5.21e-01	GO:0034504	protein localization to nucleus	BP
1	31	0.364487302284	-	5.33e-01	GO:0019058	viral life cycle	BP
1	31	0.364487302284	-	5.09e-01	GO:1990841	promoter-specific chromatin binding	MF
17	528	0.361752334562	-	1.31e-01	GO:0006915	apoptotic process	BP
5	156	0.355209488696	-	2.64e-01	GO:0006511	ubiquitin-dependent protein catabolic process	BP
16	501	0.350016819475	-	3.21e-03	GO:0006508	proteolysis	BP
47	1472	0.349710508291	-	8.18e-03	GO:0005524	ATP binding	MF
3	94	0.349057261714	-	1.71e-01	GO:0005179	hormone activity	MF
2	63	0.341403689171	-	3.76e-01	GO:0007613	memory	BP
2	63	0.341403689171	-	3.85e-01	GO:0008203	cholesterol metabolic process	BP
2	63	0.341403689171	-	6.69e-01	GO:0007059	chromosome segregation	BP
2	63	0.341403689171	-	6.69e-01	GO:0043130	ubiquitin binding	MF
4	128	0.318683612671	-	1.45e-01	GO:0005975	carbohydrate metabolic process	BP
8	256	0.318683612671	-	3.90e-01	GO:0007049	cell cycle	BP
2	64	0.318683612671	-	3.94e-01	GO:0072659	protein localization to plasma membrane	BP
1	32	0.318683612671	-	4.28e-01	GO:1900087	positive regulation of G1/S transition of mitotic cell cycle	BP
1	32	0.318683612671	-	4.56e-01	GO:0048701	embryonic cranial skeleton morphogenesis	BP
1	32	0.318683612671	-	4.70e-01	GO:0007498	mesoderm development	BP
1	32	0.318683612671	-	4.96e-01	GO:0001654	eye development	BP
1	32	0.318683612671	-	5.21e-01	GO:0007585	respiratory gaseous exchange	BP
1	32	0.318683612671	-	5.33e-01	GO:0043967	histone H4 acetylation	BP
1	32	0.318683612671	-	5.33e-01	GO:0070555	response to interleukin-1	BP
1	32	0.318683612671	-	3.51e-01	GO:0052689	carboxylic ester hydrolase activity	MF
3	96	0.318683612671	-	4.86e-01	GO:0003697	single-stranded DNA binding	MF
10	322	0.309694829443	-	3.62e-01	GO:0016032	viral process	BP
5	162	0.300761704673	-	2.43e-01	GO:0008083	growth factor activity	MF
2	65	0.296315799642	-	3.49e-01	GO:0030512	negative regulation of transforming growth factor beta receptor signaling pathway	BP
2	65	0.296315799642	-	3.58e-01	GO:0030574	collagen catabolic process	BP
2	65	0.296315799642	-	6.52e-01	GO:0050796	regulation of insulin secretion	BP
7	229	0.286834746631	-	3.81e-01	GO:0061024	membrane organization	BP
1	33	0.274289493312	-	3.98e-01	GO:0006865	amino acid transport	BP
1	33	0.274289493312	-	5.09e-01	GO:0006298	mismatch repair	BP
1	33	0.274289493312	-	5.09e-01	GO:0051262	protein tetramerization	BP
2	66	0.274289493312	-	6.69e-01	GO:0046330	positive regulation of JNK cascade	BP
1	33	0.274289493312	-	3.98e-01	GO:0004869	cysteine-type endopeptidase inhibitor activity	MF
1	33	0.274289493312	-	5.33e-01	GO:0016791	phosphatase activity	MF
1	33	0.274289493312	-	5.33e-01	GO:0032266	phosphatidylinositol-3-phosphate binding	MF
1	33	0.274289493312	-	5.45e-01	GO:0005154	epidermal growth factor receptor binding	MF
1	33	0.274289493312	-	5.56e-01	GO:0001104	RNA polymerase II transcription cofactor activity	MF
2	66	0.274289493312	-	6.66e-01	GO:0003705	transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding	MF
3	100	0.259789923617	-	7.37e-01	GO:0000082	G1/S transition of mitotic cell cycle	BP
2	67	0.252594422213	-	6.72e-01	GO:0051259	protein oligomerization	BP
2	67	0.252594422213	-	6.82e-01	GO:0038061	NIK/NF-kappaB signaling	BP
2	67	0.252594422213	-	6.79e-01	GO:0001047	core promoter binding	MF
11	372	0.2389564202	-	2.71e-01	GO:0005525	GTP binding	MF
1	34	0.23122077142	-	5.45e-01	GO:0032480	negative regulation of type I interferon production	BP
1	34	0.23122077142	-	5.78e-01	GO:0032212	positive regulation of telomere maintenance via telomerase	BP
8	272	0.23122077142	-	3.95e-01	GO:0001077	transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding	MF
1	34	0.23122077142	-	5.68e-01	GO:0048487	beta-tubulin binding	MF
1	34	0.23122077142	-	5.78e-01	GO:0051020	GTPase binding	MF
22	755	0.217782397095	-	2.02e-01	GO:0000122	negative regulation of transcription from RNA polymerase II promoter	BP
3	103	0.217145586209	-	4.59e-01	GO:0010468	regulation of gene expression	BP
2	69	0.210159155892	-	6.66e-01	GO:0006887	exocytosis	BP
2	69	0.210159155892	-	6.72e-01	GO:0050790	regulation of catalytic activity	BP
1	35	0.189400595726	-	4.96e-01	GO:0035094	response to nicotine	BP
1	35	0.189400595726	-	4.96e-01	GO:0006487	protein N-linked glycosylation	BP
1	35	0.189400595726	-	5.09e-01	GO:0002062	chondrocyte differentiation	BP
1	35	0.189400595726	-	5.45e-01	GO:0033574	response to testosterone	BP
1	35	0.189400595726	-	5.56e-01	GO:0006641	triglyceride metabolic process	BP
1	35	0.189400595726	-	5.56e-01	GO:0006418	tRNA aminoacylation for protein translation	BP
1	35	0.189400595726	-	5.68e-01	GO:0048536	spleen development	BP
2	70	0.189400595726	-	6.76e-01	GO:0001889	liver development	BP
1	35	0.189400595726	-	5.89e-01	GO:0070491	repressing transcription factor binding	MF
4	141	0.179132260272	-	5.45e-01	GO:0051056	regulation of small GTPase mediated signal transduction	BP
3	106	0.175725658829	-	4.70e-01	GO:0005178	integrin binding	MF
2	71	0.168936493166	-	6.95e-01	GO:0051436	negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle	BP
6	214	0.162179126991	-	4.69e-01	GO:0000977	RNA polymerase II regulatory region sequence-specific DNA binding	MF
2	72	0.148758611228	-	2.28e-01	GO:0016042	lipid catabolic process	BP
1	36	0.148758611228	-	4.56e-01	GO:0010811	positive regulation of cell-substrate adhesion	BP
1	36	0.148758611228	-	5.45e-01	GO:0051209	release of sequestered calcium ion into cytosol	BP
1	36	0.148758611228	-	5.45e-01	GO:0010942	positive regulation of cell death	BP
1	36	0.148758611228	-	5.78e-01	GO:0007223	Wnt signaling pathway, calcium modulating pathway	BP
1	36	0.148758611228	-	5.89e-01	GO:0006953	acute-phase response	BP
1	36	0.148758611228	-	5.99e-01	GO:0032781	positive regulation of ATPase activity	BP
2	72	0.148758611228	-	6.57e-01	GO:0098869	cellular oxidant detoxification	BP
4	144	0.148758611228	-	5.49e-01	GO:0001228	transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding	MF
1	36	0.148758611228	-	5.89e-01	GO:0019888	protein phosphatase regulator activity	MF
1	36	0.148758611228	-	5.99e-01	GO:0004879	RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding	MF
2	72	0.148758611228	-	6.92e-01	GO:0000980	RNA polymerase II distal enhancer sequence-specific DNA binding	MF
12	436	0.135461788615	-	9.03e-02	GO:0045087	innate immune response	BP
4	146	0.128859053791	-	5.65e-01	GO:0016887	ATPase activity	MF
2	73	0.128859053791	-	6.76e-01	GO:0001618	virus receptor activity	MF
4	147	0.119011267834	-	5.63e-01	GO:0051015	actin filament binding	MF
2	74	0.109230247042	-	2.37e-01	GO:0050853	B cell receptor signaling pathway	BP
1	37	0.109230247042	-	4.96e-01	GO:0008202	steroid metabolic process	BP
1	37	0.109230247042	-	5.21e-01	GO:0001942	hair follicle development	BP
1	37	0.109230247042	-	5.56e-01	GO:0032720	negative regulation of tumor necrosis factor production	BP
1	37	0.109230247042	-	5.68e-01	GO:0006749	glutathione metabolic process	BP
1	37	0.109230247042	-	5.89e-01	GO:0034446	substrate adhesion-dependent cell spreading	BP
1	37	0.109230247042	-	5.89e-01	GO:0007098	centrosome cycle	BP
1	37	0.109230247042	-	5.99e-01	GO:0000183	chromatin silencing at rDNA	BP
1	37	0.109230247042	-	6.09e-01	GO:0006296	nucleotide-excision repair, DNA incision, 5'-to lesion	BP
2	74	0.109230247042	-	7.02e-01	GO:0061418	regulation of transcription from RNA polymerase II promoter in response to hypoxia	BP
1	37	0.109230247042	-	6.09e-01	GO:0070888	E-box binding	MF
4	150	0.0898649221747	-	7.89e-01	GO:0006367	transcription initiation from RNA polymerase II promoter	BP
11	413	0.0881172598885	-	3.83e-01	GO:0006357	regulation of transcription from RNA polymerase II promoter	BP
3	113	0.0834671509766	-	5.20e-01	GO:0007219	Notch signaling pathway	BP
1	38	0.070756099227	-	4.42e-01	GO:0048468	cell development	BP
1	38	0.070756099227	-	5.68e-01	GO:0045184	establishment of protein localization	BP
1	38	0.070756099227	-	5.78e-01	GO:0045214	sarcomere organization	BP
1	38	0.070756099227	-	6.09e-01	GO:0008333	endosome to lysosome transport	BP
1	38	0.070756099227	-	6.09e-01	GO:0006289	nucleotide-excision repair	BP
1	38	0.070756099227	-	6.19e-01	GO:0030049	muscle filament sliding	BP
1	38	0.070756099227	-	6.19e-01	GO:0031623	receptor internalization	BP
1	38	0.070756099227	-	6.19e-01	GO:0033683	nucleotide-excision repair, DNA incision	BP
2	76	0.070756099227	-	7.13e-01	GO:0051437	positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition	BP
1	38	0.070756099227	-	4.56e-01	GO:0004519	endonuclease activity	MF
1	38	0.070756099227	-	6.09e-01	GO:0005484	SNAP receptor activity	MF
12	457	0.0675957583337	-	2.14e-01	GO:0007275	multicellular organism development	BP
7	269	0.0545761721716	-	6.74e-01	GO:0016579	protein deubiquitination	BP
2	77	0.0518970719757	-	6.76e-01	GO:0043085	positive regulation of catalytic activity	BP
2	77	0.0518970719757	-	6.95e-01	GO:0003690	double-stranded DNA binding	MF
4	156	0.0332813938084	-	1.36e-01	GO:0007156	homophilic cell adhesion via plasma membrane adhesion molecules	BP
5	195	0.0332813938084	-	4.35e-01	GO:0030198	extracellular matrix organization	BP
1	39	0.0332813938084	-	4.56e-01	GO:2000134	negative regulation of G1/S transition of mitotic cell cycle	BP
1	39	0.0332813938084	-	5.78e-01	GO:0060291	long-term synaptic potentiation	BP
1	39	0.0332813938084	-	4.56e-01	GO:0022857	transmembrane transporter activity	MF
1	39	0.0332813938084	-	5.09e-01	GO:0015459	potassium channel regulator activity	MF
2	79	0.0149028644935	-	6.82e-01	GO:0007626	locomotory behavior	BP
2	79	0.0149028644935	-	6.82e-01	GO:0005543	phospholipid binding	MF
